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 Summary 
Fibroblast Growth Factor (FGF) signalling is involved in numerous 
developmental processes ranging from cell determination to mitogenesis, and 
cell survival to cell migration. Interestingly, the same signalling pathway is used 
reiteratively throughout development and the question regarding the intracellular 
specificity is raised. 
Little is known about the intracellular signalling events of the FGF signalling 
pathway leading to specific cellular responses. Since the FGF signal is essential 
throughout embryonic and adult development and plays a role in many 
pathogenical processes, it is important to identify the factors, which determine 
the differential responses. 
We were interested to investigate the specificity of FGF signalling in a 
developmental context in which the signal induces directed cell migration, a 
cellular phenomenon that relies on changes of the cytoskeletal architecture. 
During gastrulation in early embryonic development, but also during the 
formation of organs in mammals and in Drosophila, FGFs have been shown to 
act as chemoattractants and guide cells toward their targets. In these contexts, 
FGF signalling has been shown to induce filopodia, which are long cellular 
extensions containing parallel actin bundles. 
Using Drosophila tracheal and mesodermal cell migration as model systems, 
we found that the intracellular domain of the two Drosophila FGF receptors 
(FGFRs) Breathless (Btl) and Heartless (Htl) can be replaced by the equivalent 
domains of Torso and EGFR, and yet these hybrid receptors will rescue cell 
migration in btl or htl mutant embryos, respectively. These chimeric receptors 
rescued cell migration even in the absence of Downstream-of-FGFR (Dof), a 
scaffolding protein that has been shown to be essential for FGF signalling in 
Drosophila. Thus, Dof acts specifically in the FGF signalling pathway. The 
functional characterization of Dof has demonstrated that Dof is indeed a FGFR 
specific phosphotarget and forms a complex with both FGFRs, but it is not a 
substrate of Torso.  
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We performed a functional deletion analysis of the Btl receptor to define the 
interaction domains of Dof and other putative adapter proteins essential in the 
process of cell migration. Deletion of all putative interaction domains outside of 
the kinase domain did not affect the rescue capacity of the truncated Btl 
receptors in vivo suggesting that the kinase domain is sufficient for transmitting 
the signal. In line with this interpretation, results from S2 cell culture 
experiments revealed that Dof interacts with the kinase domain, and it does so 
independently of the activation state of the receptor. Surprisingly, in S2 cells, Btl 
receptors lacking the C-terminus did not auto-phosphorylate, as consequence 
we could not observe phosphorylation of Dof. We assume, that the short C-
terminus is required for conformational changes of the kinase activation loop 
upon dimerization of the receptors to enable trans-phosphorylation. 
Dof belongs to a distinct family of adapter proteins than its functional 
homologue, the vertebrate FGFR adapter protein FRS2 that has been shown to 
constitutively interact with the juxtamembrane domain of the FGFRs. We could 
show that the human FGFR2, when expressed in the tracheal system, is only 
able to rescue cell migration defects effectively in the presence of Dof. These 
results suggest that Dof is able to interact with human FGFRs. At present, there 
is no evidence for a FRS2 homologue in Drosophila that might act as substitute 
for Dof.  
Upon receptor activation, Dof recruits the phosphatase Corkscrew (Csw), the 
Drosophila Shp2 homologue. Csw recruitment represents an essential step in 
FGF induced cell migration and transcriptional activation via the Ras/MAPK 
cascade. However, our results indicate that the activation of Ras is not sufficient 
to activate the migration machinery in tracheal and mesodermal cells. Ectopic 
activation of the Ras/MAPK cascade partially rescued tracheal cell migration in 
btl or dof mutant embryos. But high levels of sustained activation of Ras or the 
MAPK in wild-type tracheal cells did not disturb the migratory behaviour of the 
cells in contrast to ectopic activation of Branchless (Bnl), the Drosophila FGF 
homologue, which completely impaired primary branch outgrowth. In a wild-type 
tracheal system, MAPK activity is restricted to the tracheal tip cells. Single cell 
rescue experiments indicate that Bnl induces the migratory response 
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exclusively in the tip cells of the outgrowing tracheal branches; the stalk cells 
are pulled forward by cell-cell adhesion contacts. 
The small GTPases of the Rho family have been shown to regulate cytoskeletal 
rearrangements. For tracheal development, Dcdc42 could function in 
collaboration with Drac in the regulation of actin dynamics according to our 
experiments. Additional proteins linking either Dof or Csw to the small GTPases 
have to be identified.  
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 Introduction FGF signalling 
The Fibroblast Growth Factors (FGFs) constitute a large family of proteins that 
act in a wide range of developmental and pathological processes. The biological 
functions of FGFs include the regulation of cell proliferation, differentiation, 
survival, motility and tissue patterning.  
In early and late embryogenesis, FGF signalling is essential for mesoderm 
induction, midbrain development and patterning of the neural plate, proper 
development and branching of the lung, the development of the skin and the 
growth and patterning of the limbs and skeletogenesis. 
In the adult, FGFs are involved in tissue repair, wound healing and neurite 
outgrowth, as well as in the maintenance of the vasculature system and the 
migration in angiogenesis. 
 
By their spatially and temporally restricted availability, FGFs act as ligands at 
the outside of the cells ensuring correct activation of the FGF receptors 
(FGFRs) that belong to the receptor tyrosine kinase (RTK) family. However, 
FGF signalling is reiteratively used and intracellular signalling components are 
highly conserved within the RTK signalling. The question arises, how 
intracellular specificity is achieved resulting in all the distinct cellular responses. 
Why is the same signalling pathway interpreted differently in different tissues? 
One model proposes intrinsic differences in the intracellular signalling pathway. 
A second model suggests that specificity arises from differences in the 
magnitude or duration of MAPK activation, one of the conserved components of 
RTK signalling (Halfar et al., 2001; Marshall, 1995). And finally, a third model 
postulates that RTKs generally act via the same signalling cassette, producing a 
generic signal, but cells interpret these signals according to their distinct 
developmental histories (Simon, 2000). 
 
This introduction focuses on one specific cellular response to FGF signalling, 
namely the induction of cell motility during distinct processes of embryonic 
development. 
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Diverse migratory processes of vertebrate embryonic development are 
compared to the fruit fly Drosophila melanogaster, a model organism to study 
the basic strategies underlying development. Most developmental processes 
have been conserved among multicellular organisms. 
Furthermore, the introduction gives an overview about the molecular players 
and regulators in the FGF signalling pathway acting upstream and downstream 
of the FGFR in Vertebrates and in Drosophila. 
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I. Characterisation of the FGFRs and downstream 
signalling cascades 
In human and mice, 23 FGFs exist which are ca. 30-70% identical in their 
primary amino acid sequences and are proteolytically processed. So far 4 FGFs 
have been identified in zebrafish, 7 in Xenopus and 7 in chicken. In 
invertebrates only one FGF homologue Branchless (Bnl) has been identified in 
Drosophila and two in Caenorhabditis elegans (Egl17 and Let756) (Ornitz and 
Itoh, 2001). 
Most FGFs have amino-terminal signal peptides and are secreted from the 
cells. Some FGFs are not secreted, but however, are found on the cell surface 
within the extracellular matrix (FGF1 or acidic FGF, FGF2 or basic FGF). Some 
remain intracellular because they lack the classical signal sequence that allows 
efficient export from the cell. FGF1 stimulates in vitro endothelial cell migration 
and proliferation. FGF2 exists as a cytoplasmic 18-kDa isoform and four high 
molecular weight (HMW) isoforms that are nuclear based. A new identified 
protein called translokin, which is associated with the microtubular network, 
specifically binds FGF2. Mutation of the nuclear targeting sequence of 
translokin or RNAi interference abrogates the intracellular translocation of FGF2 
(Auguste et al., 2003). HMW isoforms but not the 18-kDa isoform of FGF2 have 
a N-terminal sequence responsible for the nuclear targeting/retention signal. 
Dominant negative strategies in cultured cells demonstrated that HMW FGF 
stimulate DNA synthesis independent of cell surface receptors to induce the 
mitogenic response, but the exact role of intracellular FGF still has to be 
elucidated (Auguste et al., 2003; Ornitz and Itoh, 2001; Powers et al., 2000). 
In vertebrates, 4 structurally related FGFR exist and alternative splicing results 
in even more receptor variations. 
The expression patterns of the FGFR are distinct but overlapping during 
embryonic development. In the mouse embryo FGFR1 is expressed in the 
mesenchyme and predominantly in the brain, FGFR2 in several epithelial 
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tissues, FGFR3 predominantly in the brain, spinal chord and cartilage rudiments 
of the developing bone and FGFR4 in tissues of endodermal and mesodermal 
origin (Klint and Claesson-Welsh, 1999).  
1. The extracellular domain of FGFRs 
All receptors consist of an extracellular domain with 3 Immunoglobulin-like 
domains (Ig-like domains), a stretch of acidic amino acids between Ig-like 
domain 1 and 2 that is unique for FGFRs and a heparin-binding domain. 
FGFR1-3 have different splice variants, these receptors either have two or three 
Ig-like domains. Two Ig domain variants may or may not have the acidic box 
and the receptors may even lack the transmembrane and intracellular parts. A 
splice variant of FGFR3 for example, in which the transmembrane domain is 
deleted, was reported to be localised into the nucleus (Klingelberg Diss). The 
third Ig-like domain can be spliced into IIIb or IIIc isoforms that have different 
ligand binding specificity. Ligand binding and specificity resides in IgII and IgIII 
and the linker that connects them (Plotnikov et al., 2000). 
Heparan sulfate proteoglycans (HSPGs) such as syndecan and glypican are a 
class of molecules that act as coreceptors of FGFRs and stabilise ligand-
receptor complex formation. Proteoglycans are abundant components of the 
extracellular matrix and are composed of core proteins with covalently attached 
modified glycosaminoglycan (GAG) polysaccharide polymer side chains. All 
heparan GAG chains undergo some N-deacetylation/N-sulfation and O-sulfation 
and they are referred as heparan sulfate (HS). Sulfation is responsible for the 
majority of the structural diversity of HS chains and different FGFs have 
different affinities for unique HS sequences. This suggests that tissue specific 
pattern of O-sulfation and the local concentration of HS can regulate the activity 
and specificity of FGFs (Nybakken and Perrimon, 2002; Ornitz, 2000).  
Crystallography experiments have shown that a minimal complex of 
FGF2/FGFR1 in the absence of heparin/HS is formed (Plotnikov et al., 2000; 
Plotnikov et al., 1999). This minimal complex allows transient receptor 
dimerization and may signal at high ligand concentrations. Heparin/HS and a 
second FGF molecule are required to stabilise the active complex to gain a 
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sustained specific intracellular response. One model suggests that heparin 
interacts with both FGF and FGFR and promotes the formation of a stable 1:1:1 
FGF:FGFR:heparin ternary complex. A second ternary complex is then 
recruited to the first complex via direct FGFR:FGFR contacts, secondary 
interactions between FGF in one ternary complex and FGFR in the other 
complex, and indirect heparin-mediated FGFR-FGFR contacts. There are no 
direct FGF-FGF interactions. One role of the acidic box laying between IgI and 
IgII could be that it competes for the binding of heparin to the basic heparin 
binding domain of FGFR thereby providing an autoinhibitory effect (Plotnikov et 
al., 1999).  
In lazy mesoderm (lzme) mutant mice, the UDP-glucose dehydrogenase, an 
enzyme required for the synthesis of the glycosaminoglycan side chains of the 
proteoglycans is not produced. In this mutant, GAG production is blocked and 
FGF signalling is disrupted downstream of FGF ligand expression since 
expression of FGF signalling target genes is reduced as for example mspry2 
comparable to FGF8-/- embryos (Garcia-Garcia and Anderson, 2003).  
2. The intracellular domain of FGFRs 
FGFRs have a transmembrane domain followed by the intracellular part that 
consists of a long juxtamembrane domain, a split tyrosine kinase domain with 
an N-terminal lobe and a C-terminal lobe and a short C-Terminus. 
Binding of two FGFs lead to receptor dimerization, conformational changes and 
autophosphorylation of the receptors on 7 conserved tyrosines.  
The kinase domain contains two functionally important binding sites, the ATP 
binding site and the substrate binding site. In the unphosphorylated FGFR1 the 
ATP binding site is accessible while the substrate binding site is blocked in the 
so-called activation loop. When another FGFR molecule comes close, the 
activation loop changes its conformation, the two conserved tyrosine residues in 
the activation loop (Y653 and Y654) get trans-phosphorylated thereby 
upregulating the kinase activity and the phosphorylation of the other 5 
phosphotyrosine residues (Klingenberg Dissertation). Two tyrosine residues Tyr 
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677 and 701 in the C-terminal lobe are not sites of autophosphorylation but they 
play a role in the stabilisation of the activation loop (Foehr et al., 2001). 
The remaining 3 phosphotyrosines are potential binding sites for Src homology 
2 (SH2) or phosphotyrosine binding domain (PTB) containing adapter proteins. 
SH2 domains are 100 aa residue long conserved motifs that are found in 
different enzymes or in proteins that lack enzymatic activities denoted as 
adapters. SH2 containing proteins are affected by binding to the receptor, either 
by tyrosine phosphorylation, and conformational changes and by increased 
availability of their substrates giving rise to a cellular response. The same is true 
for PTB domain proteins that contain the 100-150aa conserved domain. 
In the juxtamembrane domain of FGFR1 and FGFR2, there is one 
phosphorylated tyrosine motif (Y463) that serves as binding site of the adapter 
Crk (FGFR3 and FGFR4 lack the tyrosine in the juxtamembrane domain). Crk 
binds the guanine nucleotide exchange factor C3G that has been shown to 
activate the monomeric GTPase Rap1 to mediate sustained activation of the 
Mitogen-activated protein kinase (MAPK) ERK1 and 2. 
Two phosphorylated tyrosines are in the kinase insert domain of FGFR1 and 2 
(Y583, Y585), one in FGFR3 and none in FGFR4. The kinase insert tyrosine 
residues appear to be dispensable for FGFR1. Finally, the C-terminus (Y766) 
serves as binding site for PLCγ and the adapter Shb (Klint and Claesson-Welsh, 
1999). Binding of PLCγ to the activated FGFR1 leads to its translocation to the 
plasmamembrane and subsequent phosphorylation upon FGFR1. At the 
plasmamembrane, PLCγ catalyses the hydrolysis of phosphoinositol lipids to 
inositol phosphates and diacylglycerol, which in turn stimulate the release of 
intracellular Ca2+ and activation of the protein kinase C (PKC).  
Experiments have shown that PLCγ-activation is neither required for FGFR1 
mediated mitogenesis, nor for chemotaxis nor for neurite outgrowth (Klint and 
Claesson-Welsh, 1999).  
Shb is an ubiquitously expressed adapter protein containing SH2 and PTB 
domains. Interestingly, Shb binds to the same tyrosine motif at the C-terminus 
as PLCγ and according to experiments they don’t compete for each other 
(Cross et al., 2002). 
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3. Different cellular responses elicited by FGFR1  
The FGFR1 is the best-characterised FGFR and intensive studies about the 
interaction with downstream signalling components have been done. 
3.1 The MAPK cascade 
In contrast to other RTKs, all FGFRs lack a Grb2 binding site. The adapter Grb2 
is constitutively bound to the guanine nucleotide exchange factor (GEF) Son of 
Sevenless (SOS). SOS catalyses the exchange of GDP for GTP on Ras, 
thereby activating Ras which is tethered to the membrane by farnesylation. 
GTP-bound Ras binds the N-terminal domain of the serine/threonine kinase Raf 
targeting Raf to the membrane which is sufficient for its activation. Raf then 
phosphorylates and activates the dual specificity kinase MEK that finally 
activates and phosphorylates the MAPK, ERK1 and ERK2. Oligomers of the 
activated and phosphorylated MAPK ERK1 and 2 enter the nucleus and 
phosphorylate transcription factors thereby regulating the expression of certain 
genes for a given cellular response. 
3.2 The adapter FGFR substrate 2 (FRS2) 
In vertebrate FGF signalling, Grb2 is recruited to the FGFR by FRS2 (FGF 
receptor substrate 2, also called suc1-associated neurotrophic factor target, 
SNT-1) (Kouhara et al., 1997). FRS2 is a membrane associated (myristoylated) 
multiadapter protein that binds constitutively to a stretch of the juxtamembrane 
domain of the FGFR1 (407-433aa) with its N-terminal PTB domain in a 
phosphotyrosine independent interaction. PTB domains usually interact with the 
canonical NPXY motif or asparagine residues, but the juxtamembrane domain 
lacks this motif or asparagine residues. That is unique and it was suggested 
that FRS2 transiently contacts the FGFR prior to receptor activation (Ong et al., 
2000a; Xu et al., 1998).  
Nuclear magnetic resonance (NMR) studies have shown that the PTB domain 
of FRS2 possesses unique features. The most important difference is that the 
PTB domain contains an additional β-strand (β8) that is essential for the 
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interaction with the conserved domain of the juxtamembrane domain of FGFR1 
(Dhalluin et al., 2000). At the C-terminus, FRS2 contains multiple tyrosine 
phosphorylation domains, among those 4 Grb2 binding sites and two binding 
sites for the protein tyrosine phosphatase Shp2 that carries an additional Grb2 
binding site. Thus, Grb2/SOS complexes are recruited either directly or 
indirectly via Shp2 upon tyrosine phosphorylation of FRS2 in response to FGF 
stimulation. The C-terminus of FRS2 is required for the recruitment of SOS 
either to contact SOS directly or through intermediate proteins (Hadari et al., 
2001; Xu and Goldfarb, 2001; Xu et al., 1998). 
Two isoforms of FRS2 exist, they are highly homologous, but they have a 
different expression pattern. FRS2α is expressed ubiquitously and can be 
detected at every developmental stage of the mouse, whereas the expression 
of FRS2β begins at day 9 and is primarily confined to tissues of neuronal origin. 
In contrast to FRS2α, FRS2β does not bind constitutively to the juxtamembrane 
domain of FGFRs but only to activated TrkA receptors to a canonical tyrosine 
phosphorylated NPXY motif (Lax et al., 2002). 
3.3 The mitogenic response 
FGFs are potent inducers of DNA synthesis in multiple cell types. For the 
mitogenic response, complex formation of the two adapters FRS2 at the 
juxtamembrane domain, Shb at the C-terminus and the phosphatase Shp2 is 
required for maximal and sustained activation of the MAPK. Shb probably 
directly regulates phosphorylation and association of Shp2 with FRS2. The 
mechanism whereby Shp2 regulates FRS2 phosphorylation state and MAPK 
activation remains unclear, although it has been demonstrated that the catalytic 
domain of Shp2 is required for sustained MAPK activation (Cross et al., 2002; 
Hadari et al., 1998). In addition to the plasma membrane Ras activation 
pathway, Ras is activated on intracellular membranes of the Golgi apparatus 
and the endoplasmic reticulum upon RTK stimulation. Endomembrane Ras may 
be particularly important for sustained Ras activation. It has been described that 
endomembrane Ras activation requires the Src family kinases (SFKs) and 
recent studies have shown that Shp2 activates the SFKs. 
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In addition, Shp2 probably dephosphorylates the negative RTK regulator 
Sprouty (Spry) (Zhang et al., 2004). 
There is a first hint that sustained activation of the MAPK by Shp2 results in 
mitogenic activation of the cell. Also the adapter Crk seems to be involved in 
mitogenic signalling (Hadari et al., 2001). And the protein kinases C λ and ζ 
have been shown to interact with FRS2 following FGF stimulation activating 
mitogenic signalling via the MAPK cascade (Lim et al., 1999). 
 
Figure 1: Schematic representation of the mitogenic FGF signalling response.  
 
 
3.4 The cell survival response 
Recruitment and phosphorylation of the docking protein Gab1 to FRS2 
associated Grb2 activates the cell survival pathway via the PI3 kinase. Gab1 
binds constitutively to the SH3 domain of Grb2. Gab1 like FRS2 belongs to the 
family of scaffolding adapter proteins that are targeted to specific membrane 
lipids with their N-terminal pleckstrin homology domain (PH). It contains multiple 
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potential tyrosine, serine or threonine phosphorylation sites. The Drosophila 
homologue is Daughter of Sevenless (Dos) that was identified as potential 
substrate of Corkscrew (Csw), the Drosophila Shp2 ortholog. Soc1, the C. 
elegans homologue was found in a screen for suppressors of hyperactive Egl-
15, the FGF receptor ortholog. 
Interestingly, mammalian Gabs and Dos contain two Shp2/Csw binding sites 
(Gu and Neel, 2003). 
 
 
 
3.5 
There
respo
bindin
respo
 Figure 2: Schematic representation of the cell survival FGF signalling complex. The migratory response 
 is evidence that activation of Shp2 is required to elicit the migratory 
nse (Hadari et al., 2001; Rosario and Bircmeier, 2003). When the Shp2 
g sites of FRS2 are mutated, Grb2 can partially restore the chemotactic 
nse. Thus, there are some redundancies in the function of the molecules.  
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It was also shown that the adapter Shb forms additionally to Shp2 a complex 
with Src and the focal adhesion kinase (FAK), a serine-threonine kinase that 
interacts with integrins. Integrins play a role in the regulation of focal adhesion 
assembly and disassembly, a process important during cell movement. Upon 
activation and phosphorylation of FAK in response to integrin mediated cell 
adhesion or cellular stimulation by agonists, FAK associates with Src. Shp2 
promotes Src activation indirectly. It was shown that Shp2 dephosphorylates 
PAG , a transmembrane glycoprotein, thereby inhibiting the recruitment of Csk 
to PAG. Csk is responsible for the C-terminal inhibitory phosphorylation of Src 
(Zhang et al., 2004).  
Dependent on the activity of RhoA, Src transits from the perinuclear region to 
the cell periphery requiring actin stress fibres to incorporate into focal adhesions 
or into smaller focal complexes at lamellipodia and filopodia. There, Src 
phosphorylates a number of focal adhesion components including paxillin, 
tensin and p130 Crk associated substrate CAS and also the p190RhoGAP 
(Holmqvist et al., 2003; Timpson et al., 2001). The role of FAK and Src is 
thought to be in the turnover of focal adhesions (Webb et al., 2004).  
It has also been shown that FAK overexpression stimulates cellular migration, 
whereas removal of FAK decreases migration, which is associated with an 
increase in the number of focal adhesions and stress fibres (Ilic et al., 1995). 
Interestingly, cells lacking Shp2 show hyperphosphorylation of FAK, increased 
numbers of focal adhesions at the cell periphery and a decreased migratory 
capacity similar to FAK-/- cells (Larsen et al., 2003). 
In cell culture experiments, it was also shown that the urokinase type 
plasminogen activator (uPA), a proteolytic enzyme is upregulated upon FGF 
stimulation. uPA is involved in the extracellular matrix breakdown. Experiments 
in L6 myoblasts proposed that the Y463 and Y730 of FGFR1 could be essential 
for FGF2-mediated uPA induction (Boilly et al., 2000). 
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 Figure 3: Schematic representation of the migratory FGF signalling response.Negative regulation of FGF signaling 
The ubiquitin ligase Cbl 
nduced ternary complex formation of FRS2α, Grb2 and the RING type E3 
itin ligase Cbl results in ubiquitination and degradation of FRS2α and 
. In vivo, Grb2/SOS and Grb2/Cbl complexes compete for binding to 
ne-phosphorylated FRS2α. 
l-deficient fibroblasts, the FGFR receptors are internalised in a normal 
er, indicating that other mechanisms exist for downregulation of FGFR. 
g et al., 2002). 
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4.2 MAP kinase-mediated negative feedback mechanism 
MAPK dependent phosphorylation of FRS2α on threonine residues results in 
reduced tyrosine phosphorylation of FRS2α upon FGF signalling and 
subsequent reduced recruitment of the Grb2/SOS complex and the 
phosphatase Shp2. As consequence the MAPK response and other 
downstream signalling cascades attenuate. Experiments using the Boyden 
chamber assay have shown that the mobility is enhanced of FRS2α-/- mouse 
embryonic fibroblasts (MEF) expressing a mutant form of FRS2α in which the 
threonine sites are mutated to valine. The mutant MEF cells expressing the 
threonine mutated FRS2α even grew faster than MEFs expressing the wild type 
FRS2α resulting in a transformed phenotype (Lax et al., 2002). 
4.3 PLCγ as negative regulator of FGFR 
Mice homozygous mutant for FGFR1 Y766F are viable but show a gain of 
function phenotype. Phosphorylation at Y766 (the binding site for PLCγ) has 
been implicated in the internalisation and degradation of the receptor. PKC a 
target of PLCγ has also been suggested to be involved in phosphorylation and 
downregulation of Src-family kinases, which are downstream targets of FGFR1 
(Partanen et al., 1998). 
4.4 Sprouty (Spry) 
Another conserved inhibitor of RTK signalling is Sprouty (Spry). Spry was first 
identified in Drosophila as an inhibitor of FGF signalling during tracheal 
development (Hacohen et al., 1998) and subsequent studies have shown that it 
also inhibits signalling mediated by the EGFR during eye development and 
oogenesis in Drosophila (Casci et al., 1999; Kramer et al., 1999). Bnl signalling 
in the tip cells of the outgrowing tracheal branches regulates spry expression. In 
spry mutants, Aop/Yan, an ETS domain containing repressor of Bnl induced 
transcription, is degraded in an expanded domain. Subsequently, expanded 
domains of the transcription factor Pointed and the Drosophila Serum response 
factor homologue Blistered/DSRF can be observed, two transcriptional targets 
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that get expressed upon Bnl signalling. Genetic mosaic analysis has shown that 
Spry function is required in the tip cell and acts non autonomously to inhibit 
secondary and terminal branching by nearby stalk cells (for more details, see 
chapter about the development of the tracheal system in Drosophila) (Hacohen 
et al., 1998) 
In contrast, during eye development, Spry acts cell autonomously as negative 
regulator of EGF signalling in R7 cells. Thus it is possible that Spry influences 
neighbouring cells in the tracheal system maybe indirectly (Casci et al., 1999; 
Kramer et al., 1999). 
 
In mammals, four Sproutys (Spry1-4) and three Sprouty-related EVH1 domain 
proteins (Spred1-3) have been identified. In both Drosophila and mammals, 
these proteins all consist of conserved carboxy-terminal cysteine rich domains 
and highly divergent amino-terminal domains. The four mammalian Sprys are 
known to be small phosphoproteins that form oligomers through their carboxy-
terminal domains. The carboxy-terminal domains are also required for the 
translocation and for anchoring Spry to the plasma membrane through 
palmitoylation.  
Sprys have been shown to act as inhibitors of the ERK signalling cascade but 
can also function to positively regulate this pathway. The slightly different 
activities are probably due to their different interaction partners, including Cbl, 
Grb2, Raf1, FRS2, caveolin-1, and the Drosophila RasGAP, Gap1 and Drk, the 
Grb2 homologue. 
Spry1 and 2 get phosphorylated on Tyr 55 on the N-terminus, which serves as 
docking site for Cbl. The competitive binding of Cbl prevents the RTK from 
ubiquination, internalisation and the following degradation. Thus Spry acts as 
positive regulator resulting in prolonged and sustained signalling activity. 
Finally, Cbl ubiquinates Spry and Spry gets degraded by the proteasome. 
Upon FGF induced tyrosine phosphorylation, Spry translocates to the ruffling 
membrane region and binds to Grb2 at the same Tyr 55 as Cbl, thereby 
preventing recruitment of the Grb2/SOS complex to FRS2 or Shp2 and 
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inhibiting downstream events in the Ras/MAPK cascade (Hanafusa et al., 
2002). 
Another mechanism how Spry interferes with ERK activation is at the level of 
Raf. Spry2 and 4 physically associate with Raf1 through the highly conserved 
Raf binding motif (RBM) in the C-terminus thereby blocking phosphorylation of 
Ser338 on Raf1 that is essential for Raf activity.  
In summary, Sprys have a positive and negative function residing in the N-
terminal domain and a negative function in the C-terminal domain (Christofori, 
2003). 
4.5 Sef (similar expression of fgf genes) 
The Sef protein is conserved across zebrafish, mouse and humans but not 
invertebrates. Sef encodes a putative transmembrane protein, with a signal and 
transmembrane domain. There is similarity to the intracellular region of mouse 
and human interleukin 17 (IL17) receptor. A putative tyrosine phosphorylation 
site juxtaposed to the transmembrane domain was shown to be important for 
FGFR1 and FGFR2 interaction. For the inhibitory effect of Sef, both the 
extracellular and the intracellular domain have to be functional. The intracellular 
domain of Sef interacts with the FGFR1 independent of FGFR1 tyrosine kinase 
activity. 
In contrast to Sprouty, Sef seems to specifically repress FGF signalling 
(Furthauer et al., 2002; Kovalenko et al., 2003; Tsang et al., 2002). 
Overexpression of mouse Sef in NIH3T3 cells does not inhibit ERK1/2 
activation by PDGF, EGF for example. 
Coimmunoprecipitation experiments have shown that Sef binds to the FGFR1 
and mediates a reduction in tyrosine phosphorylation of FGFR1 and its 
immediate downstream target FRS2, thereby modulating multiple FGF-
mediated signalling pathways as for example regulating the mitogenic response 
(Kovalenko et al., 2003).  
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II. Chemotactic cell movement 
Cells move by locally extending filopodia (long extensions containing parallel 
actin bundles) and lamellipodia (dendritic actin network) being protrusions of the 
leading edge. Lamellipodia formation is driven by localised actin polymerisation 
under the control of Rho family of small GTPases in conjunction with loosening 
of the myosin thick filament network in the cortex to allow expansion to occur 
(Dormann and Weijer, 2003). 
To gain traction, the cell has to attach to the substrate and make new contacts 
at the leading edge. The attachment sites mature to become focal adhesions 
that allow the cell to exert force upon its surroundings by actomyosin-dependent 
contraction to pull the cell body forward. Transmembrane adhesion receptors of 
the integrin family provide a link between the actin cytoskeleton and 
extracellular matrix (ECM) components and at focal adhesions, stress fibres, 
which are long bundles of filamentous F-actin, are linked to the integrins.  
Sliding of myosin along actin filaments to mediate contraction requires specific 
phosphorylation of the myosin light-chain (MLC), which is carried out by the 
myosin light chain kinase (MLCK). The myosin light chain phosphatase (MLCP) 
opposes the action of MLCK and dephosphorylates MLC. MLCP is 
phosphorylated and inactivated by Rho kinase (Dossenbach et al.) downstream 
of Rho signalling to promote membrane ruffling and cell migration.  
Finally, the cell contacts at the rear of the cell are released from the 
extracellular matrix and the membrane receptors are recycled from the rear to 
the front. Recent evidence indicates that Rho is required for tail retraction. Rho 
regulates also the phosphorylation of moesin, a plasma-membrane-actin-
filament crosslinker (Larsen et al., 2003; Rogers et al., 2003). 
Maximal cell migration occurs when cytoskeletal forces are in balance with 
adhesion. Under conditions in which the adhesive strength is too low, cells are 
unable to generate enough traction to move, whereas under conditions of high 
adhesiveness, cells are unable to break cell-substratum attachments. 
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Chemotactic cell movement involves the detection of gradients of signalling 
molecules. Interpretation of the signal results in polarisation of the actin and 
myosin cytoskeleton of the cell along the gradient resulting in directed cell 
movement (Dormann and Weijer, 2003). 
It was also shown that an intact microtubule cytoskeleton is required to maintain 
the polarised distribution of actin-dependent distributions at the leading edge of 
migrating fibroblasts. Microtubules are arranged with their minus ends near the 
cell centre or anchored at the centrosome. The plus ends radiate towards the 
leading edge, where they display dynamic instability. Microtubules can grow 
along actin bundles. Behind the lamellum, microtubule breakage and 
depolymerization occurs as a result of the compressive forces of the converging 
actin to which they are bound. 
One hypothesis is, that microtubule growth could promote local activity of Rac in 
the cell front to drive lamellipodia protrusion, focal complex formation and 
further microtubule growth. Microtubule shortening could activate RhoA behind 
the lamellum to drive actomyosin contraction and promote the stabilisation of 
the microtubules, to protect them from breakage. 
A second hypothesis is, that microtubule-actin interactions orientate towards the 
leading edge, which could direct the delivery of signalling molecules or 
membrane components required for lamellipodia protrusion. 
It has also been shown that during dynamic instability, microtubules specifically 
target focal contacts, and that the targeting frequency is inversely proportional 
to focal contact lifetime. Further evidence indicates that a kinesin microtubule 
motor may deliver a regulatory factor that promotes focal adhesion 
disassembly. 
The Rho family of small GTPases also regulates the microtubules, for example 
RhoA mediates microtubules stabilisation. PAK kinases downstream of Rac1 
also promote microtubule growth, probably by regulating the microtubule 
destabilising protein Op18/stathmin (Rodriguez et al., 2003). 
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Figure 4: Influence of phosphatases on cell migration.  (A) Migration is initiated by 
protrusion of the leading edge and formation of new actin filaments. Rac induces lamellipodia 
and Cdc42 stimulates filopodia. Their actions are opposed by phosphatase and tensin 
homologue (PTEN). Rac activation is also opposed indirectly by protein tyrosine phosphatase 
(PTP)-PEST (for proline, glutamate, serine and threonine-rich domain). The actin-severing 
protein, actin depolymerizing factor (ADF)/cofilin, can be dephosphorylated by protein 
phosphatases (PP)1A and PP2A to stimulate migration. LIM (for LIN11, ISL1 and MEC3) kinase 
(LIMK), which is activated by Rho, phosphorylates ADF/cofilin. (B) Attachment at the leading 
edge occurs first with focal complexes, which develop into focal adhesions. Formation/turnover 
of focal adhesions is regulated by many phosphatases, some of which include: PP2A, SAP1 (for 
stomach-cancer-associated PTP) and PTP-PEST, all of which are generally inhibitory to 
migration; and PTP1B, SHP2 (Src-homology-2 domain-containing protein tyrosine phosphatase 
and PTP , all of which are generally stimulatory to migration. (C) Cell-body contraction results 
from forces generated through actomyosin interactions. Myosin light-chain (MLC) phosphatase 
(MLCP) dephosphorylates MLC to inhibit migration and oppose the action of MLC kinase 
(MLCK). Rho kinase (Dossenbach et al.) phosphorylates MLCK and inhibits its activity. (D) Rho 
stimulates tail retraction. Rho also phosphorylates the actin-binding-protein moesin, which is 
dephosphorylated at the rear of the cell, before rear release. Moesin is dephosphorylated by a 
type 1/2A PP-family phosphatase. Coloured lines indicate stimulation (green), or inhibition (red), 
of fibroblast migration (Larsen et al., 2003). 28
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1. Molecular requirements for actin-based lamellipodia and filopodia 
formation 
New actin filaments are nucleated by the Arp2/3 complex and grow in a 
polarised fashion with the fast growing barbed ends oriented toward the leading 
edge. Arp2/3 is activated by the WASP (Wiskott-Aldrich Syndrom protein) and 
SCAR family of proteins, which are in turn activated through small G proteins. 
Cortactin also binds and activates Arp2/3 complex and at the same time 
stabilises branches. 
Fed by monomeric actin-profilin from the subunit pool, new branches grow 
rapidly and push the membrane forward (for the exact process see Fig.1). 
Profilin allows elongation of barbed ends of filaments, blocks binding to the 
pointed end and inhibits spontaneous nucleation of actin filaments. Capping by 
the Capping protein or Gelsolin, another capping protein, limits the length of the 
growing branches, since short filaments are stiffer and more effective at pushing 
on the membrane.  
The Ena/VASP proteins have been shown to interact with the barbed ends of 
actin filaments, shielding them from the activity of capping protein while 
supporting filament elongation which is important for the cell to create more 
filopodia like structures to sense guidance cues in the environment (Bear et al., 
2002). Toward the rear of the lamellipodia actin filaments become debranched, 
severed and depolymerised by Cofilin-like proteins (ADF/Cofilin) and the 
released monomeric actin or globular G-actin is recycled into polymer at the 
leading edge (Petit et al., 2002; Rogers et al., 2003). Furthermore, Cofilin is 
required at the initiation of protrusion for barbed end mediated actin assembly at 
the leading edge and thereby increases levels of Arp2/3-mediated 
polymerisation (Larsen et al., 2003; Pollard and Borisy, 2003). 
Arp2/3 has not been detected in filopodia in which actin is arranged in bundles 
rather than in a branched array as in lamellipodia.  
The question remains how external stimuli are converted into signals that 
regulate nucleation-promoting factors. The strong autoinhibition of WASP is 
overcome by signalling molecules including Rho family GTPases (see next 
chapter), PIP2, Profilin, Grb2 and Nck. Requiring several signalling inputs of 
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different natures is attractive because it makes the mechanism of actin 
polymerisation sensitive to coincident signals (Carlier et al., 2003). 
 
 
 
 
 
 
 
 
 
 Figure 5: Schematic diagram representing the reactions involved in 
building a branched filament array at the leading edge. (A) Activation 
and targeting of N-WASP at the plasma membrane by signalling 
molecules. (B) Formation of the ternary branching complex G-actin–N-
WASP–Arp2/3. (C,D) Association of the branching complex with a 
nucleus or filament barbed end. (E) Growth of the branched filament from 
G-actin and profilin-actin. (F,G,H) Regulation of actin dynamics in 
lamellipodium by Actin Depolymerising Factor and capping proteins 
(represented by gelsolin, which makes a 1:2 complex with G-actin). (I) 
Sequestration of actin by thymosinb4. (J) Recycling of G-actin by 
nucleotide exchange (Carlier et al., 2003). 
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2. Role of the small Rho GTPases in cytoskeletal reorganization 
Members of the Rho (Ras homologous) family of GTPases are major 
components regulating changes in cell morphology and reorganization of the 
cytoskeleton in response to external stimuli (see also chapter II). Each Rho-
family GTPase contains a membrane-attachment domain, a GTP/GDP binding 
domain and an effector loop. These molecules cycle between inactive GDP-
bound and active GTP-bound forms. The cycling is regulated by guanine 
nucleotide exchange factors (GEFs), which exchange GDP for GTP, and 
GTPase-activating proteins (GAPs), which induce the hydrolysis of, bound GTP 
to GDP. Guanine nucleotide dissociation inhibitors (GDIs) prevent dissociation 
of GDP and the hydrolysis of bound GTP thereby preventing activation. 
In fibroblasts, RhoA is implicated in the formation of actin stress fibres and focal 
adhesions, Rac1 stimulates membrane ruffling, lamellipodia, focal complex 
formation and is present at cell junctions, and Cdc42 participate in the formation 
of filopodia, cell rounding and the loss of actin stress fibres (Van Aelst and 
D'Souza-Schorey, 1997).  
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 Figure 6: GTPase cascades involved in cytoskeleton organization in fibroblasts.
Various extracellular stimuli trigger the activation of Cdc42, Rac, and Rho GTPases and 
elicit specific short-term responses such as the formation of filopodia, lamellipodia, and 
stress fibres, respectively. Moreover, Cdc42 appears to activate Rac, which in turn activates 
Rho. The direct links between these GTPases remain to be clarified. Different agonists can 
activate the Rho GTPases independently. The mechanism by which these agonists activate 
Rho GTPases may involve GEFs, GAPs, or GDIs (Van Aelst and D'Souza-Schorey, 1997). 
 
he role of Rho family GTPases is not fully understood, numerous studies using 
utants as well as dominant negative and constitutive activated forms of these 
TPases support their importance in cell migration in vitro and in vivo (Petit et 
l., 2002). 
ne of the targets of Rac1 is the phosphatidylinositol-4-phosphate-5-kinase 
PIP 5-kinase). Through the increase of PIP2 levels, PIP5-kinase regulates the 
unction of many actin-associated proteins.  
ac1 mediates initiation of Cadherin-mediated cell-cell adhesion in a PI3-
inase-dependent manner. Rac1 is specifically expressed in initiating areas of 
ontact where lamellipodia are formed, whereas E-cadherin gradually 
ccumulates along the entire contact length. The regulatory subunit of PI3K 
ssociates with the E-cadherin/catenin complex and the Rac1 GEF Tiam1, 
hich promotes E-cadherin based cell-cell adhesion, is regulated by PI3K 
ctivity (Ehrlich et al., 2002). 
nother target of Rac1 is POR1 that specifically interacts with Rac1 in GTP-
ependent manner. Deletion mutants of POR1 inhibit the induction of 
embrane ruffles by RacV12, a constitutive active form of Rac. POR1 interacts 
ith the GTPase Arf6 that has been shown to elicit cytoskeletal rearrangements 
t the cell surface. But experiments have shown that Arf6 and Rac function on 
istinct signalling pathways to mediate cytoskeletal reorganisation (Van Aelst 
nd D'Souza-Schorey, 1997).  
ASP is regulated by Cdc42. WASP contains multiple domains that interact 
ith different signalling molecules, phosphoinositides and components of the 
achinery required for actin polymerisation, such as actin monomers and the 
rp2/3 complex. Upon activation by GTP-Cdc42, the intramolecular inhibition of 
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WASP is released and permits the binding of WASP to the Arp2/3 complex. 
This complex formation activates the actin-nucleation thereby locally increasing 
actin polymerisation. 
Contraction and stabilisation of stress fibres is obtained when phosphorylated 
myosin light chain (MLC) is associated with actin. Phosphorylation of MLC 
induces a conformational change in myosin, thereby increasing its binding to 
actin filaments and subsequently the formation of stress fibres. MLC 
phosphorylation is regulated by the opposing effect of MLC-kinase (MLCK) and 
MLC-phosphatase. Some targets of Rho proteins, for example PAK, a 
serine/threonine kinase, exert their effects by regulating the phosphorylation 
state of MLC. PAK is required for the disassembly of focal adhesions and 
promotes lamellipodia formation and membrane ruffling. Moreover PAK 
activation leads to a decrease in MLC phosphorylation through phosphorylation 
of MLCK, thus destabilising actin stress fibres. 
In contrast, the Rho associated serine/threonine kinases ROKα/β that are 
targets of the Rho GTPase, phosphorylate MLC and inactivate the MLC-
phosphatase thus increasing actomyosin assembly. 
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III. Developmental role of FGF signalling in 
Vertebrates 
1. Tumorogenesis 
Several FGFs were discovered because of their oncogenic potential. For 
example in human pancreatic cancer and in breast cancer, in lung carcinomas 
or glioma, FGFs are over expressed. 
Some tumours are mainly spread through the lymph, others mainly through the 
blood stream. A positive correlation between the vascular density of the primary 
tumour and the number of metastases formed has been reported for several 
cancers (Klingenberg Dissertation). 
Several antagonists of FGF signalling that are of pharmaceutical interest were 
tested for example antisense molecules, neutralising antibodies, dominant-
negative FGFRs or soluble FGF receptors. 
Blockade of the FGF pathway in mice by FGF2 or FGFR1 antisense molecules 
or by FGF2 neutralising antibody inhibits tumour angiogenesis and growth. 
In mice, tumour growth can also be inhibited by the adenoviral expression of 
soluble FGFR1 and VEGFR1. FGFR1 decreases the number of capillaries in 
tumours suggesting that growth is inhibited through an angiogenesis dependent 
mechanism, and the coexpression of soluble VEGFR1 has an additive effect in 
the inhibition of tumour growth (Auguste et al., 2003). 
 
2. FGF-mediated movement of mesoderm cells during gastrulation 
Gastrulation is the process that establishes the three-layered body plan, the 
ectoderm, mesoderm and endoderm of the embryo and is one of the main 
morphogenetic events that shape the early embryo. 
In mammalian and avian embryos first the embryo consists of two layers, the 
epiblast and the hypoblast. The epiblast gives rise to embryonic and 
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extraembryonic structures whereas the hypoblast gives rise to extraembryonic 
structures only. Gastrulation starts with the formation of the primitive streak. The 
anterior part of the streak is known as Hensen’s node. During gastrulation, cells 
move towards the primitive streak where they undergo an FGF-mediated 
“epithelial to mesenchymal transition” (EMT) that requires downregulation of E-
cadherin, a process probably regulated by FGFR1. Chimeric analysis of 
FGFR1-/- mice has shown that FGFR1 signalling is required for EMT to occur in 
mouse embryos and that FGFR1-/- deficient cells have strong migration defects 
(Ciruna and Rossant, 2001). FGFR1 signalling is required for the expression of 
mSnail that downregulates E-cadherin. Mouse embryos homozygous mutant for 
mSnail die late during gastrulation with mesodermal cells retaining epithelial 
characteristics including the expression of E-cadherin. Downregulation of E-
cadherin at the primitive streak not only regulates the EMT and migration of 
mesoderm progenitor cells, but also permits the rapid accumulation of cytosolic 
β-catenin levels in response to localised Wnt signalling and Wnt target genes 
are expressed, as for example Brachyury and T box genes that specify 
mesodermal cell fates (Ciruna and Rossant, 2001). 
The protein tyrosine phosphatase Shp2 seems to be required to positively 
transmit the FGFR1 signal. Shp2 mutant cells in chimeric mice accumulate 
within the primitive streak because of the incapability of the Shp2-deficient cells 
to undergo EMT, which involves changes in cell shape, adhesion or migration. 
These processes are essential for the cells to exit the streak and to contribute to 
the mesoderm. The behaviour of Shp2 mutant cells looks very similar to the one 
of FGFR1-/- cells in chimeras suggesting a specific role of Shp2 downstream of 
FGFR1 to induce chemotaxis (Saxton and Pawson, 1999). 
After passing the streak, the cells move out as individual cells into the space 
between the epiblast and the hypoblast to form the axial and lateral 
mesodermal, the definitive endoderm and extra-embryonic structures.  
The phenotypes of knockout mice already suggested that FGFs are involved in 
cell movement during gastrulation, since FGF8 and FGFR1 mutants showed 
severe defects in cell migration at the primitive streak stages (Yang et al., 
2002).  
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On the basis of the expression pattern of FGF8 and FGF4 (both are expressed 
in the streak and partially overlapping) it has been shown that mesodermal cells 
are attracted by sources of FGF4 and repelled by FGF8. It was proposed that 
cells move away for the primitive streak as a result of repulsion by FGF8 and 
that cells emerging from the anterior streak are attracted back in towards the 
midline to form somites and lateral plate mesoderm after regression of the 
node, by a FGF4 signal from the forming notochord. Cells leaving the posterior 
streak are attracted by a source of unknown chemoattractant originating from 
the boundary region between the area opaca and area pellucida to form 
extraembryonic structures. These cells never sense the attractive influence of 
the forming notochord and somites (Dormann and Weijer, 2003). 
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 Figure 7: FGF expression directs cell movement in chick embryos. Movement of cells 
emerging from the primitive streak repelled by FGF8 (orange) produced in the streak. 
Mesoderm cells are attracted back in towards the midline to form somites and lateral plate 
mesoderm (blue arrows) by FGF4 (green) produced by the forming head-process. Cells 
emerging from the posterior streak (black arrows) are attracted by a signal emitted from the 
boundary of the embryo (Dormann and Weijer, 2003). . Angiogenesis  
ngiogenesis is the formation of new blood vessels from pre-existing vessels. 
ngiogenic factors, as the FGFs and the Vascular Endothelial Growth Factors 
VEGFs), stimulate endothelial cells to secrete several proteases and 
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plasminogen activators resulting in the degradation of the vessel basement 
membrane, which allows the cells to invade the surrounding matrix. The cells 
migrate, proliferate and differentiate to form a new lumen-containing vessel. 
Finally, the endothelial cells deposit a new basement membrane and secrete 
growth factors such as the platelet-derived growth factor (PDGF), which attract 
supporting cells, the pericytes, ensuring the stability of the new vessels. This 
complex process involves other factors, as the angiopoietins and ephrins that 
act on specific receptors to regulate vessel stability (Cross and Claesson-
Welsh, 2001). 
FGF2 (also called basic FGF) was the first angiogenic factor identified and the 
FGFR1 is the main FGFR expressed in endothelial cells in vitro and has also 
been detected in activated endothelial cells in vivo. In capillary endothelial cell 
lines, stimulation of FGFR1 induces proliferation, migration, protease production 
and tubular morphogenesis, whereas activation of FGFR2 increased motility 
only. 
Studies in FGF2-/- mice have shown, that endothelial cells from these mice have 
a defect in cell migration that can be compensated by the addition of exogenous 
FGF2 (Auguste et al., 2003).  
FGFs probably regulate vascular morphogenesis indirectly by inducing 
secondary angiogenesis regulators such as VEGF. 
Disruption of FGF or FGFR genes was not very informative so far with regard to 
vessel formation in vivo. FGF1-/- or FGF2-/- mice (single or double knockouts) do 
not present a defective vascular phenotype during development. This suggests 
a functional redundancy or a non-essential role of FGFs in vasculogenesis or 
angiogenesis. Mice with gene knockouts of FGFR1 or FGFR2 yield embryos 
arrested in their development before the onset of vascularization, because of 
the lack of mesoderm inducing signals. 
But overexpression of FGF1 or FGF2 in mice hearts lead to an increase of 
vessel density. And transgenic mice that overexpress specifically a dominant-
negative FGFR1, truncated at the C-terminal kinase domain, in the retinal 
pigmented epithelium in the developing eye, show a poorly branched vascular 
bed in the choroid and an avascular neonatal retina (Auguste et al., 2003). 
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4. Development of the mammalian lung 
4.1 The morphology of the lung 
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undergo branching and are assembled into lobes, which result in more lobes in 
the right lung than in the left (mouse and human). 
4.2 Cell fate determination 
The homeodomain protein Nkx2.1 is essential for the complete induction of the 
lung branching morphogenesis. In the absence of Nkx2.1, dorso-ventral 
separation of the trachea from the esophagus, as well as lung branching 
morphogenensis and epithelial cell lineage determination at an early stage, prior 
to the specification to peripherial lung cell phenotypes is arrested. The 
hepatocyte nuclear family (HNF) of transcription factors cooperate with Nkx2.1 
to determine pulmonary epithelial cell fate. HNF-3 activates transcription of 
Nkx2.1 in respiratory epithelial cells. Another important factor is GATA-6, a 
member of the GATA family of zinc finger transcription factors, induces 
differentiation of primitive foregut endoderm into respiratory epithelial cell 
lineages by interacting with HNF3β, Nkx2.1 and GATA family members 
(Warburton et al., 2000). 
4.3 The branching process 
A large amount of factors are involved in the branching process. The most 
relevant will be discussed. In the lung branching process, localised dynamic 
FGF10 expression in the distal mesenchyme induces chemoattraction and 
epithelial cell proliferation. Little is known, how specific clusters of mesenchymal 
cells are determined in a stereotyped fashion to secrete FGF10 and stimulate 
bud outgrowth.  
Experiments have demonstrated directional chemotactic bud outgrowth in 
mesenchymal free epithelial cell cultures or whole lung cultures toward an 
implanted FGF10 soaked heparin bead. In FGF10 knockout mice, induction of 
primary bud outgrowth is disrupted and the mice have a blunt ended tracheal 
tube (Warburton et al., 2000). Other experiments have shown that in 
mesenchyme free lung epithelial cultures differential cell proliferation does not 
seem to be the initial event that triggers lung bud induction (Cardoso, 2001). 
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FGF10 binds and signals via the FGFR2 that is expressed throughout the 
respiratory tract epithelium from the earliest stages of lung development and 
during branching morphogenesis. 
There is evidence that also retinoic acid (RA) signalling is required for lung bud 
initiation. RA results from sequential oxidation of vitamin A from retinol to 
retinalaldehyde and to the acid form.  
Acute vitamin A deprivation in pregnant rats resulted in blunt end trachea and 
lung agenesis in some embryos, a phenotype similar to FGF10-/- mice. 
Probably, RA signalling restricts FGF10 expression and has to be inhibited to 
allow proper distal lung morphogenesis (Cardoso, 2001). 
The outgrowing epithelial bud expresses high levels of Sonic hedgehog (Shh) 
that acts as negative regulator and restricts also FGF10 expression in the 
immediate vicinity of the outgrowing bud. Shh signalling is initiated upon binding 
to Ptc1 and results in the activation of Shh target genes by Gli (1,2,3) 
transcription factors. Glis are expressed in overlapping but distinct domains in 
the lung mesenchyme. The distinct phenotypes observed when Gli genes are 
inactivated individually or in combinations suggest that there are complex 
interactions between Gli members in regulating lung growth and pattern 
formation.  
The Bone Morphogenetic Protein-4 (BMP-4) growth factor that belongs to the 
TGFβ superfamily is expressed throughout the epithelium but at increased 
levels at the tip cells of the bud. As the bud approaches the chemotactic source 
of FGF10, increased BMP-4 levels leading to an inhibition of cell proliferation 
slowing down bud outgrowth during the branching process. BMP-4 regulates 
also proximal-distal differentiation. 
TGFβ-1 is expressed uniformly in the subepithelial mesenchyme and 
accumulates later at sites of cleft formation and along proximal airways. TGFβ-1 
promotes the synthesis of extracellular matrix that when deposited in the 
epithelial-mesenchymal interface prevents local branching. TGFβ-1 has also 
been identified as negative regulator of epithelial cell proliferation and 
differentiation.  
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Finally during postnatal life, FGFR3 and FGFR4 play an essential role in 
regulating alveolization (Affolter et al., 2003; Cardoso, 2001; Warburton et al., 
2000) 
 
 
 
 
 
 
 
 
 Figure 9: Control of bud formation during branching morphogenesis. Diagram 
incorporates models proposed by Bellusci and co-workers and Lebeche and co-workers. (A) 
Local expression of FGF-10 in the mesenchyme induces chemo-attraction and epithelial 
growth. (B) As the bud is induced, FGF-10 is inhibited by Shh expressed at the tips and by 
TGF_-1 expressed throughout the subepithelial region. Concomitantly, proliferation is 
inhibited at the tips by FGF-10-mediated up-regulation of BMP-4. (C) These mechanisms 
limit bud outgrowth and expansion, resulting in cleft formation. FGF-10-expressing cells 
appear at other sites to induce a new generation of buds. At the cleft, low levels of FGF-10 
are maintained by subepithelial TGF_-1, which also induces synthesis of extracellular matrix 
components deposited in the epithelial-mesenchymal interface and prevents local budding 
(Cardoso, 2001). 
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IV. Drosophila melanogaster as model organism to 
study FGF-mediated chemotaxis and cell motility 
Many studies of cell movement are carried out on cultured cells because the 
migration can be observed in real time and the culture medium can be altered to 
examine the factors that affect cell motility as the FGFs do.  
During embryonic development, cell migration must be regulated temporally and 
spatially and this behaviour must be co-ordinated with cell fate specification and 
differentiation of the motile cell. 
In vitro studies can only suggest, but not establish the factors that control or 
guide cell migration in vivo. Furthermore, cellular behaviour can depend upon 
the precise composition of the cellular environment. Knockout mice have the 
disadvantage that usually several gene copies of essential factors that for 
example control cell migration exist and the generation time, until the siblings 
are born, is long.  
The fruit fly Drosophila melanogaster is a genetically tractable organism with 
only four chromosomes and many components of the mammalian signalling 
pathways are highly conserved in Drosophila. Saturating genetic screens for 
mutants were done and have resulted in the identification of genes required for 
cell migration. The strength of Drosophila is that combined cellular and genetic 
approaches are possible which have begun to elucidate the cellular 
mechanisms. Additional advantages of the fruit fly are the easy way to generate 
transgenic flies and the short generation time (10 days).  
1. FGF signalling pathway in Drosophila 
1.1 Sugarless (Sgl) and Sulfatless (Sfl) 
In Drosophila, FGF signalling is impaired when HS synthesis is compromised as 
in vertebrate FGF signalling. Two enzymes encoded by the genes sugarless 
and sulfatless are critical for the biosynthesis and modification of HS GAGs. 
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Sugarless encodes an enzyme which catalyses formation of UDP-D-glucoronic 
acid, an essential building block of heparan and sulfatless encodes an enzyme 
which catalyses the N-deacetylation/N-sulfation of heparan. Loss of function 
alleles of both sfl and sgl induce mesodermal migration defects, the heart does 
not form and tracheal development is disturbed and also Htl and Btl dependent 
MAPK activation is significantly reduced. Epistasis studies demonstrated that sfl 
and sgl function upstream of btl and htl and downstream of bnl expression. 
Overexpression of bnl partially rescues the sfl and sgl phenotypes. These 
experiments demonstrate that in vivo high levels of FGF can activate the FGFR 
in the absence of heparin (Lin et al., 1999).  
1.2 Breathless (Btl) and Heartless (Htl) 
There are two FGF receptor homologues in Drosophila encoded by the genes 
breathless and heartless (Klambt et al., 1992; Shishido et al., 1993). Btl is 
expressed in the anterior and posterior midgut and in midline glial cells. During 
stage 10-12, btl starts to be expressed on the surface of all tracheal cells. 
During stage 12, btl expression declines and gets restricted to the outgrowing 
tracheal branches, the DB, VB and anterior and posterior lateral trunks and is 
regulated by a positive feedback mechanism (Ohshiro et al., 2002). Btl is a 
receptor molecule of 1053 aa and Htl of 715 aa. The structure of Btl is 
homologous to the one of the vertebrate FGFR2. The N-terminus contains a 
highly hydrophobic signal peptide (2-20aa) 5 Ig-like domains of which two were 
found in the region flanked by the acidic domain and the transmembrane 
domain. These Ig-like domains are suggested to serve as binding sites for the 
only known FGF homologue in Drosophila Branchless (Bnl). In contrast to 
FGFR2, Btl is not modified by alternative splicing in the extracellular domain. Htl 
contains only 2 Ig domains. 
The juxtamembrane domain of Btl and Htl is highly divergent from FGFR1, the 
region used by FGFR1 to recruit FRS2. A distant relative of FRS2 exists in 
Drosophila, but is not required for the transduction of the FGF signal (Battersby 
et al., 2003). A split tyrosine kinase domain follows the juxtamembrane domain. 
Except for the kinase insert domain, the overall sequence homology of the 
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kinase domain between Btl, Htl and the vertebrate receptors is about 60%. The 
homology between the kinase domain of Btl and Htl is 79%. The kinase insert 
domain is also positioned similar to the vertebrate receptors (Btl: 22aa, FGFR2: 
14 aa) but the sequence conservation is low. As the vertebrate FGFRs, Btl and 
Htl lack a Grb2 binding site and the link to the conserved MAPK, encoded by 
the gene rolled, cascade is not known. 
 
 
 
 
 
Figure 10: Diagram showing structures of two Drosophila 
FGFRs and a human FGFR, Flg. Only conserved N-
glycosylation sites are indicated (Shishido et al., 1993). 
 
1.3 Downstream-of-FGFR (Dof) 
Interestingly, the FGF signalling pathway must have existed in a common 
precursor of vertebrates and insects but as we have seen the adapter protein 
FRS2 is not conserved in its function in insects and a functional different 
adapter molecule called Downstream-of-FGFR (Dof), also known as Stumps or 
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Heartbroken, seem to fulfil a similar role to FRS2 (Imam et al., 1999; Michelson 
et al., 1998a; Vincent et al., 1998). 
Dof is expressed in tracheal cells, mesodermal cells and a subset of glial cells 
that express either Htl or Btl. In dof mutant embryos the tracheal cells 
invaginate but fail to migrate and the induction of secondary and terminal 
branch markers is lost. This phenotype is similar to the one of btl and bnl 
mutants and csw mutants. 
Dof gets phosphorylated upon receptor activation and acts downstream of Htl 
and Btl and upstream of Ras. It is also essential for MAPK activation (Vincent et 
al., 1998). The gene encodes two transcripts to produce proteins of more than 
1000 aa that differ slightly at the N-terminus. The Dof protein from transcript II is 
a cytoplasmic protein and contains two ankyrin repeats and a coiled coil 
domain. Strikingly, the protein has no structural domains typical of molecules 
involved in signal transduction, as for example SH2 and PTB domains.  
The most closely related vertebrate protein identified is the B lymphocyte signal 
transduction molecule (BCAP), which has been found in chicken, human and 
mouse and acts as an adapter in B-cell receptor signal transmission. Upon 
phosphorylation it recruits the PI3 kinase. BCAP and another signalling 
molecule in B cells, BANK share the overall structure of Dof (Battersby et al., 
2003). 
In a yeast two-hybrid screen it was shown, that Dof probably interacts with its N-
terminal domain with the C-terminal lobes of the kinase domain of both FGF 
receptors, Btl and Htl. 
The same N-terminal domain, that is highly conserved between Dof and BCAP, 
and defined as Dof/BCAP/BANK (DBB) motif, can interact with itself and with 
the C-terminal part of the protein leading probably to a folded form in vivo that 
can be specifically regulated thereby modifying the affinity of binding molecules. 
The DBB motif also promotes intermolecular interactions with another Dof 
molecule leading to dimerization of Dof (Battersby et al., 2003). 
In the Dof protein, the environments of the tyrosines at positions 97, 914, 930 
could act as binding sites for the SH2 domain of Drk. In addition, the context of 
the tyrosine 486 could serve as binding site for the SH2 domain of the 
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regulatory subunit of Phosphatidyl 3-kinase and the tyrosine at position 844 
could represent a binding site for RasGAP. And finally, the tyrosine at position 
515 is a potential binding site for Shp2 homologue encoded by the gene 
corkscrew (csw) in Drosophila. Recruitment of Csw is essential for MAPK 
activation and transcriptional activation. Drk can either bind directly to Dof or be 
recruited indirectly by Csw as it was shown for the Torso receptor (Cleghon et 
al., 1998). Experiments have shown that the interaction of Dof and Csw is 
probably also essential to induce cell migration (Petit et al., 2004).  
To get a clue about migratory response and how cytoskeletal rearrangements 
are induced it is essential to understand the role of Dof and its interaction 
partners.  
1
C
(
v
 Figure 11: Schematic representation of Dof indicating the phospho-tyrosine motifs and 
putative SH2-interaction domains. Conserved domains are the ankyrin repeats, the coiled-
coil domain and the serine rich domain.  
.4 Corkscrew (Csw) 
orkscrew (Csw) encodes a nonreceptor protein tyrosine phosphatase 
PTPase) that is maternally contributed and homologous to the Shp2 protein in 
ertebrates (Perkins et al., 1992). Csw contains two N-terminal SH2 domains, a 
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C-terminal catalytic region, and a poorly conserved C-terminal region that 
contains a proline rich segment and a phospho-tyrosine motif that is capable of 
binding Drk. In addition, Csw contains a domain of about 150 aa that interrupts 
its PTP domain and is not present in Shp2. The crystal structure of Shp2 has 
revealed that the N-terminal SH2 domain binds to the catalytic domain, which 
keeps Shp2 inactive. The same could be true for Csw. Originally it was 
identified as a positive transducer of the Torso, EGF and Sevenless signals. 
Probably it activates Ras by bringing the Drk/SOS complex in close proximity to 
the receptor. But this model does not account for the still unknown function of 
the catalytic activity of Csw. Dominant negative phenotypes are observed when 
catalytic dead Csw proteins are expressed during embryogenesis (Johnson 
Hamlet and Perkins, 2001b; Perkins et al., 1996b). 
In csw mutant embryos, tracheal cell migration is impaired similarly to the one of 
btl, bnl and dof mutant embryos. This suggests that Csw operates positively in 
Btl signalling.  
In csw mutants also the dorsal mesodermal precursors cells are missing similar 
to htl and dof mutant embryos. In hemizygous csw mutant embryos, some 
pericardial precursor cells can be observed. Thus, Csw probably has a more 
prominent role in Htl dependent migration rather than Htl dependent pericardial 
cell specification (see next chapter). 
Csw physically interacts with the DIM-7 protein, encoded by the gene moleskin 
(msk), a nuclear import protein. DIM-7 likely transports activated MAPK into the 
nucleus (Lorenzen et al., 2001). 
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Figure 12: Schematic representation of the Bnl signalling pathway, the 
Drosophila FGF homologue.  
 
 
 
2. Developmental role of FGF signalling in Drosophila 
2.1 Htl and its role during gastrulation 
Htl is first expressed in the whole mesoderm primordium and later in a subset of 
heart and somatic muscle precursors and in certain cells of the ventral nerve 
cord.  
During the gastrulation process, the mesodermal and endodermal primordia are 
internalised by infoldings of the blastoderm epithelium and later disperse into 
individual cells that spread out to form the germ layers. The ventral blastoderm 
cells constrict their apical sides and shorten along their apical-basal axis 
forming a ventral furrow, which is going to be completely internalised. Once 
inside the embryo, the mesoderm premordium looses its epithelial structure and 
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disperses into single cells, which divide, attach to the ectoderm and migrate out 
on the ectoderm to form a single cell layer. 
The maternal protein Dorsal has its highest concentration at the ventral side of 
the embryo and activates the expression of the transcription factor Twist and 
zinc finger protein Snail that define the mesoderm primordium. Huckebein 
defines the anterior and posterior borders of the mesoderm and ventral furrow. 
(Leptin, 1999). 
Htl is already expressed during the blastoderm stage and later after the primary 
fate of the mesoderm is determined by Twist. Finally, in a second round of 
expression, Htl determines the mesodermal cell fates of the visceral mesoderm, 
heart and the somatic muscles. The dorsal most two rows of mesodermal cells 
split from the visceral mesoderm and give rise to the heart precursors. The 
dorsal row forms the dorsal vessel that are termed cardioblasts and the cells in 
the second row give rise to the pericardial cells that flank and support the dorsal 
vessel (Beiman et al., 1996). Pericardial cells express the pair rule gene 
evenskipped. 
In htl mutant embryos, mesodermal cells do not spread and migrate properly to 
reach the positions where they receive the patterning cues from the ectoderm. 
Such patterning cues are Dpp and Wg. Dpp induces the transcription of the 
homeodomain protein Tinman (Tin) that is in concert with Htl signalling 
responsible for inducing dorsal mesodermal fates including the cardiac and 
visceral derivatives. Wg is necessary for promoting the segregation of specific 
somatic muscle and cardiac founder cells. 
Due to the failure of htl mutant cells to reach the dorsal most regions, the heart 
precursor cells are lost and the visceral mesoderm is reduced. 
Unfortunately, the ligand of Htl has still not been identified yet. The differences 
in the extracellular domain of the receptor and the different expression pattern 
compared to Btl, suggests that Htl interacts with an Htl-specific ligand. The Htl-
dependent, graded activation of MAPK in the migrating mesoderm suggests 
that Htl has an instructive role in guiding mesodermal cells (Cleghon et al., 
1998; Gisselbrecht et al., 1996; Michelson et al., 1998a; Michelson et al., 
1998b; Shishido et al., 1997) 
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2.2 FGF signalling recruits mesodermal cells into the male genital 
imaginal disc 
The Drosophila sex determination hierarchy also controls the expression of bnl 
and btl in order to recruit larval mesodermal cells to become part of the male 
genital imaginal disc. 
The sex-specific transcription factor encoded by doublesex (dsx) that is spliced 
either to the DsxMale form or DsxFemale form, specifies, together with the 
homeotic genes Abdominal-A and Abdominal-B, the sexually dimorphic 
pigmentation patterns of the abdomen through their regulation and modification 
of bric-a-brac to produce either the female or male pigmentation pattern.  
There is only a single genital disc comprised of three separate primordia, 
derived from embryonic segments A8, A9 and A10. Each of these primordia 
responds in a unique manner to the sex determination hierarchy. In females, the 
A8-derived primordium grows to dominate the disc and gives rise to most of the 
female genitalia. The A9 primordium develops into the parovaria, part of the 
internal female genitalia and the A10 primordium develops into the female 
analia. 
In males, the converse happens. The A9 primordium grows to dominate the disc 
and gives rise to all of the male genitalia. A8 primordium gives rise to a 
miniature male eight tergite and the A10 primordium develops into the male 
analia. 
Bnl and btl are expressed in the mature male genital disc, but not in the female 
one. Bnl is expressed in genital disc epithelium and recruits actively btl-
expressing cells with mesodermal identity into the male genital disc during late 
larval development. After being recruited into the disc, they define a novel third 
compartment that is clonally distinct from the anterior and posterior 
compartments. Subsequently, the btl expressing cells become epithelial and 
give rise to the paragonia and vas deferens. 
The male specific deployment of FGF signalling is a consequence of bnl 
expression being repressed in female discs by DsxF. Feminised clones in the 
male genital disc repressed cell autonomously bnl expression and the btl 
expressing cells could not be recruited anymore. Feminised btl expressing cells 
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still reacted to the Bnl signal and migrated toward the disc (Ahmad and Baker, 
2002). 
2.3 The tracheal system of Drosophila melanogaster 
Our lab is particularly interested in the formation of the tracheal system, a 
branched tubular epithelial organ that delivers oxygen throughout the body of 
the fly to the target tissues. 
Oxygen enters the network of hollow epithelial tubes through the spiracles and 
diffuses passively along the major branches until reaching the fine terminal 
branches (tracheoles) that end blindly on the surface of all tissues. 
The tracheal epithelium is a monolayer with stiff extracellular cuticle that lines its 
apical (lumenal) surface and prevents the tubes from collapsing. 
The pattern of the tracheal branches is bilaterally symmetric and shows a 
segmental repeated structure. Except for the terminal branches, the pattern of 
the tracheal branches in each hemisegment is stereotyped and established by a 
fixed developmental program. 
With its small number of cells, about 80 per hemisegment, and the availability of 
a large battery of cell markers, the embryonic tracheal system provides an 
excellent model system to define the mechanisms of guided branching 
morphogenesis and the role of FGF signalling in this process (for reviews see, 
(Affolter and Shilo, 2000; Manning and Krasnow, 1993; Metzger and Krasnow, 
1999; Shilo et al., 1997). 
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Figure 13: Development of the tracheal system, the respiratory organ of Drosophila. 
Primary branch outgrowth and fusion processes of the embryonic tracheal system are 
presented from stage 11 until stage 15. One placode from a stage 11 old embryo is outlined in 
a schematic representation. The FGF receptor tyrosine kinase Breathless (Btl; blue) is 
expressed in all tracheal cells. The activation of the receptor in the cells at the tip of the 
outgrowing branches, presumably due to their proximity to the localized source of the FGF 
ligand Branchless (Bnl), leads to the formation of filopodial cell extensions indicating the Bnl 
expressing epidermal cells surrounding the placode as six clusters (dark blue) guiding the 
outgrowing primary tracheal branches in stereotypic directions. The tracheal system of 
embryos from a 1-eve-1 enhancer trap line was visualized with an anti β-Galactosidase 
antibody (green) (Figure by Valérie Petit). 
 
 
 
 
 
 
 
 
a) Tracheal cell fate determination 
The tracheal system derives from 10 clusters of ectodermal cells on each side 
of the embryo, one in each hemisegment. Two regionally transcribed 
transcription factors, Trachealess (Trh) and Drifter/Ventral veinless (Drf/Vvl) are 
required to select groups of cells within the large epithelial sheet to define the 
tracheal placode. Trh is expressed throughout the tracheal development and in 
complex with its ubiquitously expressed partner Tango, it activates the 
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transcription of genes encoding proteins essential for the subsequent branching 
process. 
b) Invagination and primary branch outgrowth 
After cell fate determination, the tracheal cells invaginate into the underlying 
mesoderm forming an elongated sac that is still connected to the surface by a 
thin stalk generating an initial lumen. The invagination process is regulated by 
Epidermal growth factor (EGF) signalling probably in collaboration with 
Wingless (Wg) and Hedgehog (Hh) signalling (Glazer and Shilo, 2001; 
Llimargas and Casanova, 1999). The cells do not undergo an epithelial-
mesenchymal transition, retain their epithelial character and undergo few 
rounds of cell division until they reach the number of about 80 cells within each 
placode. Without any further cell division, each sac initiate the outgrowth of six 
primary branches: Dorsal branch (DB), dorsal trunk anterior and posterior (DT), 
lateral branch anterior and posterior (LT), visceral branch (VB) and ganglionic 
branch (GB).  
The Decapentaplegic (Dpp) signalling pathway specifies the fate of the tracheal 
branches that will bud from the dorsal and ventral part of the tracheal placode. 
The activation of expression of the zinc finger protein Knirps (Kni) and Knirps-
related (Knrl) by Dpp is essential to determine the correct number of cells in 
dorsal and ventral branches (Chen et al., 1998). It also allows the tracheal cells 
to respond to the chemoattractant Branchless (Bnl), the only known FGF 
homologue in Drosophila, which guides the branches in stereotypic directions 
(Sutherland et al., 1996).  
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 Figure 14: Branching Morphogenesis at the Cellular Level 
Schematic representation of a typical branching process. In many cases, a subgroup of 
cells (schematically illustrated in black in [B]) of a pre-existing epithelium (A) is assigned 
to undergo branching morphogenesis by the expression of a specific subset of 
transcription factors and/or signalling mediators. As a consequence of this determination 
step, these cells invaginate or form a primary bud (C). Branch formation is then initiated in 
the invaginated (or budded) structure (from [D] to [E]) and the branching process can be 
reiterated numerous times (F). In addition, lateral branches can be induced. After the 
branching process, complex processes lead to the development of specialized terminal 
structures, a process that is different in different branched organs. Because the 
development of the vascular system does not in general follow the scheme outlined in this 
figure, we have excluded in this review a description of how the branched aspects of the 
arterial and venous network arises (Affolter and Shilo, 2000).  FGF signalling acts as guidance cue and induces directed cell migration 
l is expressed in six dynamic clusters of mesenchymal and epidermal cells 
ound the tracheal placode. Defined numbers of tracheal cells migrate toward 
ese clusters in a stereotyped manner and form the six primary branches. Bnl 
pression is downregulated when the tracheal cells reach the clusters.  
e tracheal cells react to Bnl with the formation of dynamic actin containing 
podial extensions. Experiments have shown that FGF signalling induces 
toskeletal dynamics in the absence of transcriptional induction of any known 
ne. It is suggested that Dpp signalling is required for stabilising the 
tgrowing branches (Ribeiro et al., 2002).  
 btl and bnl mutants, the specification of tracheal cells is normal and the 
code invaginates but the tracheal cells fail to migrate and primary branch 
tgrowth is blocked. Spatial regulation of Btl activity by the ligand Bnl is 
sential for the outgrowth of primary branches in the right directions (Lee et al., 
96). In contrast, ectopic Bnl can redirect tracheal cell migration to new sites of 
pression, demonstrating its role as chemoattractant (Sutherland et al., 1996).  
ch of these branches has a defined identity that specifies tube size and the 
bsequent determination of specialised cell fates at precise positions and in 
e appropriate number. 
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Bnl expression near the end of the primary branches not only guides primary 
branch outgrowth but also activates transcription of genes that activates the 
program of secondary and terminal branching, such as the ETS domain 
containing transcription factor Pointed that is required to form secondary 
branches (Samakovlis et al., 1996) and the Drosophila Serum Response Factor 
homologue Blistered/DSRF required for terminal branch formation (Guillemin et 
al., 1996). 
d) Secondary and terminal branch formation 
Secondary branches sprout from the primary branches and are unicellular tubes 
that subsequently ramify into dozens of terminal branches, which are long 
cytoplasmic extensions also forming a lumen and transporting oxygen directly to 
the target tissues. Fusion cells at the extremity of dorsal and lateral branches 
and the dorsal trunk allow the interconnection of adjacent tracheal metamers, 
leading to the formation of a continuous luminal network (Samakovlis et al., 
1996). The Wg pathway is required for the formation of the dorsal trunk by 
activating the expression of the transcription factor Spalt (Sal) (Franch-Marro 
and Casanova, 2002) that specifies DT cell fate and the fusion markers 
Escargot, Fusion-2 and Fusion-3. Additionally, Wg signalling acts in concert 
with Bnl to regulate Notch signalling by stimulating Delta expression limiting the 
number of fusion cells. (Chihara and Hayashi, 2000; Llimargas, 2000). A 
hunchback (hb) expressing bridge cell of mesodermal origin has shown to be 
essential to complete migration and the fusion process of the dorsal trunk (Wolf 
and Schuh, 2000). 
The dramatic growth of the tracheal network does not involve cell proliferation 
or apoptosis. The branches form by migration, rearrangement and by cell 
elongation. These conditions allow a precise investigation of the induction of the 
cell migratory response in absence of cell division in a developing organ 
(Samakovlis et al., 1996). 
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2.4 FGF as chemoattractant of the air sacs 
Bnl also plays a key role in the development of the tracheal system of the adult. 
Metamorphosis transforms the Drosophila larvae into an adult fly by consuming 
larval tissues and creating new organs using imaginal cells. A new tracheal 
system has to be built that will satisfy the aerobic requirements of the 
specialised tissues of the adult. But in addition, the organs of the pupa must be 
kept oxygenated while the adult develops. Transformation of the tracheal 
system begins during the third larval instar when imaginal tracheoblasts start to 
divide (reviewed in(Manning and Krasnow, 1993). 
The proliferating tracheoblasts spread over the larval tracheal system using it as 
a scaffold to form an extensive branching network before the larval cells 
histolyze. Some tracheoblasts elaborate coiled structures those are unique to 
the pupa. Others grow to form the air sacs of the adult, which are large 
reservoirs that are juxtaposed to major muscle systems, and to the brain. 
The majority of the adult thorax, the epidermis, the wing and flight muscle are 
produced by the wing imaginal disc (reviewed in (Cohen et al., 1993). This 
organ arises as a tubular invagination of the epidermis and when it grows and 
flattens during larval development, it develops four distinct cell types: 
Squamous peripodial cells on the surface, columnar epithelial cells on the other 
surface, a distinct group of adepithelial cells that nestle against the most 
proximal columnar epithelial cells and finally stalk cells that connect the disc to 
the epidermis. A large tracheal branch attaches to the columnar epithelial 
surface. It does not ramify to generate contacts with the disc cells. There are 
some adepithelial cells with tracheal identity (tracheoblasts) that maintain 
continuity with the cells of the main tracheal branch. These cells are precursors 
of the adult tracheal air sacs. They extend long cytoneme-like filopodia and 
migrate and proliferate in response to Bnl that is expressed in small groups of 
the columnar epithelium. At third larval instar, btl expressing adepithelial cells 
bud from the tracheal branch, increase in cell number and expand posterior 
toward the region of greatest bnl expression. These btl-expressing cells do not 
express htl at the same time and in contrast to tracheal cells do not form a 
lumen. How the air sacs are finally connected to the tracheal lumen is unknown. 
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Experiments inducing mitotic clones have shown that Bnl is sufficient to induce 
tracheoblast cell migration by inducing oriented filopodia formation in the 
tracheoblasts. Thus, spatially regulated Btl activity is required to induce cell 
migration and proliferation in tracheoblasts.  
This process that induces air sac tracheoblasts in the wing disc may be 
common to other discs as well, since bnl and btl are also expressed in the leg 
and eye disc after pupa formation (Sato and Kornberg, 2002). 
 
 
 
 
 
 
 
 
 
 
 Figure 15: Schematic representation of larval air sac 
development. (G–I) Schematic drawings showing FGF and 
FGF receptor expression in late third instar wing discs: TB, 
tracheoblasts (green spotted area); CE, columnar epithelium; 
AE, adepithelial cells; PM, peripodial cells; Tr, trachea; S, 
stalk. Scale bars are 100 µm (A–D) and 50 µm (E and F). (Q–
S) Schematic drawings of the formation of thoracic air sacs. 
Larva (Q), pupa (R), and adult (S) are shown. Tracheoblasts 
and air sacs, red; spiracular branches (SB), green; both air 
sac tracheoblasts and spiracular branches connect to 
transverse connectives (TC), which extend from dorsal trunks 
(DT) to lateral trunks (LT). Dorsal branches (DB) connect 
dorsal trunks. Bundles of tracheoles along dorsal branch 2 in 
(R) are pupal tracheae, which extend to the developing flight 
muscle prior to air sac formation (Sato and Kornberg, 2002).  57
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 Aim of the thesis 
FGF signalling is involved in numerous developmental processes ranging from 
cell determination to mitogenesis, and cell survival to cell migration. 
Interestingly, the same signalling pathway is used reiteratively throughout 
development and the question regarding the intracellular specificity is raised. 
Little is known about the intracellular signalling events of the FGF signalling 
pathway leading to specific cellular responses. Since the FGF signal is essential 
throughout embryonic and adult development and plays a role in many 
pathogenical processes, it is important to identify the factors, which determine 
the differential responses. 
 
We were interested to investigate the specificity of FGF signalling in a 
developmental context, in which the signal induces directed cell migration, a 
cellular phenomenon that relies on changes of the cytoskeletal architecture. 
During gastrulation in early embryonic development, but also during the 
formation of organs in mammals and in Drosophila, FGFs have been shown to 
act as chemoattractants and guide cells toward their targets (Cardoso, 2001; 
Dormann and Weijer, 2003; Sutherland et al., 1996; Warburton et al., 2000; 
Yang et al., 2002). 
We were wondering whether the FGF signal not only guides the cells in specific 
directions, but also whether it directly regulates cytoskeletal rearrangements 
thereby inducing cell movement. 
 
In Drosophila, only the FGF homologue Branchless, the FGF receptor 
homologue Breathless and the adapter protein Downstream-of-FGFR (Dof) 
have been identified so far as essential components for tracheal and 
mesodermal cell migration.  
 
The aim of the thesis was the functional characterization of Breathless to 
identify domains that specifically interact with adapters eliciting chemotaxis by 
providing a link to the cytoskeleteton. 
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To address the question of FGF signalling specificity in the induction of directed 
cell movement, we asked whether FGF signalling provides specificity due to its 
specific intrinsic interpretation or whether the intracellular part of the receptor 
can be replaced by another RTK. 
 
Additionally, we wanted to analyze the role of Dof. We asked whether Dof is a 
FGF-specific signalling mediator, or whether it is required by other RTKs to 
transmit the migratory cellular response.  
Since we found that Dof acts exclusively in the FGF signalling pathway, we 
were wondering, whether Dof directly interacts with the FGF receptors and if so, 
with which domain of the receptors Dof interacts with. We performed a 
functional deletion analysis of Breathless in vivo and in vitro to address this 
question. 
 
Another aspect we wanted to investigate was, whether Dof is a functional 
homologue of the vertebrate scaffolding adapter protein FRS2, which has been 
shown to recruit the Grb2/SOS complex and the phosphatase Shp2 to the 
activated FGFRs. 
 
Further, we wanted to investigate other known downstream FGF signalling 
components for their capacity to induce a migratory response. 
Experiments in vertebrates have shown that the Rho family of small GTPases 
regulate focal adhesion assembly, disassembly and induce filopodia and 
lamellipodia. It is still not known how RTKs and other downstream targets 
regulate the small GTPases, neither in vertebrates nor in Drosophila. The 
GTPase homologues in Drosophila were tested for their function in migration. 
Further we tested whether additional components of the conserved MAPK 
cascade provide a cytoplasmic link to the cytoskeleton.  
 
And finally, we were interested in the question of whether the migratory 
response is only activated in the tip cells of the outgrowing tracheal branches, 
the following cells being pulled by cell-cell adhesions, or whether all tracheal 
cells have the capacity to migrate. 
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 Experiments:  
Functional dissection of the FGF signalling 
pathway 
I. The GAL4-UAS system for directed gene 
misexpression 
The GAL4-UAS system is a very effective systematic misexpression system. 
The yeast transcriptional activator Gal4 can be used to regulate gene 
expression in Drosophila by inserting the upstream activating sequence (UAS), 
to which Gal4 binds, next to a gene of interest (gene X). The Gal4 gene has 
been inserted at random positions in the Drosophila genome to generate 
enhancer trap lines that express Gal4 under the control of nearby genomic 
enhancers. There is now a large collection of lines that express Gal4 in a variety 
of cell-type and tissue specific pattern. The expression of gene X can be driven 
in any of these patterns by crossing the appropriate Gal4 enhancer-trap line to 
flies that carry the UAS-gene X transgene (Brand and Perrimon, 1993; St 
Johnston, 2002). 
For most of our studies, we made use of an engineered btl-Gal4 driver line 
generated by the group of Shigeo Hayashi (Shiga et al., 1996).  
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 Figure 1: Directed gene expression in Drosophila.
Transgenic lines were  generated in which the GAL4 
gene was inserted randomly into the genome driving 
GAL4 expression from specific genomic enhancers. A 
GAL4-dependent target gene could then be 
constructed by subcloning the sequence of interest 
behind the GAL4 binding sites. To activate the target 
gene, flies carrying the target (UAS gene X) were 
crossed to flies expressing GAL4 (enhancer trap 
GAL4). In the progeny of this cross, the effect of the 
directed misexpression could be observed (Brand and 
Perrimon, 1993; St Johnston, 2002). 61
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II. Localization of Breathless in the outgrowing 
tracheal branches 
First, we were interested in Btl localization in migrating tracheal cells. 
Directional cell movement requires a defined cell polarity in which cytoskeletal 
components are differentially localized at two poles of the cell. This polarization 
can be an intrinsic property of the cell or can arise in response to directional 
signals. The question arises whether in migrating tracheal tip cells Btl 
accumulates at the leading edge, or whether it is distributed uniformly 
throughout the plasmamembrane and only receptors in close proximity to the 
spatially controlled ligand get activated. Experiments have shown that Bnl 
signalling induces long filopodia in direction of the guidance cue in the tip cells 
of the outgrowing primary branches (Ribeiro et al., 2002).  
 
Figure 2: Localization of Btl-GFP. View on tip cell 
of an outgrowing dorsal branch (red arrowhead). 
Expression of the fusion protein Btl-GFP was 
regulated by btl-GAL4. Btl-GFP accumulated in bright 
spots within the cytoplasma and along the filopodial 
extensions (white arrow).  
 
A btl-GFP fusion construct was expressed specifically in the tracheal system by 
the btl-Gal4 driver. Btl was linked to the fluorescent tag called green fluorescent 
protein (GFP) allowing the visualization of the location and trafficking of the 
protein of interest in vivo.  
We observed Btl-GFP concentrated in bright spots in the cytpoplasma of all 
tracheal cells and along the filopodial extensions (Fig.2, white arrow). The tip 
cell of an outgrowing dorsal branch is shown with long filopodia (Fig.2, red 
arrowhead) in direction of the ligand source. This phenomenon was also 
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observed in another context (filopodia of tracheoblasts in airbags) by Sato and 
Kornberg (Sato and Kornberg, 2002). Interestingly, the filopodia may have the 
capability to sense Bnl and activate the signal by presenting the receptor as 
close as possible to the ligand source. But a more likely explanation is that, due 
to overexpression of the btl-gfp transgene by the Gal4-UAS system, these 
bright spots are vesicle structures, internalizing and downregulating the 
receptors.  
 
Acknowledgements: 
Thomas B. Kornberg kindly provided the UAS btl-gfp line. 
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III. Publication: Specificity of FGF signalling in cell 
migration in Drosophila 
 
Caroline Dossenbach, Salome Röck and Markus Affolter 
Development 128, 4563-4572 (2001) 
 
A biological response is determined by the combination of pathways 
transducing a signal from a cell surface RTK receptor to a spectrum of 
signalling molecules present in a given cell. Specificity can be achieved by a 
dedicated factor acting downstream of a receptor and by recruiting and 
activating novel combinations of additional signalling molecules. 
Thus, the activation of tissue specific effectors, as for example Dof, can 
determine the unique effect of cell the migratory response upon activation of 
RTKs.  
In the following paper, we surprisingly found that tracheal and mesodermal cells 
respond to a RTK signal with directed cell migration independent of the 
presence or absence of Dof. Thus, Dof is a specific adapter protein of FGF 
signalling triggering downstream cellular responses.  
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IV. Publication: Downstream-of-FGFR (Dof) is a FGF-
specific scaffolding protein and recruits 
Corkscrew upon receptor activation 
 
Valérie Petit, Ute Nussbaumer, Caroline Dossenbach and Markus Affolter 
Molecular and Cellular Biology, May 2004, in press 
 
In this paper, a functional characterisation of Dof was performed, by combining 
reverse genetic and biochemical approaches. It was demonstrated that Dof is a 
specific substrate for the two Drosophila FGFRs. The N-terminal region of Dof 
was defined to interact constitutively with the kinase domain of Btl. 
Tyrosine 515 becomes phosphorylated upon receptor activation and recruits 
Csw, an essential step in FGF-induced cell migration and the activation of the 
Ras/MAPK pathway. However, the activation of Ras is not sufficient to activate 
the migration machinery in tracheal and mesodermal cells. 
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V. Functional deletion analysis of Breathless (Btl) in 
vivo and in vitro  
Expression of a btl cDNA under the indirect control of the tracheal specific 
enhancer btl-Gal4 was sufficient to fully rescue the migration defects of the 
tracheal system in btl mutant embryos (Fig. 5C,C’). The rescue capacity was 
tested under different temperature conditions (18°C, 25°C and 29°C) but we 
could not observe any differences of the rescue potential of the btl transgene at 
the different temperatures. Therefore we decided to induce the rescue by the 
Gal4-UAS system at 25°C for all the following experiments (data not shown).  
For all the experiments, we used the btlH82∆3 null allele, which has been 
generated by imprecise excision of the lacZ-containing P element inserted 
upstream of the btl locus. Homozygous btlH82∆3 mutant embryos did not show 
any btl transcription but retained βGal expression in the tracheal and midline 
cells (Reichman-Fried et al., 1994). 
We used this rescue assay for a functional deletion analysis of Btl, since its 
intracellular domains have not been characterized yet. 
1. Constructs 
Modified UAS btl transgenes were expressed by the btl-Gal4 driver in btl mutant 
embryos in order to identify domains of Btl essential for binding proteins 
triggering the tracheal migratory response. For each construct (Fig.3), four 
transgenic lines were established and tested for their rescue capability. 
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 Figure 3: Schematic representation of Btl derivates tested in vivo. (A) Representation 
of the Btl wild-type construct. SP: signal peptide; AB: acidic box; HB: heparin binding 
domain; TM: transmembrane domain; JM: juxtamembrane domain; KD-N: kinase domain, 
N-terminal lobe; KD-C: kinase domain, C-terminal lobe; CT: C-terminus. (B) Schematic 
representation of the Btl deletion constructs used in the rescue assays. Deletions within the 
juxtamembrane domain (Btl ∆JM1 and Btl ∆JM2), deletion of the whole juxtamembrane 
domain (Btl ∆JM3); deletion of the kinase insert domain (Btl ∆KI); deletion of the C-terminus 
(Btl ∆CT); deletion of the juxtamembrane and the C-terminus (Btl ∆JM3+∆CT). Each 
construct was placed downstream of UAS sequences. irst, the sequence of the juxtamembrane domain of Btl was blasted and 
ompared to the sequence of the vertebrate Btl homologue FGFR2 to identify 
onserved structures of the juxtamembrane domain. This analysis was done to 
nvestigate whether Dof could be a functional homologue of the vertebrate 
caffold adapter FRS2 interacting with the same domain of the receptor. Like 
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FRS2, Dof provides binding motifs of the Drk/SOS complex and the Shp2 
homologue Csw.  
The sequence homology of the two compared juxtamembrane domains is low 
(Fig.4). The sequence within the juxtamembrane domain of FGFR1 (but also 
FGFR2 and 3) required for the specific interaction of the receptor with FRS2, 
was identified as KRIPLRRQVTVS (421-430aa) which includes the alternatively 
spliced VT motif (Burgar et al., 2002). Unfortunately, this conserved VT motif 
(Fig.4, indicated in red) that is essential for the binding of the PTB domain of 
FRS2 is lacking in the Btl juxtamembrane domain.  
 
Btl:   626  XXXXXXXXX--XXXIETVHQWTKKVIIYRPXXXXXXXXXXXDLQMPVIRIEKQRXXXXXXXX 
                             VH+ TK++ + R            +   P++RI  +          
FGFR2: 399  CRMKNTTKKPDFSSQPAVHKLTKRIPLRRQ ESSSSMNSNTPLVRITTRLSSTADTPM 
 
Btl:   686  XXXDPAQGFNEYEFPLDSNWE 
                   G +EYE P D  WE 
FGFR2: 362  LA-----GVSEYELPEDPKWE 
 
VTVSA 
 
 
Figure 4: BLAST of FGFRs juxtamembrane domain sequences. The sequence of the 
juxtamembrane domain sequence of Btl compared to the sequence of the juxtamembrane domain of 
FGFR2. The conserved VT-motif essential for the PTB domain of FRS2 binding within the sequence 
of FGFR2 is highlighted in red. Btl lacks this motif. The conserved phospho-tyrosine within the Crk 
binding motif is indicated in blue. 
 
 
Nevertheless, we generated three deletions within the juxtamembrane domain. 
The first region of 641-671aa that was deleted, corresponds to the stretch of 
amino acids of the juxtamembrane domain of FGFR1 FRS2 constitutively 
interacts with (Fig.3B, Btl ∆JM 1). The second deletion (672-699aa) contains the 
conserved phosphotyrosine binding motif of Crk in vertebrate FGFRs and Btl 
(Fig3B, Btl ∆JM 2) (Fig.4, indicated in blue). The third deletion eliminates the 
whole juxtamembrane domain (641-699aa) (Fig.3B, Btl ∆JM 3). 
The two phosphotyrosines within the kinase insert domain of FGFR1 (Y583 and 
Y585) and FGFR2 have been shown to be essential for the mitogenic response 
in vertebrates (Wang et al., 1996). FGFR3 contains only one phosphotyrosine 
and is weakly mitogenic. Btl also only contains one putative phosphotyrosine 
within the kinase insert domain and could provide another functional binding 
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site. Thus, we deleted the kinase insert domain (814-835aa) of Btl (Fig.3B, Btl 
∆KI). 
Finally, the remaining short C-terminus of Btl has been deleted (1000-1153aa) 
(Fig.3B, Btl ∆CT). The C-terminus contains a phosphotyrosine motif that has 
been shown to interact with PLCγ. However, it has been shown that 
autophosphorylation on the Tyr 766 of FGFR1 is required for efficient 
endocytosis of the receptor, but not for mitogenesis, differentiation or 
chemotaxis (Mohammadi et al., 1996; Partanen et al., 1998). But interestingly, it 
has been demonstrated that a stretch of 15 aa c-terminal of the second kinase 
domain is critical for FGFR1 mediated cell migration in a modified Boyden 
chamber assay. The role of this stretch in regulation of migration has still to be 
determined (Landgren et al., 1998). 
As control, a double deleted truncated receptor lacking the juxtamembrane 
domain and the C-terminus was generated to exclude functional redundancies 
between the two putative interaction domains (Fig.3B, Btl ∆JM 3+∆CT).  
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2. Rescue of tracheal cell migration in btl mutant embryos by the 
truncated Btl receptors 
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 Figure 5: Rescue of tracheal cell migration by truncated versions of Btl. BtlH82∆3
embryos expressing btl transgenes lacking either the juxtamembrane domain, the kinase 
insert domain or the C-terminus rescued tracheal cell migration and induced terminal cell 
fates. The lumen of the tracheal system was visualized with the 2A12 antibody (green; A-I, 
red; A’-I’). Terminal cells were visualized with the anti-DSRF antibody (green; A’-I’). 
Confocal projections of a representative embryo are shown of a (A,A’) wild-type embryo, 
(B,B’) a rescued btlH82∆3 embryo expressing the UAS btl transgene under the control of the 
btl-GAL4 driver and (C,C’) a btlH82∆3 mutant embryo. Rescued btlH82∆3 embryos expressing 
the following Btl derivates under the control of btl-GAL4 are shown: (D,D’) UAS btl ∆JM1, 
(E,E’) UAS btl JM∆2, (F,F’) UAS btl ∆JM3, (G,G’) UAS btl ∆KI, (H,H’) UAS btl ∆CT, (I,I’) 
UAS btl ∆JM3+∆CT. The yellow arrowhead points on the lacking ganglionic branches 
(D,E,F,H), the red arrowhead on dorsal trunk or lateral trunk fusion defects (D,E,F,H), and 
the white arrowhead on dorsal branch outgrowth defects (D,F). Abbreviations: JM: 
juxtamembrane domain; KI: kinase insert; CT: C-terminus. tl mutant embryos expressing deleted versions of Btl either lacking the first 
tretch of the juxtamembrane domain from amino acid 641-671 (Fig.5,D,D’), the 
econd stretch from amino acid 672-699 (Fig.5E,E’) or the whole 
uxtamembrane domain from amino acid 641-699 (Fig.5F,F’) were able to 
ubstitute the UAS btl-transgene (Fig.5B,B’) by rescuing tracheal cell migration 
lmost completely.  
owever, the rescue capacity of the truncated receptors was less efficient than 
he wild type btl transgene (Fig.5D,E,F). In some segments, the dorsal trunk 
nd the lateral trunk failed to fuse (red arrowheads) and the dorsal branches 
ere rescued with various efficiency (white arrowheads). The visceral branches 
ere misguided sometimes. Interestingly, one of the major defects was the 
omplete lack of ganglionic branches (yellow arrowheads). 
e were wondering whether these minor defects were due to a reduced 
fficiency of signal transmission. To investigate whether transcriptional 
ctivation is induced, we looked at the expression of the terminal cell fate 
arker blistered/DSRF, a transcriptional target of Bnl signalling and the 
ownstream MAPK cascade (Fig.5,A’-I’). Indeed, induction of terminal cells was 
lso reduced in the rescued tracheal systems by the transgenes UAS btl ∆JM 1-
 (Fig.5D’,E’,F’), indicating a less efficient signal propagation via the MAPK 
ascade (compare to the wild type tracheal system with the stereotyped pattern 
f terminal cells) (Fig.5A’ or Fig.5B’). 
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We observed a similar rescued tracheal system phenotype when a btl 
transgene lacking the C-terminus (1000-1153aa) was expressed in btl mutant 
embryos (Fig.5H,H’). Expression of the btl transgene lacking the kinase insert 
domain (814-835aa) completely restored the tracheal system (Fig.5G,G’).  
Albeit with reduced efficiency, all these transgenes were able to rescue all six 
primary branch outgrowth and branch fusion occurred in most segments. 
Unexpected and in contrast to the vertebrate FGFRs (Hadari et al., 2001; 
Landgren et al., 1998), the crucial link of Btl to the cytoskeleton is neither 
provided by the juxtamembrane domain, nor by the kinase insert domain, nor by 
the C-terminus. 
As control, a double deletion construct consisting intracellular only of the kinase 
and kinase insert domain (Fig.5I,I’) was tested for its rescue capacity to identify 
possible functional redundancies within the juxtamembrane domain and the C-
terminus. This truncated receptor was not able to rescue tracheal cell migration 
anymore, although some dorsal branches and lateral trunk cells migrated and in 
some segments the dorsal trunk fused. These minor migration events were 
never observed in btl mutant embryos (Fig.5C,C’). Additionally and in contrast 
to btl mutant embryos, blistered/DSRF was induced (Fig.5I’). 
The loss of a complete rescue potential is probably due to steric defects of the 
dimerising receptors. The kinase domain fails to undergo proper conformational 
changes due to its close proximity and interactions with the plasmamembrane. 
Thus the kinase activity could be reduced because the tyrosines essential for 
kinase activity are not presented in the optimal conformational state to get 
trans-phosphorylated. 
3. S2 assay: Molecular analysis of the Btl-Dof interaction 
Previous experiments have shown that Dof is a phosphotarget of Btl and Htl 
(Petit et al., 2004; (Wilson et al., 2004) and that Dof is an essential and specific 
FGF signalling mediator for tracheal and mesodermal cell migration 
(Dossenbach et al., 2001; Imam et al., 1999; Michelson et al., 1998a; Vincent et 
al., 1998). 
 
72
Experiments 
 
We addressed the question, whether rescue of cell migration in btl mutant 
embryos by the truncated receptors is due to their remaining capacity to interact 
with Dof thereby phosphorylating Dof. We generated myc-tagged constitutive 
active versions of the truncated receptors by exchanging the extracellular and 
transmembrane domain of Btl with the one of Torso4021 (mycTor4021-Btl) 
(Reichman-Fried et al., 1994). These modified receptors were expressed in 
Drosophila Schneider cells (S2) together with Dof1-600 (V5-tagged) that has 
been considered as minimal Dof protein (Petit et al., 2004) under the control of 
a heavy metal-inducible promoter (see Materials and Methods). 
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Figure 6: Dof interacts with the kinase domain of Btl and gets phosphorylated upon FGF 
signalling. S2 cells transfected with the following plasmids: lane 1: myc- tor4021-btl ∆JM1+dof600-
V5; lane 2: myc- tor4021-btl ∆JM2+dof600-V5; lane 3: myc- tor4021-btl ∆JM3+dof600-V5; lane 4: myc-
tor4021-btl ∆CT+dof600-V5; lane 5: myc- tor4021-btl (∆JM3+∆CT)+dof600-V5; lane 6: myc- tor4021-btl 
+dof600-V5; lane 7: myc-btl+dof600-V5; lane 8: myc-btl kinase dead+dof600-V5; lane 9: myc-
tor4021-btl ∆KI+dof600-V5. The cells were lysed after 20h induction of expression with 0.6mM 
CuSO4. (A) Whole cell lysates were subjected to SDS-PAGE and tyrosine phosphorylation levels 
were examined by anti-phosphotyrosine immunoblotting. Protein levels were evaluated for the 
receptors with anti-myc antibodies and for dof600 with anti-V5 antibodies. (B) S2 cells were 
transfected with the indicated combinations of constructs as described in (A) lane 1-9. Whole cell 
lysates were immunoprecipitated with anti-Myc antibodies, subjected to SDS-PAGE and 
immunoblotted with anti-V5 antibodies. Ig: Immunoglobulins. 
 
 
As control, we expressed the constitutive active Btl (Tor4021-Btl). Co-expression 
of Dof1-600 resulted in strong phosphorylation of Dof detected with an anti-
phospho-tyrosine antibody (Fig6A, lane6).  
The non-activated receptor with the extracellular and intracellular domain of Btl 
was expressed as negative control. These non-activated receptors should not 
be able to dimerize in absence of the ligand. Unexpectedly, the receptors auto-
activated their kinase activity, probably due to their overexpression in the S2 
cells (Fig.6A, lane7). Consequently, we decided to generate a kinase-dead 
version of Btl in which the conserved lysine in the ATP binding domain was 
substituted with an arginine as described by T. Lee (Lee et al., 1996). Indeed, 
the kinase-dead receptor did not phosphorylate Dof anymore (Fig.6A, lane8). 
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Dof1-600 got strongly phosphorylated upon expression of the receptors lacking 
amino acid stretches of the juxtamembrane domain. Lane1 corresponds to 
Tor4021-Btl ∆JM 1, lane2 to Tor4021-Btl ∆JM 2 and lane 3 to Tor4021-Btl ∆JM 3. 
Surprisingly, the receptors lacking the C-terminus (Tor4021-Btl ∆CT) or both 
domains, the juxtamembrane domain and the C-terminus (Tor4021-Btl ∆JM 
3+∆CT), were not able to phosphorylate Dof1-600 (Fig.6A, lane4 and 5). The 
experiment was repeated using Dof full-length to investigate whether the C-
terminal part of Dof is required to interact with the C-terminus of Btl. Also Dof 
full-length was not phosphorylated upon expression of the c-terminal truncated 
receptors (data not shown).  
In contrast, in vivo, Btl lacking the C-terminus almost completely rescued 
tracheal cell migration in btl mutant embryos and we know from previous 
experiments that tracheal cell migration is absolutely dependent on Dof (Imam 
et al., 1999; Vincent et al., 1998). We assume that interaction with Btl and 
subsequent phosphorylation of Dof is essential to recruit other molecules that 
are putative migratory signalling mediators (Petit et al., 2004; (Wilson et al., 
2004). However, we could not even detect any phosphorylation of the c-terminal 
truncated receptors themselves in S2 cells (compare to the other lanes where 
the receptor tyrosine phosphorylation is indicated by arrows). This result 
indicates that the C-terminus is essential to allow the receptors to dimerize and 
to undergo the subsequent conformational changes, transphosphorylation and 
upregulation of the kinase activity. As consequence, we assume that the 
phosphorylation of Dof as downstream target is not possible. The receptors 
lacking the kinase insert domain phosphorylated Dof1-600 (Fig.6A, lane9).  
From these results we can conclude that neither the juxtamembrane domain nor 
the kinase insert domain function as Dof interaction domains. According to the 
in vivo data also the C-terminus can be excluded. 
 
Since Dof gets phosphorylated by the activated Btl receptors (including the 
truncated versions), we were interested to study whether Dof directly interacts 
with the receptor and if so, whether it interacts with the kinase domain. S2 cells 
were co-transfected with the myc-tagged activated version of Btl and V5-tagged 
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Dof1-600 and we investigated the capability of these two proteins to form a 
complex by co-immunoprecipitation with an anti-myc antibody from S2 cell 
lysates. The SDS pages were blotted with an anti-V5 antibody.  
Dof1-600 was able to form a complex with the activated Btl receptor (Fig.6B, 
lane6). The receptors lacking parts of the juxtamembrane domain (Fig.5B, 
lanes1-3) and the receptor lacking the kinase insert domain (Fig.5B, lane9) also 
formed a complex with Dof 1-600.  
Receptors lacking the C-terminus do not co-immunoprecipitate with Dof1-600, 
which is in line with the previous results that have shown the incapability of 
these receptors to phosphorylate Dof (Fig.6B, lanes4-5).  
However, from the in vivo results we concluded that the C-terminus can not 
provide the interaction domain of Dof and we analyzed whether Dof could 
interact with the kinase domain of Btl and whether this interaction is dependent 
on the phosphorylation state of the receptor.  
Interestingly, Dof co-immunoprecipitated with the kinase-dead version of Btl 
indicating a direct and constitutive interaction with the kinase domain of the 
receptor independent of the activation state (Fig.6B, lane8). Recent data 
confirms these results. In yeast two hybrid assays, Dof has been shown to 
directly interact with the kinase domain of both Btl and Htl (Battersby et al., 
2003). 
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VI. The role of Dras, Draf and Rolled in the migratory 
response 
Two downstream signalling components have already been identified to play an 
essential role in mediating the FGF signal to the migration machinery, the 
adapter Dof and the phosphatase Csw (Petit et al., 2004; (Imam et al., 1999; 
Johnson Hamlet and Perkins, 2001a; Michelson et al., 1998a; Perkins et al., 
1996a; Vincent et al., 1998). Further experiments have shown that recruitment 
of Csw via Dof is also essential for the activation of the MAPK pathway and 
transcriptional activity (Petit et al., 2004; (Gabay et al., 1997a).  
Either Csw or its downstream targets could provide the essential link to the 
cytoskeletal components. Csw has been shown to act as positive signalling 
transducer and activator of Ras in Torso, EGFR and Sevenless signalling 
pathways (Johnson Hamlet and Perkins, 2001a; Perkins et al., 1996a). Since 
the csw mutant phenotype shows impaired tracheal and mesodermal cell 
migration, the question is raised whether the MAPK cascade induces the 
migratory response or whether unidentified components activated by the 
phosphatase activity of Csw induce migration. Ras and the MAPK not only 
induce transcriptional activity but have also a wide range of substrates in the 
cytoplasma. In later stages of the tracheal development, the activation of the 
MAPK can be observed only in migrating tip cells suggesting an additional role 
in inducing cytoskeletal rearrangements (Gabay et al., 1997a; Sutherland et al., 
1996). The following experiments try to identify the function of Ras, Raf and 
Rolled (MAPK) in the process of cell migration. 
1. Ras effector mutants 
Activation of the small GTPase Ras is associated with a wide variety of cellular 
responses. In Drosophila, Ras specifies the larval head and tail structures, the 
ventral ectoderm fate and the dorso-ventral polarity in the eggshell. In imaginal 
discs, Ras is required for cell growth, differentiation of wing veins and 
photoreceptor cells. Since Ras is such an essential signalling component of 
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RTK signalling during egg and embryonic development, it is impossible to 
investigate Ras maternal and zygotic mutant embryos. The embryos die at early 
stages, because Ras null mutant cells fail to differentiate and undergo apoptosis 
upon exit from the cell cycle. Only effects of constitutive active (RasV12) and 
dominant negative Ras (RasN17) can be investigated, but overexpression of a 
constitutive active form of Ras does not reflect the physiological situation, 
especially during tracheal primary outgrowth where Ras gets locally activated in 
the tip cells upon Bnl signalling.  
But interestingly, in cultured cells, the constitutive active Ras induces 
membrane ruffling due to cortical actin rearrangements. 
Molecular defined partial loss of function mutations of Ras that affect specific 
signalling pathways downstream of Ras could provide further insights to the 
function of Ras. Single amino acid substitutions in the Ras effector loop result in 
Ras variants that interact only with one of the putative effector molecules known 
(Halfar et al., 2001; Rommel and Hafen, 1998). 
RasV12E38 interacts with the serine-threonine kinase Raf but no longer with 
other effector proteins. RasV12C40 exclusively interacts with the PI3K, another 
downstream effector of Ras, and RasV12G37 only interacts with the small G-
protein Ral. At present, the function of Ral is unknown. Recently, a protein that 
interacts with Ral has been identified containing a RacGAP domain (Rodriguez-
Viciana et al., 1997; Rommel and Hafen, 1998) providing an interesting link to 
the Rho family of small GTPases that regulate cytoskeletal rearrangements. 
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 Figure 7: Ectopic activation of Ras is required but not sufficient to rescue tracheal 
cell migration. No rescue by expression of partial loss of function mutations of Ras 
that affect specific signalling pathways downstream of Ras. The lumen of the tracheal 
system was visualized with the 2A12 antibody (green; A-L, red; A’-L’). Terminal cells were 
visualized with the anti-DSRF antibody (green; A’-L’).  A) Rescued btlH82∆3 embryos 
expressing a btl wild-type transgene under the control of btl-GAL4. B) Rescued dof1740
embryo expressing a dof wild-type transgene. The irregular pattern of the tracheal system is 
due to mesodermal defects in dof1740 embryos. (C) BtlH82∆3 embryo. (D) Dof1740 embryo. 
Rescued btlH82∆3 and dof1740 embryos expressing the following Ras constructs under the 
control of btl-GAL4: (E,F) UAS ras V12, constitutive active Ras; (E’,F’) Ectopic terminal cells 
in embryos expressing UAS ras V12; (G,H) UAS ras V12 E38, target specific Ras mutation 
exclusively activating Raf; (I,J) UAS ras V12 G37, target specific Ras mutation exclusively 
activating Ral; (K,L) UAS ras V12 C40, target specific Ras mutation exclusively activating 
PI3K. o address the question whether Ras is able to rescue tracheal cell migration 
efects, we expressed the constitutive active form of Ras (UAS rasV12) in 
tlH82∆3 (Fig.7C) and dofp1740 (Fig.7D) (Vincent et al., 1998) null mutant embryos 
nder the control of btl-Gal4.  
s controls, we showed the complete rescue of tracheal cell migration by 
xpression of the UAS btl transgene in a btl mutant embryo (Fig.7A) and the 
escue of an UAS dof transgene in a dof mutant embryo (Fig.7B).  
s shown in Fig.7E and F, the transgene UAS rasV12 was able to rescue 
odestly tracheal cell migration, either in btl or in dof mutant embryos. Ectopic 
ctivation of the transcriptional target blistered/DSRF, which resulted in 
dditional terminal cells, could also be observed (Fig.7E’,F’).  
xpression of the target specific Ras mutation activating only Raf seemed to be 
ufficient to rescue minor cell migration and dorsal trunk fusion in btl and dof 
utant embryos (Fig.7,G,H). It activated also transcription of blistered/DSRF 
lbeit reduced compared to RasV12 (Fig.7,G’,H’).  
he specific activation of the effectors Ral and PI3K neither rescued tracheal 
ell migration nor induced dorsal trunk fusion in btl and dof mutant embryos 
Fig.7I,I’,J,J’,K,K’,L,L’). 
n general, we could observe a reduction in transcriptional activity by all the 
arget specific mutations of Ras. 
rom these results, we conclude that ectopic activation of Ras in the tracheal 
ells is required but not sufficient to rescue tracheal cell migration.  
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2. Local activation of Raf 
Since Ras is ectopically expressed and constitutive active in all tracheal cells, 
the question arises, whether local activation of Ras would be sufficient to rescue 
completely directional tracheal cell migration upon Bnl signalling. 
Experimentally, it is difficult to activate a small GTPase in a distinct subset of 
tracheal cells. Therefore, we decided to activate the downstream serine-
threonine kinase Raf locally.  
A chimeric UAS torso-raf construct has already been generated by B. Dickson, 
where the kinase domain of Raf was fused to the extracellular and 
transmembrane domain of Tor (Dickson et al., 1992).  
We adapted this construct and generated a fusion protein with the extracellular 
and transmembrane domain of Btl fused to the kinase domain of Raf (330-
740aa). With the extracellular domain of Btl, we ensured the correct spatial and 
temporal activation of the construct UAS btl-raf by Bnl in btl and btl,dof double 
mutant embryos. 
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 Figure 8: Local activation of Raf. The lumen of the tracheal system was visualized with 
the 2A12 antibody (green; A-F, red; A’-F’). Terminal cells were visualized with the anti-
DSRF antibody (green; A’-F’). (A) Wild-type embryo. (B) btlH82∆3 embryo expressing a btl
wild-type construct under the control of btl-GAL4. (C) btlH82∆3 embryo. (D) btlH82∆3, dof1740 
double mutant embryo expressing a btl wild-type construct. In the absence of Dof there is 
no rescue of tracheal cell migration. (E) btlH82∆3embryo expressing the Btl-Raf fusion protein 
under the control of btl-GAL4. (E’) Ectopic terminal cells in btlH82∆3embryos expressing UAS 
btl-raf. Instead of local Bnl-dependent activation, ectopic activation of the chimeric Btl-Raf 
fusion protein. (F) btlH82∆3, dof1740 embryos expressing UAS btl-raf. (F’) Induction of ectopic 
terminal cell fates in btlH82∆3, dof1740 embryos expressing UAS btl-raf. 83
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As control, we expressed a wild type UAS btl construct under the control of btl-
Gal4 in btl and btl,dof mutant embryos (Fig.8B,B’,D,D’). As previously shown, 
Btl was not able to rescue tracheal cell migration in the absence of Dof (Fig.8D) 
and there was no transcriptional activation of blistered/DSRF (Fig.8D’).  
Unfortunately, the rescue of tracheal cell migration by the expression of the 
chimeric construct UAS btl-raf was poor in btl and btl,dof mutant embryos upon 
the correct activation by Bnl. The rescued tracheal phenotype showed some 
similarity to the expression of activated Ras (UAS RasV12) in btl and dof mutant 
embryos (Fig.7). Expression of UAS btl-raf mainly rescued dorsal trunk fusion in 
btl and btl,dof mutant embryos and induced ectopic terminal cell fates 
(Fig.7E,E’,F,F’). 
These results indicate a constitutive activation of the chimeric Btl-Raf protein in 
all tracheal cells, even in cells that do not receive Bnl signalling. Similar to 
RasV12, constitutive active Raf is not able to restore a wild-type tracheal 
system. 
 
Acknowledgements:  
B. Dickson kindly provided the cDNA of Draf. 
 
3. MAPK activity in tracheal cells 
Thus far, we could show that ectopic activation of Ras or Raf in btl and dof 
mutant embryos is required but not sufficient to rescue directional tracheal cell 
migration. Local activation of Ras or Raf in the tip cells of the outgrowing 
branches was experimentally not possible.  
Another approach to investigate whether the Ras/MAPK signalling is linked to 
the cytoskeleton is the overexpression of components of the Ras/MAPK 
cascade in wild-type embryos. We were interested whether wild type (wt) 
tracheal cells form ectopic filopodia and loose polarity upon overexpression of 
Ras or the MAPK.  
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First evidence that hyper-activated Ras/MAPK signalling does not influence the 
polarity and the capacity of a cell to migrate was gained from the results 
described in chapter III. We could show, that the fusion receptor Btl-Tor 
completely rescued tracheal cell migration in the absence of Btl and Dof. 
Interestingly, rescue by the Btl-Tor receptor in btl,dof mutant embryos hyper-
activated the Ras/MAPK pathway visualized by the ectopic expression of 
blistered/DSRF in the tracheal cells. Almost all cells adapted terminal cell fate. 
These results indicated that even when the Ras/MAPK cascade is hyper-
activated, the cells are still able to respond to Bnl by directional cell movement. 
We analyzed MAPK activity and the induction of blistered/DSRF expression in 
wt embryos expressing UAS btl-tor, UAS bnl, UAS rasV12 and the activated 
version of btl (UAS tor4021-btl) constructs in all tracheal cells under the control of 
the btl-Gal4 driver to investigate effects on tracheal cell migration. 
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Figure 9: Hyperactivity of 
Ras/MAPK signalling does not 
influence the capacity of tracheal 
cells to migrate. The lumen of the 
tracheal system was visualized with 
the 2A12 antibody (red; A-J). MAPK 
activity was visualized with anti-
dpERK antibodies recognizing the 
tyrosine-threonine phosphorylated 
MAPK (dpERK) (green; A,C,E,G,I) 
and terminal cells with the anti-DSRF 
antibody (green; B,D,F,H,J). (A) In 
wild-type embryos (stage 14-16), the 
MAPK activity is restricted to the tip 
cells of the outgrowing branches. (B) 
DSRF expression is restricted to 
cells with terminal cell fate. Confocal 
projections are shown for wild-type 
embryos (stage 16) expressing the 
following constructs under the 
control of btl-GAL4: (C,D) UAS bnl. 
(E,F) UAS btl-tor, stage 14 embryo, 
ectopic MAPK activation in all 
tracheal cells. (G,H) UAS ras V12, 
stage 14 embryo, ectopic MAPK 
activation in all tracheal cells. (I,J) 
UAS tor4021-btl.  
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In wt embryos, the MAPK is activated in the outgrowing tip cells of the dorsal 
branch, the visceral branches, the lateral trunk anterior and posterior and the 
ganglionic branches (Fig.9A) (Gabay et al., 1997a; Ohshiro et al., 2002). MAPK 
activity was visualized by the anti-dpERK antibody that recognizes the tyrosine-
threonine phosphorylated MAPK (dpERK) (Fig.9A,C,E,G,I). At the same time, 
terminal cells were highlighted by the expression of blistered/DSRF 
(Fig.9B,D,F,H,J). 
Under conditions in which wt tracheal cells sustain high levels of Ras activity 
upon RasV12 overexpression, cells were not disturbed in their migration 
behaviour (Fig.9G,H). 
In contrast, ectopic expression of the ligand Bnl completely blocked directional 
primary branch outgrowth. The MAPK was ectopically activated which resulted 
in ramifying ectopic terminal branches (Fig.9C,D). 
Expression of the chimeric receptor Btl-Tor did not influence the direction of 
migration of wt tracheal cells although the MAPK was activated in all cells at 
stages where usually MAPK activity is restricted to the tip cells (Fig.9E,F). 
 
 
 
 
 
 
 
 
 
 Figure 10: In the absence of Bnl, tracheal cell 
migration is not rescued, but the MAPK is activated 
by Btl-Tor. The lumen of the tracheal system was 
visualized with the 2A12 antibody (red; A,B). MAPK 
activity was visualized with anti-dpERK (green; A,B). 
(A) bnlP1 embryos do not show MAPK activity. (B) bnlP1 
embryos expressing the UAS btl-tor construct. No 
rescue of cell migration but ectopic activation of the 
MAPK. 
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Interestingly, in the absence of Bnl, the chimeric Btl-Tor receptor was not able 
to rescue cell migration anymore but still constitutively activated the MAPK 
(Fig.10B) compared to a bnlP1 null mutant embryo, which lacked Bnl-dependent 
MAPK activity at late stages (Fig.10A).  
Constitutive activation of Btl in all tracheal cells by expression of the UAS 
Tor4021-Btl construct did not disturb tracheal cell migration in wt embryos 
(Fig.9I,J), only bifurcated dorsal branches could be observed (Fig.9J, 
arrowhead).  
Previous experiments showed that the chimeric Tor4021-Btl receptor did not 
provide a strong kinase activity since tyrosine phosphorylation was reduced. 
Another activated Btl receptor (λBtl) was expressed in wt cells resulting in 
disrupted primary branch outgrowth, incomplete dorsal trunk and lateral trunk 
fusion, extra-branching and misguidance of the dorsal and ganglionic branches 
(Lee et al., 1996).  
These results suggest that local activation of the Bnl/Btl signalling, or local 
activation of the chimeric Btl-Tor receptor, is essential for directional outgrowth 
of the tracheal cells to form a functional respiratory system. Ectopic activation of 
either the ligand or the receptor impairs tracheal cell migration. In contrast, 
ectopic activation of either Ras or the MAPK in the tracheal cells does not 
influence the capacity of the cells to move toward the Bnl guiding cue. 
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VII. The Rho family of small GTPases 
The small GTPases of the Rho family have been shown to regulate cytoskeletal 
reorganization, motility and adhesion. In cultured fibroblasts, RhoA is implicated 
in the formation of actin stress fibres and focal adhesions, Rac1 stimulates 
membrane ruffling, lamellipodia, focal complex formation and is present at cell 
junctions, and Cdc42 participate in the formation of filopodia, cell rounding and 
the loss of actin stress fibres. The precise mechanism by which Rho proteins 
affect cytoskeletal changes is not yet understood and even less is known about 
the upstream signalling pathways that lead to the activation of the Rho 
GTPases. 
In Drosophila, six closely related homologues of the mammalian Rho, Rac and 
Cdc42 proteins have been identified thus far. These include Rho1, RhoL, 
Dcdc42 and three Rac homologues, Drac1, Drac2, and Mig-2-like (Mtl, the 
ortholog of C. elegans Mig-2). They are 70-90% conserved to their mammalian 
counterparts. 
The Rho small GTPases are essential proteins functional throughout Drosophila 
embryogenesis in many tissues. Some of them show a more restricted 
expression in the mesoderm, gut and nervous system later in development. 
Several experiments have already shown that also in Drosophila the small 
GTPases may be implicated in the regulation of cytoskeletal reorganizations. 
Dominant negative Drac1 and activated Drac1 have been shown to block 
completely border cell migration during oogenesis without affecting other follicle 
cells (Duchek and Rorth, 2001; Duchek et al., 2001; Murphy and Montell, 1996). 
Drac1 and Dcdc42 are also involved in the stretching of the epidermal cells 
required for dorsal closure. Further, Drac has a specific role in axon outgrowth 
initiation and elongation and activated Dcdc42 inhibits axon and dendrite 
outgrowth. And finally, dominant negative Drac affects myoblast fusion 
(reviewed in (Lu and Settleman, 1999). 
The RhoGEF2 has been shown to be essential for cell shape changes during 
gastrulation (Barrett et al., 1997). 
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Since the small GTPases are essential in early embryonic developmental 
processes, we investigated the effect on tracheal cell migration by the 
expression of activated or dominant interfering alleles of Drac, Dcdc42 and 
Drho. 
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 Figure 11: The small GTPases of the Rho family regulate tracheal cell-cell adhesion 
and actin cytoskeleton reorganizations. Tracheal cells were visualized by anti-
βGalactosidase antibodies (brown; A-I). (A) Confocal projection of a representative wild-type 
embryo expressing the UAS lacZ construct. (B,D,F,H) Wild-type embryos expressing 
constitutive activated versions of the small GTPases Cdc42, Rac, Rho and Mtl were 
crossed to a btl-GAL4 carrying additionally UAS.GFPN.lacZ. (C,E,G,I) represent embryos 
expressing dominant negative versions of the small GTPases Cdc42, Rac, Rho and Mtl. (D) 
Stage 15 embryo expressing the constitutive active form of Rac. (D’) Stage 13 embryo 
expressing the constitutive active form of Rac. Already at early stages, primary branch 
outgrowth is affected. (D’’) Sal expression is visualized with an anti Sal-antibody (Boube et 
al.). Dorsal trunk cell fate specification was normal. Tracheal cells visualized with anti-β
Galactosidase antibody (blue). (E) Stage 15 embryo expressing the dominant negative form 
of Rac. (E’) In stage 13 embryo expressing the dominant negative Rac primary branch 
outgrowth is normal. Only at later stages, the tracheal cells lost polarity. (E’’) Embryos 
expressing dominant negative Rac showed normal dorsal trunk cell fate specification 
visualized by the anti Sal-antibody.  o visualize the tracheal system, we expressed an UAS lacZ construct 
pecifically in the tracheal cells under the control of the btlGal4 (Fig.11A). 
xpression of activated Dcdc42 (DcdcV12,2) or dominant negative Dcdc42 
Dcdc42N17,3) in wild-type embryos did not affect tracheal cell migration 
ramatically (Fig.11B,C). Embryos expressing activated Dcdc42 lacked dorsal 
nd ganglionic branches in few segments (Fig.11B). 
 very dramatic effect could be observed in embryos carrying an activated UAS 
rac1V12,1 (Fig.11D) or the dominant negative UAS Drac1L89 construct 
Fig.11E). Already at early stages (Fig.11D’, stage13) primary branch outgrowth 
as stalled. From stage14 on, the epithelial tracheal cells expressing UAS 
rac1V12 seemed unable to downregulate cell-cell adhesion contacts. Instead, 
he mutant cells intermingled and retained clustered to end up in heaps. The 
ell number remained constant.  
sually, during development of a wild-type tracheal system, the epithelial cells 
ust transiently rearrange their polarity and move without loosing but 
earranging cell-cell adhesions and change their relative positions to intercalate 
ubsequently forming unicellular tubes. Careful regulation of adherens junctions 
s thus required.  
ime lapse movies of Marc Neumann have shown that cells expressing 
ctivated Drac1,V12,1 were not able to move dorsally and he observed ectopic 
ilopodia extensions in all tracheal cells including the dorsal trunk. 
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Other experiments have shown that RacV12 induced reorganization of cell-cell 
junctions in MDCK cells such that the contacts were not restricted to the apical 
side anymore but extended over the entire lateral membranes (Rosario and 
Bircmeier, 2003). 
In contrast, early stage embryos expressing DracL89 showed normal primary 
branch outgrowth (Fig.11E’). But with time, the cells seemed to loose polarity. 
F-actin was expressed all over the cells, forming ectopic filopodia in the dorsal 
branches (data from Marc Neumann and Fig.11E).  
Since the cells form like two dorsal trunk-like structures, we essayed for dorsal 
trunk cell fate specification by using an anti-Sal antibody. From stage 13 until 
stage 15 only dorsal trunk cells express Sal in both embryos either expressing 
activated or dominant negative Drac1 (Fig.11D’’,E’’). 
Rac has been implicated in the regulation of cadherin-dependent cell adhesion 
and the formation of cadherin-catenin complexes at cell junctions (Chihara et 
al., 2003). In contrast to our results, the group of S. Hayashi showed that in 
zygotic null mutant rac1, 2 embryos, E-cadherin as well as α-catenin and β-
catenin, key components of adherens junctions, are broadly accumulated in the 
epithelial cells and change the epithelial architecture. On the other hand, they 
claim that hyper-activation of Rac prevents incorporation of E-Cadherin into cell 
junctions thereby reducing cell adhesiveness. 
Embryos expressing an activated version of Drho1 showed some dorsal and 
lateral trunk fusion defects (Fig.11F). The tracheal system of embryos 
expressing the dominant negative UAS Drho1,N19 transgene looked like wild-
type (Fig.11G). Also the third Rac-like GTPase Mtl did not influence tracheal cell 
migration neither in an activated nor in a dominant negative version and we 
observed only minor defects (Fig.11H,I). 
None of the activated forms of the small GTPases (neither UAS Drac1V12,1 nor 
UAS Dcdc42V12,2 nor UAS Drho1V14, nor UAS MtlV15) were able to rescue 
tracheal cell migration in btl or in dof mutant embryos (data not shown).  
From these results, we assume that Drac is essential to downregulate cell-cell 
adhesion contacts and additionally, it could play a role in the regulation of 
directional actin polymerization. 
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1. Cdc42 heteroallelic mutant embryos 
The question whether endogenous small GTPases indeed are required for 
cytoskeletal regulation can not be answered by dominant mutant proteins. They 
require the phenotypic analysis of loss of function mutations of each of the 
endogenous small GTPase genes.  
Loss of function Dcdc42 alleles, kindly provided by R. Fehon, were investigated 
to examine the effects on tracheal cell migration. Heteroallelic combinations of 
weak and strong alleles were used to produce females that, while viable, had 
reduced Cdc42 activity (Fehon et al., 1997; Genova et al., 2000). We examined 
the tracheal phenotype of the heteroallelic combination Cdc423/Cdc425 and 
Cdc424/Cdc425. Cdc423 is a lethal missense mutation, Cdc424 carries a lethal 
mutation in the splice acceptor site, while Cdc425 is a viable mutation which has 
the aspartic acid 65 mutated to asparagine.  
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 Figure 12: Cdc42 heteroallelic mutant embryos show strong primary branch 
outgrowth defects. (A) Confocal projection of a trachealess 1-eve-1 enhancer trap 
embryo representing the wild-type tracheal system. The tracheal cells were visualized 
with an anti-β Galactosidase antibody. (B) Merged image showing the wild-type tracheal 
system visualized with anti-β Galactosidase antibodies (red) and the epidermal derived 
epithelial cells with the septate junction marker anti-Fascilin 3 (green). (C,D) Two 
representative embryos carrying the cdc42 heteroallelic combination cdc42 3/ cdc42 5. 
(C’,D’) Higher magnification of three tracheal segments of cdc42 heteroallelic mutant 
embryos showing the primary branch outgrowth defects and clustering of the tracheal 
cells within the placodes.  e embryos were stained with the septate junction marker anti-Fasciclin 3 to 
hlight the ectodermally derived epithelial cells. Additionally, the trachealess 
hancer trap marker 1-eve-1 was crossed in to visualize the tracheal cells by 
ining with an anti-βGal antibody (Fig.12A,B).  
 cdc423/cdc425 mutant embryos (Fig.12C,D), several defects could be 
served. Germband retraction failed to proceed to completion, leaving the 
bryos dorsal open. In addition holes appeared in the embryonic epidermis 
ng the ventral midline.  
terestingly, the tracheal cells showed impaired outgrowth and clustered within 
e tracheal placode resulting in a strong tracheal defect phenotype.  
hether these defects were exclusively caused by reduced activity of Dcdc42 
 whether this mutant phenotype was a secondary phenotype caused by 
ncated embryonic surrounding tissues remained an open question.  
e heteroallelic combination Cdc424/Cdc425 unfortunately was less efficient 
d did not result in a mutant tracheal phenotype (data not shown).  
dc42 could function in collaboration with Drac in the regulation of actin 
namics. 
 Rac germline clones 
 Hakeda-Suzuki generated loss of function mutants of Drac1, Drac2 and Mtl 
d examined the role of Drac in axon development (Ng et al., 2002). 
ushroom body (MB) axons were strongly misguided in RacJ11 mosaic mutant 
bryos using the MARCM (Mosaic Analysis with a Repressible Cell Marker) 
stem (Lee and Luo, 1999). The defect increased if the neuroblast clone 
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additionally was homozygous for ∆Rac2 and heterozygous for ∆Mtl. It has been 
shown that different downstream effector pathways mediate axon growth, 
guidance and branching and require combined Rac GTPase activity.  
Other developmental processes are regulated preferentially by one of the Rac’s 
(Hakeda-Suzuki et al., 2002). Dorsal closure seems to rely more on Drac1 than 
on Drac2 or Mtl, whereas myoblast fusion requires either Drac1 or Drac2 but 
not Mtl. Longitudinal axons across the CNS midline require Mtl.  
Drac1 point mutation and loss of function alleles were recovered from an 
ethymethane sulphonate (EMS) screen (Rac1J11). Rac1J10 is a hypomorphic 
allele. ∆Rac2 is a null mutation but homozygous viable. Finally, ∆Mtl is a null 
allele generated by an imprecise excision of a P-element. Each single mutation 
is homozygous viable, the Rac2∆,Mtl∆ double mutant is also viable but all other 
combinations are lethal (Hakeda-Suzuki et al., 2002). 
Like described in the paper (Hakeda-Suzuki et al., 2002; Xu and Rubin, 1993), 
we generated germline clones, embryos lacking maternal and zygotic 
contribution of one or more rac genes, with the lines Rac1J11, Rac1J10, 
∆Rac2, ∆Mtl in different combinations to analyse the function of the Rac’s in 
tracheal development. Mutant females (∆racs, FRT/ TM6 y+) were crossed to 
hs FLP; ovoD / MKRS males according to the scheme described in the Materials 
and Methods. The progeny larvae of the age 24h, 48h, 72h were heat-shocked 
for 1-1,5h at 37°C and the larvae further developed at 25°C until adult stage. 
Heat-shocked virgins were collected and crossed back to heterozygous rac 
mutant males from the original stock. Eggs from the females carrying the 
mutation ovoD do not develop (Pauli et al., 1995). The progeny was stained with 
an anti-Crumbs antibody, an apical cell marker, to visualize early tracheal 
development.  
By using the Rac1J11 null allele in different combinations, we could not recover 
any germline clones. 
Only few embryos could be collected that were rac1J10,∆rac2,∆mtl triple mutant 
and they did not develop further than blastoderm stage. Germline clones that 
were rac1J10,∆rac2 mutant either showed a wild type tracheal system or no 
anti-Crumbs staining. In parallel germline clones that were rac1J10,∆mtl mutant 
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were either completely deformed and did not show any anti-Crumbs staining, or 
we could observe embryos with dorsal closure defects, but normal primary 
branch outgrowth of the tracheal system (data not shown).  
 
It is difficult to evaluate the data of the experiments of the small GTPases. Drac 
has been shown to regulate epithelial cell adhesion and also Dcdc42 seems to 
be required for directional tracheal cell migration. But how the small GTPases 
are regulated by Bnl signalling has to be elucidated. At the moment, at least 22 
Rho family GTPase exchange factors are encoded by the Drosophila genome 
that requires further investigation. 
 
Acknowledgements:  
I would like to thank Valérie Petit and Marc Neumann for the collaboration in 
this project. R. Fehon kindly provided the Dcdc42 mutant alleles and S. 
Hakeda-Suzuki provided all rac mutant alleles and was very helpful giving me 
advise to keep the stocks. I would also like to thank Anna Jazwinzka for 
explaining how to generate germline clones at the best conditions. 
 
96
Experiments 
 
VIII. Comparison to vertebrate FGF signaling 
Interestingly, the vertebrate FGF signalling adapter protein FRS2 and the 
Drosophila adapter Dof are divergent in the amino acid sequence and they do 
not share functional protein-protein interaction domains and bind to different 
stretches of the FGFRs. Dof could be an example of a fast evolving gene used 
exclusively for FGF signalling in Drosophila, which has acquired novel functions 
in vertebrate immune system signalling. Nevertheless, FRS2 and Dof seem to 
be functional homologues, since both are adapters that bind to the FGFR 
constitutively and get tyrosine phosphorylated upon receptor activation. Both 
recruit the Grb2 (Drk)/SOS complexes and the phosphatase Shp2 (Csw) that 
are essential for MAPK activation and the induction of the migratory response.  
We were interested to elucidate whether FRS2 could compensate for the 
function of Dof in Drosophila embryos and in S2 cells and vice versa.  
One of the main differences is that FRS2 contains a non classical PTB domain, 
which is missing in Dof. Unlike known PTB domains that end with a C-terminal 
α-helix, FRS2 contains an additional β-strand (β8) that is essential for the 
constitutive interaction with the 22 aa stretch of the juxtamembrane domain of 
FGFR1 (409-430 aa) (Dhalluin et al., 2000). Only the valine427 and threonine 
428 splice variants of the FGFR juxtamembrane (VT+) are able to interact with 
FRS2. The motif for the specific interaction was identified as KRIPLRRQVTVS 
including the VT motif (as it was already shown in Fig.4). Studies in transfected 
mammalian cells have shown that only the VT+ FGFR variant but not the VT- 
could activate the MAPK. And interestingly, both VT isoforms are co-expressed 
in the same organs in mice in vivo. However, differential expression of VT+ and 
VT- isoforms of FGFR1 have been identified during mesoderm formation in 
Xenopus embryos (Burgar et al., 2002). 
First, we were interested to study whether Dof acts as functional homologue of 
FRS2 and is able to interact with the FGFR2 to trigger downstream signalling 
cascades. The kinase domains of human FGFRs and Btl are conserved to 
about 60% and could provide enough sequence similarity to serve as interaction 
domain for Dof. 
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 Figure 13: The chimeric Btl-FGFR2 receptor does not rescue cell migration defects, 
but activates transcriptional targets in the absence of Dof. The lumen of the tracheal 
system was visualized with the 2A12 antibody (green; A-F, red; A’-F’). Terminal cells were 
visualized with the anti-DSRF antibody (green; A’-F’). (A) Wild-type embryo. (B) Tracheal 
cell migration defects of btlH82∆3 embryos are fully rescued by expression of a btl wild-type 
transgene under the control of btl-GAL4. (C) btlH82∆3 embryo. (D) In btlH82∆3, dof1740 mutant 
embryos, expression of Btl does not rescue primary branch outgrowth defects. (D’) There 
is no transcriptional activation of blistered/DSRF. (E,E’) Expression of a chimeric receptor, 
which consists of the intracellular domain of the human FGFR2, partially rescues primary 
branch outgrowth and induces terminal cell fates in btlH82∆3 embryos. (D,D’) In the absence 
of Dof, expression of the chimeric Btl-FGFR2 receptor does not rescue cell migration but 
induces transcription of blistered/DSRF. e expressed a chimeric Btl-FGFR2 receptor construct under the control of btl-
l4 in btl and btl,dof mutant embryos (Fig.13E,E’,F,F’) and compared tracheal 
ll migration to the wild type tracheal system (Fig.13A,A’) and the rescue by 
e UAS btl transgene in btl and btl,dof mutant embryos (Fig.13B,B’,D,D’). We 
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could observe partial rescue of tracheal cell migration in the presence of Dof 
(Fig.13E). Some dorsal branches grew out, the visceral branches were formed 
and one or two ganglionic branch grew toward the central nervous system, 
although it seemed to be stalled half-way. The dorsal trunk and the lateral trunk 
did not fuse properly. Also transcriptional activation of blistered/DSRF was 
induced by Btl-hFGFR2 (Fig.13E’) in contrast to btl mutant embryos (Fig.13C). 
In contrast to the deletion receptors in the previous deletion analysis, this 
chimeric receptor induced terminal cell fates in all the primary branches that 
grew out, including the tip cell of the dorsal and ganglionic branches. These 
results indicate that the kinase domain of the human FGFR provides enough 
sequence homology to interact with Dof, although the interaction might be 
weak. 
In btl,dof double mutant embryos UAS btl-fgfr2 was not able to rescue cell 
migration effectively anymore (Fig.13F). Strikingly, the chimeric receptor 
activated transcription of blistered/DSRF (Fig.13F’). We assume that Btl-FGFR2 
is able recruit other unknown adapters in the absence of Dof that are able to 
substitute for the function of Dof and activate the MAPK cascade as for example 
Shc. Shc has been shown to recruit the Grb2/SOS complex (Luschnig et al., 
2000). Nevertheless, Dof seems to be essential for the interaction with FGFR2 
to trigger the migratory response at least partially and FGFR2 can not fully 
substitute the activity of Btl. 
The sequence analysis of the two FGFRs Btl and FGFR2 showed that Btl does 
not contain a VT+ motif in the juxtamembrane domain, and we assume that 
FRS2 is not able to interact with Btl. 
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Figure 14: In vitro assay to investigate the interaction and phosphorylation of the 
adapters Dof and FRS2 by Btl and FGFR2. S2 cells transfected with the following plasmids: 
lane 1: myc- tor4021-btl +dof600-V5; lane 2: myc- tor4021-btl kinase dead+dof600-V5; lane 3: myc-
tor4021-btl; lane 4: myc- tor4021-btl +frs2-V5; lane 5: myc- tor4021-fgfr2; lane 6: myc- tor4021-fgfr2 
+frs2-V5; lane 7: myc-tor4021-fgfr2+dof600-V5. The cells were lysed after 20h induction of 
expression with 0.6mM CuSO4. (A) Whole cell lysates were subjected to SDS-PAGE and 
tyrosine phosphorylation levels were examined by anti-phosphotyrosine immunoblotting. Protein 
levels were evaluated for the receptors with anti-myc antibodies and for dof600 and frs2 with 
anti-V5 antibodies. (B) S2 cells were transfected with the indicated combinations of constructs 
as described in (A) lane 1,4,6,7. Whole cell lysates were immunoprecipitated with anti-myc 
antibodies, subjected to SDS-PAGE and immunoblotted with anti-V5 antibodies. Ig: 
Immunoglobulins. 100
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However, we tested whether the activated version of Btl was able to 
phosphorylate FRS2 in S2 cell culture experiments. In addition, we were 
interested whether the activated FGFR2 receptor phosphorylates Dof1-600.  
FRS2 (V5-tagged) is a protein of 509 aa and should run between 50 and 75 
kDa. Fig.14A shows SDS pages where the subjected lysates were detected 
with anti-phospho tyrosine antibodies. The receptors again are myc-tagged.  
Lane1 shows the positive control with the activated Btl receptor (Tor4021-Btl) (red 
arrows) strongly phosphorylating Dof1-600. The negative control receptor Btl 
kinase-dead does not phosphorylate Dof1-600 (lane2). 
As expected, the activated Btl receptor was not able to phosphorylate FRS2 
(lane4). But somewhat surprising, the chimeric Tor4021-FGFR2 (blue arrows) 
also did not phosphorylate FRS2 in S2 cells (lane6). An additional unexpected 
result was, when compared to the in vivo rescue experiments, that Tor4021-
hFGFR2 did not phosphorylate Dof1-600 (lane7). Lane 3 and 5 show receptor 
expression alone as additional control. 
Fig.14B shows a co-immunoprecipitation experiment with an antibody against 
anti-myc to analyze complex formation between activated Btl, FGFR2 and the 
adapters Dof or FRS2. The immunoprecipitates were analyzed by SDS page 
followed by immunoblotting with an anti-V5 to visualize Dof1-600 and FRS2. 
Corresponding to the previous results obtained, we could not observe any 
complex formation neither between Tor4021-Btl and FRS2 (lane4), nor between 
Tor4021-hFGFR2 and FRS2 (lane6), nor between Tor4021-hFGFR2 and Dof1-600 
(lane7).  
We can not explain the failing interaction between hFGFR2 and FRS2 since the 
VT+ spliced variant of the human receptor was used for the experiment.  
The Drosophila S2 cell maybe miss stabilizing molecules of mammalian cells to 
form a constitutive complex between the human FGFR and FRS2. Depending 
on the mammalian cell types used for co-immunoprecipitation experiments, the 
complex formation of FGFR1 and FRS2 has also shown either to be weak or 
could not be detected at all. We assume that some cells types provide 
additional components to stabilize the constitutive interaction between the 
FGFRs and FRS2 (Cross et al., 2002; Ong et al., 2000b). 
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IX. Btl mutant mosaic clones in the tracheal system 
Finally, we were interested in the question whether Bnl signalling induces the 
migratory response only in the tip cell of the outgrowing primary branches and 
the stalk cells would be pulled behind the migrating tip cells by cell-cell 
adhesion forces. 
Or all the tracheal cells have the capacity to move according to their 
developmental history and Bnl signalling determines the tip cells as leading 
cells followed by the other migrating stalk cells. 
We prefer the first model. Experiments have shown that btl expression declines 
in later stages of tracheal development and gets restricted to the tips of the 
outgrowing branches (Ohshiro et al., 2002). It has also been shown, as the 
migration of the tracheal tips begins, the pattern of dp-ERK dependent on FGF 
signalling refines and can be observed within each branch only in the migrating 
tip cells (Gabay et al., 1997b). Therefore, we assume that Bnl signalling 
activates not only the MAPK cascade but also cytoskeletal rearrangements 
exclusively in the tip cells. 
To determine in which tracheal cells Bnl signalling induces the capability to 
move, we carried out a genetic mosaic analysis using the FLP recombination 
system as it was already performed for spry-/- mosaic mutant cells in the 
tracheal system (Hacohen et al., 1998).  
The FLP recombination system induces high frequency mosaicism for a 
particular gene by the use of the FRT sequence from yeast. The FLP 
recombinase induces mitotic recombination between the FRT sites located on 
homologous chromosome arms. The FRT sites have to be located closer to the 
centromere than the gene of interest (Xu and Rubin, 1993). 
To confirm our model, a btl mutant tip cell does not respond to the ligand Bnl 
anymore and is not able to migrate. Subsequently, the stalk cells should stay at 
their original position within the placode. 
If the second model would be true, the nearby stalk cells could compensate for 
the function of the btl mutant tip cell and would be able to respond to Bnl 
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signalling at early stages of tracheal development by moving toward the ligand 
source. 
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 Figure 15: Bnl signalling induces the migratory response exclusively in the tip cells. 
(A) View on wild-type dorsal branches of a 1-eve-1 enhancer trap embryo. The trachea cells 
are visualized with an anti-β Galactosidase antibody (red). (B) Embryo with the genotype 
hsFLP; btlH82∆3,FRT/ 1-eve-1, FRT. To induce btl mutant mosaic clones, 6h old embryos 
were heat-shocked for 20 min. at 37°C. The tracheal cells are visualized by anti-β
Galactosidase antibodies (red) and the lumen of the tracheal system with the 2A12 marker. 
The arrow points on a btl mutant clone within the dorsal branch. (C) Single cell rescue 
experiment. Flies with the genotype btl<y+>Gal4, UAS actin-GFP/ Cyo; btlH82∆3 / TM3 were 
crossed to hsFLP/ hsFLP;; UAS btl, btlH82∆3 / TM3 flies. The 6h old progeny was heat-
shocked for 30 min. at 37°C. Btl mutant show nuclear lacZ expression that  was visualized 
by antiβ-Galactosidase antibodies (blue). Anti-Crumbs antibodies outline the apical cell 
surfaces (green). Single rescued cells expressing the btl transgene are labelled with anti-
GFP antibodies (red). The white arrow points on two rescued tip cells pulling the btl mutant 
stalk cells to form a dorsal branch (grey arrow). ecombinant lines were generated using the FRT line w;P[w+]70C, P[ry+;hs-
eo;FRT] 80B and btlH82∆3. Additional recombinants with the same FRT line and 
he 1-eve-1 marker were generated. (Fig.15A, view on dorsal branches). 
omozygous mutant btlH82∆3 clones were generated by FLP-mediated 
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recombination in heterozygous embryos of the genotype hsFLP; btlH82∆3,FRT/ 1-
eve-1, FRT. The heterozygous embryos were collected after 6h developing on 
grape juice plates, heat-shocked for 20 minutes at 37°C to induce mitotic 
recombination and further developed at 25°C for another 10h (according to the 
protocol in (Hacohen et al., 1998). 
Additionally to βGal staining (Fig.15B, red), the tracheal system was stained 
with the luminal marker 2A12 (Fig.15B, green) to visualize the lumen of the 
homozygous btlH82∆3 mutant cells that have lost the btl+ chromosome carrying 
the 1-eve-1 tracheal lacZ marker.  
The problem was that the btlH82∆3 mutant cells also showed nuclear βGal 
staining (see chapter V) what made it very difficult to distinguish the btlH82∆3 
mutant clone cells from the btl+ cells. 
We screened several hsFLP; btlH82∆3,FRT/ 1-eve-1, FRT recombinant lines for 
btl mutant clones. The results were difficult to interpret. Fig.15B shows dorsal 
branches of a mosaic clone embryo. Either some btl mutant stalk cells were not 
able to follow the tip cells retaining nearby the dorsal trunk (Fig.15B, arrow 
pointing out no βGal staining and no lumen). The other dorsal branch cells, 
which seemed to be btl+ and show cytoplasmic βGal staining migrated dorsally. 
These results suggest that Bnl signalling regulates cell-cell adhesion contacts 
which allows the epithelial stalk cells to arrange from multicellular complexes to 
unicellular tubes and to follow the tip cells. In the btl mutant stalk cells, the cell-
cell adhesion contacts probably are not downregulated anymore.  
Another explanation could be, that the tip cells were mutant and retained nearby 
the dorsal trunk unable to move (arrows). The stalk cells responded to the Bnl 
signal by directed cell migration compensating for the function of the tip cells 
and moved along the dorsal branch migratory route. 
However, we could not find an answer whether only the tip cells are able to 
migrate or whether all tracheal cell have the capacity to move. 
 
Marc Neumann established an experiment, which allowed to express genes of 
interest in single tracheal cells of btl mutant embryos. He generated a line with a 
flipout cassette allowing specific expression of a gene in tracheal cells after 
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heat-shock induction (btl<y+>Gal4, UAS actin-GFP/ Cyo; btlH82∆3 / TM3). 
Additionally, I generated the following recombinant line hsFLP/ hsFLP;; UAS btl, 
btlH82∆3 / TM3 and crossed the two described transgenic lines together. The 
progeny was heat-shocked after 6h at 37°C for 30 minutes and the embryos 
developed further at 25°C for another 10h. The FLP recombinase induced 
homologous recombination at the FRT sequences (symbolized here as <>) and 
flipped out the y+ containing cassette thereby bringing the btl-enhancer in 
proximity of the open reading frame of Gal4 and activates expression of Gal4 
and the subsequent expression of Btl in some of the tracheal cells. 
Interestingly, a dorsal branch grew out from a placode (surrounded by a white 
line) (Fig.15C). We could observe two rescued leading tip cells expressing Btl 
and GFP at the same time (white arrow) and the btl mutant stalk cells (grey 
arrow) were pulled by the migrating tip cells along the migratory axes and 
formed an unicellular branch. 
This result is more convincing than the previous ones and a first indication, that 
induction of migration in the tip cells by Bnl signalling is sufficient to form the 
primary branches. The stalk cells do not require Bnl signalling and are pulled 
dorsally by cell-cell adhesion contacts.  
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 Discussion 
In this thesis we performed a functional analysis of the Drosophila FGF receptor 
homologue Breathless with the aim to identify domains specifically interacting 
with Dof or other putative adapter proteins that are essential to trigger the cell 
migration response. Furthermore, we were interested to identify downstream 
targets of Dof providing a direct link to the cytoskeleton. 
And finally, another intention was to gain more information about the specificity 
of the FGFRs compared to other RTKs with regard to cell migration.  
As a model system to study cell movement, we investigated the development of 
the tracheal system in Drosophila melanogaster. This respiratory organ is, after 
cell fate determination and few cycles of cell divisions, only established by 
directional cell migration, cell differentiation and cell fusion processes without 
any further cell divisions.  
Bnl/FGF signalling has been shown to act as chemoattractand and guides the 
outgrowing tracheal buds (Sutherland et al., 1996). In contrast, during mouse 
lung development, FGF signalling not only induces chemoattraction but also 
proliferation of the epithelial cell sheet also at later stages (Cardoso, 2001; 
Warburton et al., 2000). 
I. Tracheal and mesodermal cells respond to 
functionally distinct RTKs with directed migration 
Previous experiments have already addressed signalling specificity in tracheal 
cell migration (Reichman-Fried et al., 1994). Chimeric receptors were generated 
with the extracellular and transmembrane domains of the dominant Tor (Tor4021) 
fused to the intracellular domains of the following RTKs: Tor, EGFR and 
Sevenless. A minimal rescue of tracheal migration in btl mutant embryos under 
the control of an hsp70 promoter could be observed. The chimeric receptors 
were ubiquitously expressed and activated in all tracheal cells. Dorsal trunk 
formation was mainly rescued in contrast to dorsal and ganglionic branches. 
Lateral trunk fusion could not be rescued under these assay conditions. 
 
107
Discussion 
 
Experiments have shown that overexpression of Bnl or an activated form of Btl 
(λ-Btl) in all tracheal cells disrupted or even completely impaired primary branch 
outgrowth (see chapterVI,3, (Lee et al., 1996; Sutherland et al., 1996). 
Since local activation of Btl by the spatially restricted ligand Bnl is essential for 
guiding the tracheal cells in six stereotyped directions, we thought to generate 
chimeric receptor proteins with the extracellular and transmembrane domain of 
Btl. Thereby we ensured that the transmembrane receptor proteins were 
activated at the correct time and in the correct local position mimicking wild type 
situation as closely as possible.  
Interestingly, we found that a chimeric receptor with the extracellular domain of 
Btl and the intracellular domain of Tor could functionally substitute for wild-type 
Btl and almost completely rescued tracheal cell migration in btl mutant embryos. 
Also the chimeric Btl-EGFR could rescue tracheal cell migration, albeit less 
efficiently.  
II. Dof acts specifically in the FGF signalling pathway 
We were interested whether the previously identified adapter protein Dof is 
specifically required to trigger the migratory response and whether it interacts 
with distinct RTKs. In dof mutant embryos, tracheal and mesodermal cell 
migration is completely impaired. Surprisingly, the chimeric Btl-Tor and Btl-
EGFR were able to rescue cell migration in the absence of Btl and Dof. In 
addition, both fusion receptors efficiently activated the transcriptional targets of 
the tracheal secondary and terminal cell differentiation program. 
The results were confirmed by S2 cell culture assays, which showed that Dof is 
exclusively a phospho-target of FGFRs and is not a substrate of Tor (Petit et al., 
2004). 
These results demonstrated that tracheal and mesodermal cells respond to 
RTK signalling with directed cell migration and the induction of the 
differentiation program in the absence or presence of Dof. Thus, Dof acts 
specifically in the FGF signalling pathway (Dossenbach et al., 2001; Vincent et 
al., 1998). 
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Interestingly, in another model system used to study cell migration in 
Drosophila, namely border cell migration during oogenesis, guidance seems to 
be receptor specific. The border cells are specified somatic follicle cells that 
migrate through the nurse cells toward the oocyte. They turn at the oocyte and 
continue to migrate dorsally. EGFR signalling guides the border cells dorsally 
and interestingly, this migration is EGFR specific and not dependent on MAPK 
activation. In contrast to our results, an activated form of Htl could not substitute 
for the function of the EGFR (Duchek and Rorth, 2001).  
1. Dof provides a functional homologue of FRS2 in Drosophila 
The question rose whether RTKs produce an intrinsic generic signal differently 
interpreted by different cell types. We wanted to investigate whether conserved 
components of RTK signalling as for example Ras, Raf and the MAPK are 
putative inducers of the migratory response or whether FGF signalling specific 
components as for example Dof (or the functional adapter homologue FRS2 in 
vertebrates) provide the essential link to the cytoskeleton.  
Dof mutant embryos show strong tracheal and mesodermal migration defects. 
Also FRS2α-/- knockout mice die at early embryonic stages because of severe 
gastrulation migratory defects (Hadari et al., 2001). 
Although there is no sequence homology between the vertebrate and the 
Drosophila adapter protein and they contain different protein-protein interaction 
domains, they can be considered as functional homologues. Both adapters 
recruit the Grb2/SOS complexes thereby providing a link to the MAPK cascade 
and subsequent transcriptional activation. In addition, both recruit the 
phosphatase Shp2/Csw upon tyrosine-phosphorylation of FGFRs and activate 
the PI3K pathway (Petit et al., 2004; (Hadari et al., 2001; Xu and Goldfarb, 
2001; Xu et al., 1998).  
Dof belongs to a small family of proteins including BCAP and BANK, two 
vertebrate scaffolding proteins that have recently been identified (Okada et al., 
2000; Yokoyama et al., 2002). However, unlike Dof they are not implicated in 
FGF signalling, but in downstream signalling of the B-cell antigen receptor. Both 
proteins regulate the release of calcium within B cells. BANK interacts directly 
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with the IP-3 receptor, whilst BCAP is thought to be an adapter protein that 
mediates the activation of the PI3K and phospholipase Cγ2 upon B-cell antigen 
receptor stimulation. Thus, Dof, BCAP and BANK are all involved in signalling, 
although they appear to have undergone rapid change during the course of 
evolution and may have evolved in parallel with FRS2. 
Our in vivo experiments have shown that Dof partially substituted for the 
function of FRS2 when a chimeric Btl-FGFR2 receptor was expressed in btl 
mutant embryos. In fact, we observed a quite effective rescue of cell migration. 
Interestingly, this chimeric receptor is not able to trigger cell migration anymore 
in the absence of Dof, but still induces transcriptional activation via the MAPK 
cascade. In contrast to Btl and Htl, which are absolutely dependent on Dof to 
induce cell migration but also to activate transcriptional targets, FGFR2 seems 
to be able to interact with other adapter proteins in the absence of Dof to 
activate transcription. Shc provides a good candidate to link the FGFR2 to the 
downstream MAPK cascade, since it has been shown to recruit the Grb2/SOS 
complex upon phosphorylation by RTKs (Luschnig et al., 2000).  
We assume that in the opposite situation, FRS2 is not able to interact with Btl to 
fulfil the function of Dof, because the sequence homology of the juxtamembrane 
domains of Btl and the FGFR2 is poor. FRS2 binds with its PTB domain to a 
highly conserved stretch of amino acids within the vertebrate FGFRs containing 
the differentially spliced VT motif. Btl lacks this essential VT motif. Thus, it does 
not provide a binding site for FRS2. 
In our cell culture assay, we observed neither phosphorylation of FRS2 by an 
activated version of FGFR2 nor complex formation between FRS2 with FGFR2. 
Furthermore, Dof became not phosphorylated upon FGFR2 activity and an 
activated version of Btl did not phosphorylate FRS2.  
This experiments should be repeated in mammalian cells, as for example Cos 
cells. In mammalian cells, additional components might be provided for a stable 
constitutive interaction of FRS2 with the FGFRs.  
Co-immunoprecipitation experiments in different mammalian cell lines have 
shown that complex formation between the FGFRs and FRS2 was weak or 
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could not be detected at all depending on the cell line (Cross et al., 2002; Ong 
et al., 2000b). 
2. Dof probably interacts constitutively with the kinase domain of Btl 
Our co-immunoprecipitation experiments have shown that Dof interacts 
independent of the activity state of Btl with the kinase domain of the receptor 
(see chapter V,1-3). Furthermore, yeast two hybrid assays proposed that Dof 
interacts with the C-terminal-lobe of the kinase domain (Battersby et al., 2003). 
A conserved domain within the N-terminus of Dof is required for the interaction 
with the receptor (Petit et al., 2004; (Wilson et al., 2004).  
The functional deletion analysis of Btl is in line with these results. Deletion of all 
putative interaction domains for adapter proteins, either the juxtamembrane 
domain, the kinase insert domain or the C-terminus of Btl, did not affect the 
capacity of Btl to rescue tracheal cell migration in btl mutant embryos and 
terminal cell fate differentiation was induced.  
To define the exact sequence stretch of the interaction domain Btl with Dof, 
point mutations have to be introduced within the C-terminal lobe of the kinase 
domain without affecting the essential and highly conserved 
autophosphorylation sites required for the kinase activity. 
The S2 cell culture assays revealed that Dof is able to form a complex with Btl 
and becomes phosphorylated upon Btl activation. Also receptors either lacking 
the juxtamembrane domain or the kinase insert domain phosphorylated Dof. 
Surprisingly, in S2 cells, Btl receptors lacking the C-terminus did not auto-
phosphorylate. Consequently, we did not observe any phosphorylation of Dof. 
We assume, that the short C-terminus is required for conformational changes of 
the kinase activation loop upon dimerization of the receptors to enable trans-
phosphorylation. In vivo, probably a mechanism or chaperone proteins exist 
substituting for the function of the C-terminus. The S2 cells apparently lack this 
mechanism or proteins.  
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III. Csw provides the essential link to the cytoskeleton 
Finding that mutations in csw produce the same tracheal phenotype, as bnl, btl 
and dof embryos, in which tracheal cell migration is completely blocked, indicate 
an essential role of Csw in the induction of cell locomotion (Perkins et al., 1992). 
Also the vertebrate homologue Shp2 has been shown to be essential for EMT 
at initial steps of gastrulation, which includes cellular differentiation processes 
as cell shape changes, adhesion or migration (Saxton and Pawson, 1999). 
In addition, Shp2 was shown to be required for tubulogenesis by another 
chemotactic factor, the Hepatocyte Growth Factor/ Scatter Factor (HGF/SF). 
HGF signalling has been implicated in stimulating tubulogenesis during 
angiogenesis and during the development of the lung. Shp2 regulated 
cytoskeletal structures and cellular adhesion, inhibited the Rho GTPase and 
promoted cellular motility downstream of Met, the RTK activated by HGF. 
Further experiments have shown that Shp2 was essential for sustained 
activation of the MAPK and for the induction of branching morphogenesis of 
MDCK cells. Interestingly, sustained activation of the MAPK through different 
adapters (Grb2, Shc, or Shp2) was not required for cellular motility (compare 
also to chapter VI,3; reviewed in (Rosario and Bircmeier, 2003). 
The group of L. Perkins already performed a yeast two-hybrid screen to identify 
proteins potentially interacting with Csw. They used the C-terminus of Csw as 
bait and screened Drosophila ovary and imaginal disc yeast fusion libraries. 
Thereby they identified the Drosophila homologue of Importin-7 (DIM-7). DIM-7 
associated with phosphorylated D-ERK and was required for the nuclear import 
of D-ERK (Lorenzen et al., 2001).  
Unfortunately, L. Perkins did not publish other Csw interacting factors. It would 
be interesting to know whether one of the 22 Rho family GEFs, identified in the 
Drosophila genome, interact with Csw. It has been shown that Rac1, Rac2 and 
Mtl have largely overlapping functions and probably share a common set of 
effectors. Thus, the activators of the Rac proteins (RacGEFs) seem to be 
essential for a limited activation of the Racs resulting in a specific cellular 
response (Hakeda-Suzuki et al., 2002). 
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We assume that Csw recognizes and recruits activated and phosphorylated 
proteins and subsequently dephosphorylates these proteins to transduce a 
specific cellular response. 
Co-immunoprecipitation experiments or GST pull-downs in the S2 cell culture 
system would provide more information about complex formation of Csw upon 
Btl activation with different candidate interaction partners. An interaction 
between the phosphorylated version of Dof and Csw has already been shown 
by co-immunoprecipitation experiments (Petit et al., 2004). 
Another possibility to identify new Csw interaction partners involved in cell 
motility would be to use S2 cells in a different context. Under routine culture 
conditions, S2 cells display a spherical morphology and are not motile. The cells 
undergo a dramatic change of morphology when they are plated on glass 
coverslips coated with the lectin concanavalin A by forming actin containing 
membrane ruffles. Some cells do not possess this kind of lamella but rather 
possess dynamic filopodia.  
RNAi studies were performed to identify proteins involved in lamella formation. 
19 proteins were identified as candidates and implicated in aspects of actin 
function or in cell motility. Most candidates were direct actin-binding proteins, 
like Profilin, CAP and Cofilin. Also the small GTPase Cdc42 was identified to 
prevent normal lamella formation when inhibited by RNAi. Interestingly, Rac1, 
Rac2 and Mtl did not prevent lamella formation. Only when additionally the 
SH2-SH3 adapter protein Nck was inhibited, lamella defects could be observed 
indicating that Rac-like proteins and Nck were partially redundant in activating 
the WASP/SCAR complex (Rogers et al., 2003). 
Slingshot, a phosphatase that activates the actin severing activity of Cofilin 
could be another interesting candidate to test. 
If proper cues are provided to S2 cells, probably other aspects of the actin 
cytoskeleton such as filopodia formation, cell migration and cell polarity could 
be investigated. 
Other candidates that would be interesting to investigate have been proposed 
by the following experiments in mammals. Experiments with isolated fibroblasts 
of Shp2-/- mutant mice have shown that Shp2 promoted Src family kinases 
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(SFK) activation by an indirect mechanism. Shp2 regulated the phosphorylation 
of the Csk regulator PAG/Cbp, thereby controlling Csk access to SFKs. SFKs 
have been shown to activate the p190RhoGAP subsequently providing a link to 
stress fibres and focal adhesion regulation.  
Impaired spreading of Shp2-/- cells might also reflect hyperphosphorylation of 
Vav2, a Rho GTPase GEF that has been shown to be recruited to the tips of 
filopodia in living cells (Kranewitter et al., 2001). It would be interesting to 
investigate whether Drosophila homologues of SFKs, Csk, PAG/Cbp, 
p190RhoGAP and Vav2 exist. 
IV. Ras is not sufficient to elicit the migratory 
response 
Experiments have shown that recruitment of Csw via Dof is essential for the 
activation of the Ras/MAPK pathway (Petit et al., 2004). We investigated 
whether activation of Ras in the tracheal tip cells is sufficient to trigger the 
migratory response upon Bnl signalling. The results we obtained make us 
believe that Ras activation is required but not sufficient to activate this 
response.  
Expression of a constitutive active form of Ras (RasV12) specifically in tracheal 
cells of btl and dof mutant embryos partially rescued primary branch outgrowth, 
mainly dorsal trunk fusion occurred. Other experiments have shown that 
expression of RasV12 in mesodermal cells of htl mutant embryos resulted in a 
certain rescue of mesodermal cell migration (chapterVI,1 and (Michelson et al., 
1998a). 
However, when we tried to disturb cell migration under conditions, where all 
tracheal cells of wild-type embryos sustained high levels of Ras activation by 
expressing RasV12, tracheal cell migration and primary branch formation were 
not affected (chapterVI,1-3). Also when the chimeric receptor Btl-Tor was 
expressed in the tracheal cells, the Ras/MAPK pathway got hyper-activated, but 
directional outgrowth of the tracheal branches was normal (chapterVI,3).  
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Additional experiments of Marc Neumann indicated that Ras was not sufficient 
to regulate cytoskeletal reorganizations. He could show that overexpression of 
RasV12 in wild type embryos did not produce ectopic filopodia in dorsal trunk 
cells.  
In sharp contrast, ectopic activation of Bnl or λBtl, a constitutive active version 
of Btl, completely impaired tracheal cell migration and ectopic filopodia 
formation could be observed (chapterVI,3 and Marc Neumann). 
Also during border cell migration in oogenesis, expression of RasV12 or 
RasN17 in the border cells only moderately affected their migration (Duchek 
and Rorth, 2001). 
1. Local activation of Raf 
We were interested to study whether spatial correct activation of the Ras/MAPK 
cascade would be sufficient to fully rescue tracheal cell migration in btl or dof 
mutant embryos. Experimentally, it is difficult to activate the small GTPase Ras 
at the correct local position.  
Thus, we tried to activate the downstream target of Ras, the serine-threonine 
kinase Raf, at the correct local position of the outgrowing branches by 
generating a chimeric Btl-Raf protein. The kinase domain of Raf was fused to 
the extracellular domain of Btl. Unfortunately, we were not able to mimic the 
physiological more relevant situation activating the construct by the spatially 
restricted ligand Bnl because the chimeric Btl-Raf construct auto-activated itself 
even in cells that did not receive Bnl.  
Indeed, previous experiments have shown that expression of both, Tor-Raf and 
Tor4021-Raf fusion constructs in the eye resulted in a dominant rough eye 
phenotype indicating that even in absence of a ligand, the Tor-Raf fusion 
protein was constitutive active. In the eye, Tor-Raf activation was sufficient to 
rescue the R7 precursors from adopting the cone cell fate in the absence of sev 
function (Dickson et al., 1992). 
Further evidence that even local activation of Ras is not sufficient to induce a 
migratory response has been provided by Valérie Petit. She generated a 
minimal Dof (Dof1-600) construct lacking the ankyrin-repeats. This truncated 
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Dof construct was not able to rescue cell migration anymore in contrast to the 
minimal Dof protein (Dof1-600) in dof mutant embryos but it still activated Ras 
and downstream transcriptional targets (Petit et al., 2004). 
2. Drac and Dcdc42 are involved in the regulation of actin dynamics 
The small GTPases of the Rho family have been shown to regulate cytoskeletal 
rearrangements. Unfortunately, it is very difficult to address genetically the 
importance of the small GTPases. Therefore, we precisely examined the effect 
of constitutive active and dominant negative versions of these proteins. 
Additionally, we made use of the Rac mutations (rac1J10, ∆rac2, ∆mtl) 
generated by the group of B. Dickson (Hakeda-Suzuki et al., 2002) and 
investigated the tracheal development of mutant germline clones. Unfortunately, 
we could not draw any conclusions from these experiments, since triple rac 
mutant embryos stopped developing at blastodermal stage. Combinations of 
double rac mutant embryos (either rac1J10,∆rac2 or rac1J10,∆mtl) also lacked 
development of a tracheal system probably due to severe defects raised 
already during early embryonic development.  
In contrast, genetic analysis of cdc42 mutant embryos by generation of 
heterozygous embryos carrying a lethal cdc42 allele over a cdc42 viable allele, 
clearly showed strong defects in primary branch outgrowth.  
According to the analysis of the effects of activated and dominant negative 
versions of Rac expressed in wild-type embryos, Drac has been proposed to 
downregulate cell-cell adhesion contacts and to regulate directional actin 
dynamics probably in collaboration with Dcdc42. 
None of the small GTPases of the Rho family rescued cell migration in dof 
mutant embryos probably due to the fact that at least two or three members of 
the small GTPases are essential to rescue cell migration. 
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V. Mitotic clones to identify new targets involved in 
cell migration 
Previous conclusions have suggested that Shp2/Csw is the key molecule in 
FGF signalling regulating directed cell migration and tubulogenesis. Additional 
downstream targets of Csw have to be identified as it has been outlined before. 
We assume, that these downstream targets activate the small GTPases and 
regulate subsequent cytoskeletal reorganizations.  
Since most of the potential downstream Csw candidates identified by screens 
so far are maternally contributed and essential during oogenesis or early 
embryonic development, we tried to establish a genetic mosaic analysis using 
the FLP recombination system to test potential downstream candidates of Csw. 
1. Single mutant tracheal cells 
We wanted to analyze single mutant tracheal cells and the effect of these 
mutant cells on their neighbours with regard to migration.  
First, we investigated the effect of single btl mutant cells and their environment 
to establish the experiment. We addressed the following questions: Is primary 
branch outgrowth completely blocked when the tip cells lack Btl? Are btl mutant 
stalk cells pulled by cell-cell adhesion contacts by the wild-type tip cells or do 
they stop moving?  
To answer these questions, single mutant btl cells were generated as it was 
already described by the group of M.A. Krasnow (Hacohen et al., 1998). Spry-/- 
mosaic mutant cells were performed in the tracheal system and the mutant cells 
were recognized by negatively labelling the cells. The mutant cells lost the 
tracheal cell marker 1-eve-1 lacZ upon mitotic recombination (Hacohen et al., 
1998).  
The problem with this approach was that the tracheal cells undergo only about 
two cycles of cell divisions previous to invagination, and we observed only 
single cell clones that hardly could be recognized by negative labelling, since 
they still showed some lacZ expression due to the btlH82∆3 allele (imprecise 
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excision of the P-element containing lacZ). Therefore we were not able to draw 
any conclusions from this experiment. 
The system would also not be ideal to investigate candidate genes acting 
downstream of Csw. Despite the fact that the single mutant cell clones should 
not show any lacZ expression anymore, it is difficult to visualize negatively 
labelled clones.  
Consequently, we thought to label the single mutant cells positively. 
A very nice system was developed to label mitotic clones positively, the 
MARCM system (described in detail in (Lee and Luo, 1999). Gal80 antagonizes 
Gal4 activity thereby repressing the expression of the marker protein with UAS 
sequences introduced upstream of the gene. Only mitotic clones loosing Gal80 
induce the positive marker (GFP for example) upon activation by Gal4. At the 
same time, these clones are homozygous mutant for the gene of interest. 
Unfortunately, the MARCM system cannot be used to induce mitotic clones in 
the tracheal system. The Gal80 protein expressed under the control of a tubulin-
promoter for example is stable for 48h until it gets degraded in the cells. Since 
tracheal development starts from 6h after egg lying and is finished after 18h, the 
Gal80 protein is still present even in cells that have lost the gene due to mitotic 
recombination. 
Since the MARCM system is not feasible in the embryonic tracheal system, 
again, we had to find another system to induce mitotic clones. A very promising 
system to identify downstream components of Csw and candidates of 
directional cell motility are the air sacs in larvae (Sato and Kornberg, 2002). 
Clemens Cabernard established this project.  
2. Larval air sac development is promising to identify regulators of cell 
migration 
In the developing air sacs adepithelial cells with tracheal identity (tracheoblasts) 
extended long cytoneme-like filopodia, migrated and proliferated in response to 
Bnl. At third larval instar, btl expressing adepithelial cells budded from the 
tracheal branch, increased in cell number and expanded posterior toward the 
region of greatest bnl expression.  
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In contrast to the tracheal cells during embryonic development, the tracheoblast 
during air sac formation in larvae undergo several cycles of cell division, 
therefore providing better conditions to induce mitotic clones by the MARCM 
system. Additionally, we assume that air sacs not only develop by cell 
proliferation but also by migration of the cells. Sato and Kornberg showed in 
their experiments that indeed, the tracheoblast extend long filopodia extensions 
toward ectopic Bnl expressing clones in the wing disc. 
From vertebrate FGF signalling we know that FGFs not only induced migratory 
responses but also mitogenic responses. We do not know whether in air sac 
development Bnl signalling induces both, the mitogenic and the migratory 
response. Dissecting the two downstream cascades remains challenging.  
This approach is the most effective way to identify putative interacting 
molecules of Csw to provide the link to the small GTPases and other direct actin 
binding molecules. 
First, btl, dof and csw mutant clones should be generated as control. Further 
candidates to test are Ras, Raf and Rolled, the small GTPases and actin 
binding proteins, which are also strong maternally contributed. Also interesting 
candidates to investigate would be Shc, the Drosophila homologues of FAK and 
Src.  
Using the NCBI Blast program one putative Drosophila homologue of FAK, the 
FAK-like protein CG10023 that shows 38% sequence identity to the vertebrate 
FAK, could be identified. Another very interesting protein to test is the 
Drosophila Src42A that has been shown to genetically interact with Csw, Ras, 
Pole hole (Raf), Dsor1 (MEK) and SOS. Unfortunately the Blast results did not 
show any homologue of the vertebrate adapter protein Shb that has been 
shown to form a complex with Shp2, Src and FAK in mammalian cells.  
And finally, the p21-activated kinase (Pak) that is known to act as a mediator of 
the activity of the Rac GTPase has to be tested. In pak mutants, similar defects 
has been described as those to zygotically null rac1,2 mutants (Chihara et al., 
2003). 
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3. Single cell rescue experiment using the flipout system 
Marc Neumann established another approach to test signalling components and 
their ability to rescue migration of single cells within the tracheal system.  
By using the flipout system (described in detail in (Zecca et al., 1995) we can try 
to rescue single cell migration in btl mutant embryos by expressing the genes of 
interest (UAS X) and actin-GFP (UAS actin-GFP) under the control of a 
btl<y+>Gal4 enhancer induced by hsFLP.  
The preliminary results, which showed two single tip cells expressing Btl in a btl 
mutant background were a first indication that Bnl signalling induced the 
potential to migrate exclusively in the tracheal tip cells. The btl mutant stalk cells 
followed the rescued tip cells, intercalated and formed an unicellular dorsal 
branch. Furthermore, these results indicate that Bnl signalling is not required to 
regulate the rearrangement of the cell-cell adhesion contacts of the epithelial 
stalk cells.  
Drac that has been shown to regulate cell-cell adhesion is probably not a 
downstream target of Bnl signalling as it was proposed by the group of S. 
Hayashi (Chihara et al., 2003). Bnl signalling also does not induce cytoskeletal 
reorganizations within the stalk cells and they seem to be pulled only by cell-cell 
adhesion forces rearranged by the leading tip cells. 
In the tip cells, Bnl signalling might induce the migratory response by regulating 
Drac in collaboration with Dcdc42 to control F-actin reorganizations and 
subsequent formation of filopodia. The experiments of Marc Neumann have 
shown that the activated version of Rac (RacV12) induced non-orientated 
ectopic filopodia also in dorsal trunk cells. Cells expressing RacL89 showed 
ectopic filopodia in the dorsal branches and F-actin was visible all over the cells. 
In triple mutant rac1J10, ∆rac2, ∆mtl embryos, the embryos showed dorsal 
closure defects and lacked both lamellipodia and filopodia formation (Hakeda-
Suzuki et al., 2002). These are further indications that Rac and Cdc42 play a 
role in regulating the formation of actin containing filopodia. 
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VI. Concluding remarks 
We strongly assume that spatially and timely limited induction of FGF signalling 
in the tracheal tip cells is required for the formation of orientated filopodia to 
sense the guidance cue Bnl but also to reorganize the cytoskeleton of the cell 
body in order to move toward the guidance cue. This possibility is strengthened 
by the observation that Dof, a protein essential for tracheal cell migration, is 
indeed observed to be expressed stronger in the tip cells (Vincent et al., 1998). 
In addition, transcription of btl gets restricted to the tip cells during tracheal 
development (Ohshiro et al., 2002). 
Dof links the FGFR to the downstream conserved MAPK cascade and 
transcriptional activation, but triggers additional cytoplasmic signalling events by 
recruiting Csw. Csw has been shown to activate Ras and transcriptional targets 
but it also elicits the migratory response. Downstream effectors of Ras seem to 
be required but not sufficient to induce cell migration. 
Using the larval air sac system, we hope to identify soon new components 
essential for cell migration. Additionally, with this system, we can confirm 
whether the small GTPases Rac and Cdc42 indeed regulate the actin 
cytoskeleton of tracheal cells. Furthermore, we are able to identify downstream 
targets of Csw and upstream effectors of the small GTPases. 
The identification of new components of FGF signalling regulating tracheal cell 
migration in Drosophila is challenging because it could help to identify new drug 
targets in humans against cancerogenic metastasis formation or tumour 
angiogenesis. Several FGFs were discovered because of their oncogenic 
potential.  
Except the adapter proteins FRS2 and Dof, which show only functional 
homologies, other components of the FGF signalling pathway are highly 
conserved within the animal kingdom. Albeit, different migrating cell types may 
use different combinations of these proteins. Dissection and understanding of 
the Drosophila FGF signalling pathway in detail could provide ideas which 
molecules are essential linkers to the actin cytoskeleton. Furthermore, it is 
essential to distinguish the different downstream cellular responses elicited by 
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FGF, if we want to generate effective antagonists blocking the FGF signal in 
diverse pathogenic situations. 
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 Materials and Methods 
I. Drosophila strains and genetics 
The generation of the transgenic UAS btl, UAS btl-htl, UAS btl-tor, UAS btl-
EGFR, UAS htl, UAS htl-btl, UAS htl-tor and UAS htl-EGFR flies was described 
in detail in (Dossenbach et al., 2001; Vincent et al., 1998). The original UAS btl 
cDNA was kindly provided by B. Shilo and modified by C. Dossenbach. The 
UAS btl derivates (including the UAS btl deletion versions) were introduced into 
the Drosophila genome by P-element-mediated germline transformation (Rubin 
and Spradling, 1982). At least four independent transformant lines were 
analysed for each construct.  
The btl-Gal4 line kindly provided by S. Hayashi (Shiga et al., 1996) was used to 
drive the UAS transgenes specifically in tracheal cells, the twist-Gal4 line 
(obtained from M. Akam) was used to drive expression in mesodermal cells.  
The btlH82∆3 null allele was generated by imprecise excision of the lacZ-
containing P-element inserted upstream of the btl locus. Homozygous btlH82∆3 
mutant embryos did not show any btl transcription but retained βGal expression 
in the tracheal and midline cells (Reichman-Fried et al., 1994). The dof mutant 
(dofP1740) is a lethal P-element enhancer trap insertion in 88C (Vincent et al., 
1998). Using the mentioned btl and dof alleles, a btl,dof double mutant 
chromosome was generated. BnlP1 contains a P[lacZ,ry+] element and 
corresponds to the line l(3)0857 from A. Spradling (Sutherland et al., 1996). For 
the crosses, we additionally used the following marker lines: +/+; 73B/ TM2 
Blue69 (provided by M. Bienz) and L/Cyo; rf10/ TM3 (Ubx lacZ) (a gift from L. 
Keegan). 
 
Thomas B. Kornberg kindly provided the UAS btl-gfp line (Sato and Kornberg, 
2002). The group of E. Hafen provided the Ras effector mutant lines (Halfar et 
al., 2001; Rommel and Hafen, 1998). B. Dickson kindly provided the cDNA of 
Draf to generate the UAS btl-raf construct. The UAS torso4021-btl (UASbtlact) flies 
were provided by S. Leevers and E. Hafen (derived from the hs-torso4021-
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FGFR1 construct described in (Reichman-Fried et al., 1994)). UAS bnl was 
kindly provided by the group of M. Krasnow to ectopically activate FGF 
signalling. The trachealess enhancer trap line 1-eve-1 was used to visualize the 
tracheal cells (Perrimon et al., 1991). UAS rasV12 was provided by E. Hafen 
and N. Perrimon. R. Fehon kindly provided the cdc42 mutant alleles (Fehon et 
al., 1997; Genova et al., 2000) and S. Hakeda-Suzuki provided all rac mutant 
alleles (Hakeda-Suzuki et al., 2002). The following lines are listed in the stocks 
of U. Nussbaumer without further references: #218 UAS dcdc42N17,3, #478 
UAS dracV12,1, #479 UAS dcdc42V12,2, #480 UAS dracL89. UAS rhoV14 and 
UAS rhoN19 were kindly provided by M. Mlodzik and UAS mtlV15 and UAS 
mtlN20 by B. Dickson. J. Xu and M. Goldfarb kindly provided the cDNAs of 
hFGFR2, hFGFR1 and FRS2 (Ong et al., 2000a; Xu et al., 1998). B. Müller from 
the lab of E. Hafen kindly provided the FRT-line: w;P[w+]70C, P[ry+;hs-
neo;FRT] 80B to establish btl mutant mosaic clones. And finally, M. Neumann 
kindly provided the line btl<y+>Gal4, UAS actin-GFP/ Cyo; btlH82∆3/ TM3 for the 
single cell rescue experiment.  
II. Rescue assays 
To test whether the UAS constructs were capable of rescuing the tracheal or 
mesodermal defects of btl, btl,dof, htl, and dof mutant embryos, respectively, 
the following crosses were set up: 
btl-Gal4 transgenic flies (second chromosome insertion) and the Btl derivates 
(UAS c; on the second chromosome) were crossed to L/ Cyo; rf10/ TM3 (Ubx 
lacZ) flies. The progeny btl-Gal4/ Cyo; +/ TM3 (Ubx lacZ) and UAS c/ Cyo; +/ 
TM3 (Ubx lacZ) were crossed to +/ +; btlH82∆3/ TM2 (Blue69) flies. Subsequently, 
btl-Gal4/ +; btlH82∆3/ TM3 (Ubx lacZ) and UAS c/ +; btlH82∆3/ TM3 (Ubx lacZ) flies 
were crossed and the progeny was collected at 25°C for 15 hours and at 18°C 
for 30 hours. The Ubx lacZ marker on the TM3 balancer chromosome was used 
to distinguish between homozygous and heterozygous btl H82∆3 mutant embryos.  
The crosses were repeated using a btl,dof chromosome +/ +; btlH82∆3,dofP1740/ 
TM2 (Blue69) in order to test whether the constructs were able to rescue 
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tracheal defects in btl,dof double mutant embryos under the control of the btl-
Gal4 driver.  
We tested the mesodermal rescue capacity of the UAS constructs following the 
above described strategy. To test whether mesodermal defects could also be 
rescued in dof mutant embryos, we crossed dofP1740 mutant flies to either UAS 
gene c transgenic flies or to twist-Gal4 transgenic flies: UAS c/ +; dofP1740/ + 
flies were further crossed to twist-Gal4/ +; dofP1740/ + flies as it was described 
previously in (Vincent et al., 1998). Embryos were collected at 25°C for 15 
hours. Homozygous dofP1740 mutant embryos were identified either by the lack 
of Eve-expressing cells at the dorsal midline, which indicate defects in 
mesoderm spreading (btl-Gal4 crosses), or by the lack of tracheal cell migration 
(twi-Gal4 crosses). Rescue of mesodermal cell migration was scored with the 
Evenskipped antibody (see main text). 
1. Schematic representation of the crosses 
IA) 
btl GAL-4     +                      L                   rf10                   btl GAL-4        + 
________;_____   X   _________;_____________   →   ________;_________ 
btl GAL-4     +                    Cyo         TM3 (Ubx lacZ)           Cyo       TM3 (Ubx lacZ) 
 
IB) 
UAS c          +                     L                    rf10                   UAS c                + 
________;_____   X   _________;_____________   →   ________;___________ 
UAS c          +                   Cyo          TM3 (Ubx lacZ)          Cyo        TM3 (Ubx lacZ) 
 
IIA) 
btl GAL-4           +                     +      btlH82∆3       btl GAL-4      btlH82∆3 
________;__________   X   _____;_____   →   ________;___________ 
   Cyo     TM3 (Ubx lacZ)          +    TM2 Blue69             +        TM3 (Ubx lacZ) 
 
IIB) 
UAS c             +                        +      btlH82∆3       UAS c            btlH82∆3 
________;__________   X   _____;_____   →   ________;___________ 
   Cyo     TM3 (Ubx lacZ)          +    TM2 Blue69             +        TM3 (Ubx lacZ) 
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III) 
UAS c            btlH82∆3                  btl GAL-4        btlH82∆3                     UAS c     btlH82∆3 
________;____________   X   _________;_____________   →   ________;_______ 
      +        TM3 (Ubx lacZ)                 +          TM3 (Ubx lacZ)          btl GAL-4 btlH82∆3 
 
UAS c         dofP1740      btl GAL-4    dofP1740       btl GAL-4    dofP1740 
_________;_____   X   ________;_____   →   ________;________ 
        +            +                    +           +              UAS c          dofP1740 
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III. Genetic mosaic analysis using the FLP/FRT 
system 
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 Figure 1: The genetic mosaic analysis using the FLP recombination system was carried 
out as it was already performed for spry-/- mosaic mutant cells in the tracheal system 
(Hacohen et al., 1998). Instead of spry-/-, btlH82∆3 was recombined onto the FRT80 
chromosome. e genetic mosaic analysis using the FLP recombination system was carried 
t as it was already performed for spry-/- mosaic mutant cells in the tracheal 
stem (Hacohen et al., 1998).  
e FLP recombination system induces high frequency mosaicism for a 
rticular gene by the use of the FRT sequence from yeast. The FLP 
combinase induces mitotic recombination between the FRT sites located on 
mologous chromosome arms. The FRT sites have to be located closer to the 
ntromere than the gene of interest (Xu and Rubin, 1993) 
Materials and Methods 
 
Recombinant lines were generated using the FRT line w;P[w+]70C, P[ry+;hs-
neo;FRT] 80B and btlH82∆3. Additional recombinants using the same FRT line 
and the 1-eve-1 marker were generated. Flies carrying the P[ry+; hs-neo, FRT] 
element were selected by their resistance to G418 (Geneticin, GIBCO 
laboratories). G418-containing medium was made as follows: a few holes were 
made in the fly medium with toothpicks that was previously heated up in the 
microwave for a few seconds, and 0.2-0.3ml of 25mg/ml freshly prepared G418 
solution was added and mixed. The vials were allowed to dry over night at 
18°C.  
Additionally, the progeny of the recombinant stocks were stained with an anti β-
Gal antibody to visualize the remaining nuclear β-Gal staining of the btlH82∆3 
allele and the cytoplasmic β-Gal of the enhancer trap line 1-eve-1. Homozygous 
mutant btlH82∆3 clones were generated by FLP-mediated recombination in 
heterozygous embryos of the genotype hsFLP; btlH82∆3,FRT/ 1-eve-1, FRT. The 
heterozygous embryos were collected after 6h developing on grape juice plates, 
heat-shocked for 20 minutes at 37°C to induce mitotic recombination and further 
developed at 25°C for another 10h (according to the protocol in (Hacohen et al., 
1998). 
IV. Rac germline clones 
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 Figure 2: Schematic representation of the cross to generate germline clones, which 
are triple mutant for rac1,rac2 and mtl. Mutant females (∆racs, FRT/ TM6 y+) were 
crossed to hs FLP; ovoD / MKRS males. The progeny larvae of the age 24h, 48h, 72h were 
heat-shocked for 1-1,5h at 37°C and the larvae further developed at 25°C until adult stage. 
The developing heat-shocked virgins were collected and crossed back to heterozygous rac
mutant males from the original stocks (see Fig.2). Eggs from the females carrying the 
mutation ovoD do not develop (Pauli et al., 1995). s described in the papers (Hakeda-Suzuki et al., 2002; Xu and Rubin, 1993), 
ermline clones were generated with the mutant lines rac1J11, rac1J10, ∆rac2, 
mtl in different combinations (single, double or triple rac mutant embryos). 
utant females (∆racs, FRT/ TM6 y+) were crossed to hs FLP; ovoD / MKRS 
ales. The progeny larvae of the age 24h, 48h, 72h were heat-shocked for 1-
,5h at 37°C and the larvae further developed at 25°C until adult stage. The 
eveloping heat-shocked virgins were collected and crossed back to 
eterozygous rac mutant males from the original stocks (see Fig.2). Eggs from 
he females carrying the mutation ovoD do not develop (Pauli et al., 1995). 
. Immunohistochemistry 
. Embryo collection and fixation 
mbryos were collected overnight at 25°C for approximately 16h on grape juice 
lates. After collection and dechorionation in 4% chlorax solution they were 
ashed with 120mM NaCl, 0.03% TritonX-100 solution and subsequently fixed 
n 9.6% formaldehyde/heptan solution (1:1) for 15 minutes. The formaldehyde 
olution was replaced by 700µl MeOH and the embryos were heavily shacked 
or 2 min. to remove the viteline membrane. Finally, after removing the Heptane 
olution, the embryos were washed with MeOH several times and stored in 
eOH at -20°C.  
. Protocol of fluorescent antibody stainings 
fter replacing the MeOH with PBST (1,3M NaCl, 0.03M Di-
atriumhydrogenphosphat, 10% Tween-20), the embryos were blocked with 
129
Materials and Methods 
 
400µl 10% BSA in PBST for 45 min. on the slow rotor. In PBST diluted 1° 
antibody was added and incubated 2h at room temperature or at 4°C overnight. 
After washing the embryos 3x 15 min. with PBST, in PBST diluted 2° antibody 
(Peroxidase conjugated antibody usually diluted 1:500) was added and 
incubated for 1h at room temperature. The 2° antibodies were preincubated at 
4°C overnight using wild-type embryos in order to reduce background 
fluorescence.  
Again the embryos were washed 3x 15 min. with PBST. For confocal analysis 
the signal was amplified. 300µl of biotinylated tyramide (NEN Life Science 
Product) (stock solution diluted 1:50 in amplification diluent solution) was added 
and incubated for 10 min. on the slow rotor. Finally, after washing the embryos 
several times, 300µl of Streptavidin conjugated antibody (for example SA-
Fluorescein diluted 1:300) was added and incubated at room temperature for 30 
min. The embryos were washed a last time 3x 15 min. in PBST and mounted 
directly in Vectashield and the coverslip was sealed with nail polish. 
Pay attention when performing fluorescent immunostainings using 2A12. IgG 
antibodies have to be hybridized before the 2A12 IgM antibody. 
Fluorescent images were captured using confocal microscopy (Leica TCS SP2) 
and processed using the Leica TSC NT 1.6 program and Photoshop 7.0 
(Adobe). All images represent projections of sections on one focal plane. 
3. Antibodies 
The following antibodies were used: mouse mAB 2A12 against the lumen of the 
trachea (dilution 1:10; provided by N. Patel), rabbit anti β-galactosidase (dilution 
1:500; Cappel), mouse anti-DSRF (dilution 1:50; Guillemin et al., 1996) and 
mouse anti-Evenskipped (both have to be diluted 1:50; provided by M. Frasch). 
Anti-Fasciclin 3 7910 and mouse anti Crumbs Cq4 (dilution 1:20; 
Developmental studies of Hybridoma Bank, University of Iowa), anti GFP 
(dilution 1:500; MBL) and anti-dpERK (dilution 1:200; SIGMA). 
We used as secondary antibodies peroxidase-conjugated antibodies followed 
by biotinylated-tyramide (NEN Life Science Product), which is recognized by 
streptavidin-Fluorescein or streptavidin-Texas Red. In addition, rabbit anti-Cy3 
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affinity pure F(ab)2 fragments (Jackson) were used as secondary antibodies. 
For the other stainings, we used as secondary antibodies biotinylated anti-
mouse IgG and biotinylated anti-mouse IgM, which were revealed by using the 
biotinylated horseradish peroxidase ABC kit (Vectastain) or by staining for 
alkaline phosphatase activity. 
VI. Molecular biology 
Standard molecular protocols are described in detail in Maniatis (Sambrook et 
al., 1989). The constructs prepared for the rescue assay were generated by 
PCR using the appropriate oligonucleotides and subcloned into the pUASt 
vector to generate transgenic fly lines. For expression in Schneider (S2) cells, 
the cDNAs were cloned into the pMT/V5-HisA vector (Invitrogen) containing the 
heavy metal methalothionein promoter. Commercial kits were used for 
extraction and purification of the plasmid DNA from E. coli (Quiagen or SIGMA). 
All constructs were verified by sequencing (ABI PRIM 310 Genetic Analyzer) 
before embryo injection or before transfection of S2 cells. 
1. Cloning 
1.1 Btl derivates to generate transgenic flies 
Btl derivates were generated by polymerase chain reaction (PCR) using the 
appropriate oligonucleotides. The strategy and oligonucleotides used to 
generate the Btl and Htl chimeric fusion proteins are described in detail in 
(Dossenbach et al., 2001; Vincent et al., 1998).  
Internal deletions of Btl were generated by PCR removing those amino acids, 
which have to be annotated to be part of the domain to be removed. The UAS 
btl construct (kindly provided by B. Shilo and modified by C. Dossenbach) was 
used as template. In a first PCR reaction, a fragment was created with a primer 
containing the Bsu36I restriction site within the btl sequence in 5’-3’ direction 
and a primer designed at the position, where the deletion starts, in 3’-5’ 
direction. A second fragment was generated with the primer designed at the 
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position, where the deletion stops, in 5'-3' direction, and a primer containing the 
Asp718I site of pUASt in 3'-5' direction. The primers creating the deletion should 
have an overlap of 40°C for proper annealing and fusion of the two fragments in 
the second PCR round. 
 
UAS btl ∆JM 1:  deletion from bp 2049-2139 
UAS btl ∆JM 2:  deletion from bp 2139-2223 
UAS btl ∆JM 3:  deletion from bp 2049-2223 
UAS btl ∆KI:  deletion from bp 2566-2631 
UAS btl ∆CT: deletion from bp 3128 on 
 
Primers: 
 
Bsu36 I d  CAGTGTACCTTAGGGTAGTG 
Asp718 c  CGGGGTACCCTCGAGCC 
UAS btl∆JM 1: 
De 2049 c  CGATCCTAACCGTTTCGATGC 
De 2139 d  AACGGTTAGGATCGAGAAGC 
UAS btl∆JM 2: 
De 2139 c  CAGCGGTATCACTGGCATCTG 
De 2223 d  CAGTGATACCGCTGGACTCAAAC 
UAS btl∆JM 3: 
De 2223 db  AACGGTTCCGCTGGACTCAAAC 
De 2049 cb  CAGCGGAACCGTTTCGATGC 
UAS btl∆KI: 
Btl ki c  CGCCAAGACCAGGTCGATTCTG 
Btl ki d  CCTGGTCTTGGCGAAAAGGAG 
 
Deletion of the C-terminus of the btl gene was generated by PCR with the 
primer designed of the XhoI site of btl in 5'-3' direction and a primer introducing 
a stop codon CAG-›TAG at position bp 3128 containing a XhoI site in 3'-5' 
direction. 
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XhoI d  CAAATCGCTCGAGGAATGGAG   
De 3128 c  CCGCTCGAGCTACAGGATCCCATCG 
 
UAS btl∆JM 3+∆CT was generated by introducing a deletion of the C-terminus 
using the previously prepared UAS btl∆JM3 construct as template. 
 
To generate the UAS btl-raf construct, we used the following primers: 
 
Btl EcoRI d  CGGAATTCGACCGCAACTGTAAC 
Raf XbaI c  CTAGTCTAGACTAGATATTCCCAGC 
Btl raf c  GTCGATGCAGCATGAACGTTATG 
Btl raf d  CGTTCATGCTGCATCGACAGGGTCG 
 
And finally, to generate the UAS btl-fgfr2 construct, we used the following 
primers: 
 
Btl EcoRI d  CGGAATTCGACCGCAACTGTAAC 
Fgfr2 XbaI c  GCTCTAGATCATGTTTTAACAC 
Btl fgfr2 c  CATTCGCAGCATGAACGTTATG 
Btl fgfr2 d  CATGCTGCGAATGAAGAACAC 
1.2 Btl derivates to transfect S2 cells 
Ute Nussbaumer subcloned the constitutive active version of Btl in which the 
extracellular and transmembrane domain of torso4021 (Reichman-Fried et al., 
1994) was fused to the intracellular domain of btl derived from the hs tor4021-btl 
cDNA (kindly provided by E. Hafen) into the PMT/V5-HisA vector. This construct 
was used as template for the S2 cell culture assays. The same internal primers 
creating the deletions previously described were used but instead of Bsu36I d 
and Asp 718 c, the following primers were generated.: 
 
Tor4021 DraIII d TACAGGCACACGGTGGAC 
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Btl AvrII c  GTGGACTCCTAGGGAGAC 
For the deletion of the C-terminus: 
De 3128 NotI c TTGCGGCCGCCTACAGGATCCCATCGAAACTC 
 
For generation of the myc-tagged Btl construct, the following strategy was used: 
PUASt carrying the original btl gene was digested with EcoRI and SspI and the 
btl fragment was isolated (bp 421-3316). This insert was triple ligated with a 
PCR amplified fragment containing the Asp 718 site of pUASt, the myc Tag and 
the amino acid sequence of btl until the SspI site and a PMT/V5-HisA vector 
fragment that has been previously digested with Asp 718I and EcoRI (ratio 
vector: insert1: insert2; 1:2:2).  
The following primers were used: 
 
Myc Asp718 d CGGGTACCATGTTCAAGATCCTG 
Btl SspI c  CAGGGAAATATTGTACCATCTG 
Myc btl c  ACTTTTGCGGCGCCCGTTC 
Myc btl d  GGCGCCGCAAAAGTGCCGATC 
 
The kinase dead version of myc-btl was generated by the following strategy 
using the primers described in (Lee et al., 1996): The PMT/V5-HisA vector 
carrying the myc-tagged btl gene was digested with Asp718I and XhoI; the 
isolated vector fragment was subsequently ligated with an insert fragment 
containing part of the btl sequence flanked with the Asp718I and Asp700I sites 
and a PCR fragment that was performed to mutate the highly conserved lysine 
residue within the ATP binding domain to arginine. Unfortunately, the btl 
sequence contained an additional internal XhoI site at position bp 2673 (aa 748) 
and the sequence between the XhoI site of btl and the XhoI site of PMT/V5-
HisA was still missing. Thus the isolated vector construct containing part of the 
btl sequence was recut with XhoI and a small fragment flanked with XhoI sites 
isolated from PMT/V5-HisA myc-btl was subcloned into the vector construct. 
 
Btl Asp700 d  CTCCGCATCGAAACGGTTCATCAGTGG 
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Btl XhoI c  GGTACTCCATTCCTCGAGCGATTTGAA 
Btl K748 c  CTCCTTGACCATCCGGACGGCCACGAT 
Btl K748 d  ATCGTGGCCGTCCGGATGGTCAAGGAG 
 
To generate the PMT/V5-HisA myc-tor4021-fgfr2 construct and the PMT/V5-HisA 
FRS2 construct, we used the following primers: 
 
Tor4021 DraIII d TACAGGCACACGGTGGAC 
Fgfr2 NotI c  TTTATAGCGGCCGCTCATGTTTTAACACTGC 
Tor fgfr2 c  CTTCATTCGGCAGAACGTCAGGG 
Tor fgfr2 d  TCTGCCGAATGAAGAACACG 
FRS2 EcoRI d CGGAATTCATGGGTAGCTGTTG 
FRS2 XhoI c  CCGCTCGAGCATGGGCAGATCAG 
2. The polymerase chain reaction (PCR) 
PCR reactions were carried out in a thermocycler (Techne Thermal Cycler). A 
50µl reaction contained 1µl of each primer (10µM), 10µl polymerase buffer 
(Roche), 200µM dNTP mix, 1µl Pfu Turbo polymerase (Stratagene) or 
Dynazyme (Bioconcepts) and variable amounts of template (100µg/µl). The 
following PCR cycles were applied: 
 
94.5°C 1' 
80°C  1' (add Pfu) 
 
94.5°C 30'' 
35°C  30''  2 cycles 
72°C  (60’’ per 1kb cDNA) 
 
94.5°C 30'' 
50°C  30''  20 cycles 
72°C  (60’’ per 1kb cDNA) 
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72°C  10' 
 
For fragments longer than 1000 bp, the ExpandTM High Fidelity PCR Kit was 
used (according to the protocol from Boehringer Mannheim). 
The PCR reactions were purified (QIAEX gel extraction kit or QIAQUICK PCR 
purification kit from QIAGEN) for further use. 
3. Restriction digests 
4µg of vector was digested overnight at 37°C in a volume of 50µl and 
subsequently dephosphorylated by the alkaline phosphatase (ROCHE) for 
1h at 37°C. The PCR products were digested in a volume of 50µl for 1h at 
37°C. The cDNAs were purified through agarose gel electrophoresis. 
4. Ligation and bacterial transformation 
Ligation (T4 DNA ligase, Biolabs) and bacterial transformations were carried out 
using standard protocols. All vectors carried an ampicillin resistance for 
bacterial selection. E. coli XL1 blue bacteria were used for plasmid 
amplification. The bacterial colonies were amplified in an overnight culture (3ml 
L. Broth medium containing 100µg/µl ampicillin) and the plasmids were isolated 
using a Miniprep kit (Sigma). The presence of an insert was verified by 
restriction digest before isolating large amounts of plasmids (30ml L. Broth 
medium and 100µg/µl ampicillin) following the protocol of the Midiprep kit 
(QIAGEN). 
VII. S2 cell culture assay 
1. Cell transfection 
Drosophila Schneider (S2) cells were cultured at 25°C in Schneider’s 
Drosophila medium (GIBCO) supplemented with 10% heat-inactivated FCS, 2 
mM glutamine, 50 units/ml penicillin and 50 µg/ml streptomycin (complete 
medium). For transfection experiments, 3,5x106 S2 cells were plated per 35mm-
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diameter dish in complete medium. Cells were transiently transfected with 
different combinations of plasmids (0.6 µg total) using the Effectene reagent 
following the manufacturer's instructions (QIAGEN). Protein expression was 
induced 20 hours after transfection by addition of 0.6 mM CuSO4.  
2. Cell lysates 
Cells were lysed in modified RIPA buffer (50 mM Tris pH8, 150 mM NaCl, 1% 
Nonidet P-40, 0.5% Deoxycholate, 0.1% SDS, 0.4 mM EDTA, 10% glycerol, 0.2 
mM sodium orthovanadate, 1mM phenylmethylsulfonyl fluoride (PMSF) and 
Protease Inhibitors Cocktail (ROCHE).  
3. Immunoprecipitation 
For immunoprecipitation assays, cell lysates were precleared with protein G-
Sepharose beads (Amersham Pharmacia) for 3 hours at 4°C on a rocking 
platform and then incubated with the primary antibody overnight at 4°C on a 
rocking platform. Protein-antibody complexes were recovered by incubation with 
protein G-Sepharose beads for 1 hour at 4°C. Bead-bound complexes were 
washed four times with cold lysis buffer and boiled with 2X SDS sample buffer. 
4. Western blots  
For Western blot analysis of total cell lysates, equal amounts of protein were 
separated by SDS-PAGE under reducing conditions, transferred on 
nitrocellulose or PVDF Immobilon (Millipore) membranes and probed using 
appropriate antibodies in 5% dry milk in TBS-T (20 mM Tris-HCl pH 7,6; 150 
mM NaCl, 0.1 % Tween 20). Proteins were visualized using enhanced 
chemiluminescence (ECL kit; Amersham Corp.) following the manufacturer's 
instructions. The following primary antibodies were used for 
immunoprecipitation and Western blot experiments: anti-Myc 9B11 (dilution 
1:1000; Cell Signalling), anti-V5 (dilution 1:5000; Invitrogen), anti-dpERK 
(dilution 1:2000; Sigma), anti-PY20 (dilution1:2000; Transduction Laboratories), 
as secondary antibody we used the anti-mouse HRP P0260 (dilution 1:2000; 
Dako).
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